<SUBMISSION>
<ACCESSION-NUMBER>0001193125-14-395316
<TYPE>424B5
<PUBLIC-DOCUMENT-COUNT>3
<FILING-DATE>20141104
<DATE-OF-FILING-DATE-CHANGE>20141104
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>CLEAN DIESEL TECHNOLOGIES INC
<CIK>0000949428
<ASSIGNED-SIC>3564
<IRS-NUMBER>061393453
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B5
<ACT>33
<FILE-NUMBER>333-181443
<FILM-NUMBER>141191300
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>1621 FISKE PLACE
<CITY>OXNARD
<STATE>CA
<ZIP>93033
<PHONE>805 639 9458
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>1621 FISKE PLACE
<CITY>OXNARD
<STATE>CA
<ZIP>93033
</MAIL-ADDRESS>
</FILER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>d815101d424b5.htm
<DESCRIPTION>424B5
<TEXT>
<HTML><HEAD>
<TITLE>424B5</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Filed Pursuant to Rule 424(b)(5) <BR>Registration No. 333-181443 </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><B>Prospectus Supplement </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><B>(to Prospectus dated May&nbsp;21, 2012) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g815101g16o58.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>CLEAN DIESEL TECHNOLOGIES, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>1,385,000 Shares of Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>388,393 Series A Warrants </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>168,571 Series B Warrants </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:3%; font-size:9pt; font-family:Times New Roman">We are offering
1,385,000 shares of our common stock, warrants to purchase up to 388,393 shares of our common stock (the &#147;Series A Warrants&#148;) and warrants to purchase up to 168,571 shares of our common stock (the &#147;Series B Warrants&#148; and,
together with the Series A Warrants, the &#147;Warrants&#148;) in this offering. Each share of common stock is being sold together as a unit with 0.28 of one Series A Warrant to purchase one share of common stock. Each Series A Warrant is
immediately exercisable to purchase one share of common stock at an exercise price of $3.25 per share for five years from the date of issuance. Each Series B Warrant is immediately exercisable to purchase one share of common stock at an exercise
price of $0.01 per share for six months from the date of issuance. The shares of common stock and the Warrants will be issued separately. There is no established public trading market for the Warrants, and we do not expect a market to develop. In
addition, we do not intend to apply for listing of the Warrants on any national exchanges or other nationally recognized trading system. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:3%; font-size:9pt; font-family:Times New Roman">Our common stock is listed on the NASDAQ Capital Market under the symbol &#147;CDTI.&#148; On November&nbsp;3, 2014, the last reported sale
price of our shares of common stock was $3.17 per share. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:3%; font-size:9pt; font-family:Times New Roman">Based on the reported sale price of $3.91 of our common stock on the NASDAQ
Capital Market on October&nbsp;30, 2014, the aggregate market value of our public float, calculated according to General Instruction I.B.6 of Form S-3, is approximately $48.4 million. Under the registration statement to which this prospectus
supplement forms a part, we may not sell our securities in a primary offering with a value exceeding one-third of our public float in any 12-month period (unless our public float rises to $75.0 million or more). We have offered securities for an
aggregate market value of $10,076,920 during the 12 calendar months preceding and including the date of this prospectus supplement pursuant to General Instruction I.B.6, and, accordingly, may sell up to $6,059,373 in stock and Warrants hereunder.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:3%; font-size:9pt; font-family:Times New Roman">We have engaged Cowen and Company, LLC as our exclusive placement agent in connection with this offering. The placement agent has no
obligation to buy any of the securities from us or to arrange for the purchase or sale of any specific number or dollar amount of securities. See &#147;Plan of Distribution&#148; beginning on page S-15 of this prospectus supplement for more
information regarding these arrangements. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:11pt; font-family:Times New Roman"><B>Investing in
our securities involves a high degree of risk. We refer you to the section entitled &#147;<A HREF="#suptoc815101_3">Risk Factors</A>&#148; on page S-6 of this prospectus supplement and on page 3 of the accompanying prospectus and under similar
sections in the documents we incorporate by reference into this prospectus. </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Per Share and<BR>corresponding<BR>Series&nbsp;A&nbsp;Warrant</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Per&nbsp;Series&nbsp;B<BR>Warrant</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Public Offering Price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.8000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.7900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,348,313.0900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Placement Agent Fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.1960</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.1953</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">304,381.9163</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Proceeds to CDTi (before expenses)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.6040</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.5947</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,043,931.1737</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">We have also agreed to reimburse the placement agent for certain expenses incurred by the placement agent up to an amount not to exceed $80,000. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:3%; font-size:9pt; font-family:Times New Roman">Delivery of the securities is expected to be made on or about November&nbsp;7, 2014. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:3%; font-size:9pt; font-family:Times New Roman"><B>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed
upon the adequacy or accuracy of this prospectus supplement or the accompanying prospectus. Any representation to the contrary is a criminal offense. </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>Cowen and
Company </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Prospectus Supplement dated November&nbsp;4, 2014 </B></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="94%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="4" ALIGN="center"><B>Prospectus Supplement</B></TD>
<TD VALIGN="top"><B>&nbsp;&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suptoc815101_1">ABOUT THIS PROSPECTUS SUPPLEMENT</A></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suptoc815101_2">PROSPECTUS SUPPLEMENT SUMMARY</A></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suptoc815101_3">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suptoc815101_4">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suptoc815101_5">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suptoc815101_6">CAPITALIZATION</A></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suptoc815101_7">DILUTION</A></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suptoc815101_8">MARKET PRICE AND DIVIDEND INFORMATION</A></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suptoc815101_9">DESCRIPTION OF SECURITIES</A></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suptoc815101_10">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suptoc815101_11">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suptoc815101_12">EXPERTS</A></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suptoc815101_13">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suptoc815101_14">INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE</A></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="4" ALIGN="center"><B>Prospectus</B></TD>
<TD VALIGN="top"><B>&nbsp;&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx815101_1">ABOUT THIS PROSPECTUS</A></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx815101_2">ABOUT OUR COMPANY</A></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx815101_3">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx815101_4">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx815101_5">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx815101_6">DILUTION</A></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx815101_7">RATIO OF EARNINGS TO FIXED CHARGES</A></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx815101_8">DESCRIPTION OF COMMON STOCK</A></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx815101_9">DESCRIPTION OF PREFERRED STOCK</A></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx815101_10">DESCRIPTION OF WARRANTS</A></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx815101_11">DESCRIPTION OF UNITS</A></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx815101_12">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx815101_13">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx815101_14">EXPERTS</A></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx815101_15">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx815101_16">INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE</A></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-i </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suptoc815101_1"></A>ABOUT THIS PROSPECTUS SUPPLEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This document is part of a registration statement that we filed with the Securities and Exchange Commission (&#147;SEC&#148;) using a
&#147;shelf&#148; registration process and consists of two parts. The first part is this prospectus supplement, which describes the terms of the securities being offered by us and also adds to and updates information contained in the accompanying
prospectus as well as the documents incorporated by reference into this prospectus supplement and the accompanying prospectus. The second part, the accompanying prospectus, gives more general information about securities we may offer from time to
time. To the extent any inconsistency or conflict exists between the information included in this prospectus supplement and the information included in the accompanying prospectus, the information included or incorporated by reference in this
prospectus supplement updates and supersedes the information in the accompanying prospectus. Generally, when we refer only to the &#147;prospectus,&#148; we are referring to both parts combined. This prospectus supplement incorporates by reference
important business and financial information about us that is not included in or delivered with this prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It is
important for you to read and consider all information contained in this prospectus supplement and the accompanying prospectus in making your investment decision. You should also read and consider the information contained in the documents
identified under the headings &#147;Incorporation of Certain Documents by Reference&#148; and &#147;Where You Can Find More Information.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should rely only on the information provided in this prospectus supplement and the accompanying prospectus, including the information
incorporated by reference. We have not authorized anyone to provide you with different information. You should not assume that the information contained or incorporated by reference in this prospectus supplement or the accompanying prospectus is
accurate as of any date other than as of the date of this prospectus supplement or the accompanying prospectus, as the case may be, or in the case of the documents incorporated by reference, the date of such documents regardless of the time of
delivery of this prospectus supplement and the accompanying prospectus or any sale of our securities. We are not making an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated or the context otherwise requires, references to &#147;Clean Diesel Technologies,&#148; &#147;Clean Diesel,&#148;
&#147;CDTI,&#148; the &#147;Company,&#148; &#147;we,&#148; &#147;our&#148; or &#147;us,&#148; unless the context otherwise requires, refer to Clean Diesel Technologies, Inc. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suptoc815101_2"></A>PROSPECTUS SUPPLEMENT SUMMARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>This summary highlights certain information contained elsewhere in this prospectus supplement or incorporated by reference herein. This
summary does not contain all of the information that you should consider before investing in our securities. You should read the entire prospectus supplement and the accompanying prospectus carefully, including the risks related to our business and
investing in our securities discussed under &#147;Risk Factors&#148; beginning on page&nbsp;S-6 and the other information and documents incorporated by reference into this prospectus supplement, including our consolidated financial statements and
related notes thereto. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a leading technology-focused, global manufacturer and distributor of light duty vehicle catalysts and heavy duty diesel emissions
control systems and products to major automakers, integrators and retrofitters. We have more than 13 years history of supplying catalysts to light duty vehicle original equipment manufacturers, or OEMs, and over 30&nbsp;years of experience in the
heavy duty diesel systems market. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We organize our operations in two primary divisions: our Catalyst division and our Heavy Duty Diesel
Systems division. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I><U>Catalyst</U></I>: Our Catalyst division develops and produces catalysts to reduce emissions from gasoline, diesel
and natural gas combustion engines. Most catalytic systems require significant amounts of costly platinum group metals, or PGMs, to operate efficiently. Using our proprietary mixed-phase catalyst, or MPC
<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, technology, we have developed a family of unique high-performance catalysts, featuring inexpensive base-metals with low or even no PGM content. Our technical and manufacturing capabilities
have been established to meet auto makers&#146; most stringent requirements. Since 2001, we have supplied over eleven million parts to light duty vehicle customers. Our Catalyst division also provides catalyst products for our Heavy Duty Diesel
Systems division. Revenues from our Catalyst division accounted for approximately 43% and 44% of the total consolidated revenues for the six months ended June&nbsp;30, 2014 and 2013, respectively. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I><U>Heavy Duty Diesel Systems</U></I>: Our Heavy Duty Diesel Systems division specializes in the design and manufacture of verified exhaust
emissions control solutions. This division offers a full range of products for the verified retrofit and non-retrofit OEM and replacement markets through its distribution/dealer network and direct sales. Our DuraFit&#153;, Purifilter<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Purifier&#153;, Combifilter<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Cattrap<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> and Actifilter&#153; products, along with
our catalyst technologies, are used to reduce exhaust emissions created by on-road, off-road and stationary diesel, and alternative fuel engines including propane and natural gas. We also provide Platinum Plus <SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP> fuel-borne catalyst technology, ARIS<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> airless return flow system technology and exhaust gas recirculation with selective catalyst
reduction technologies. Revenues from our Heavy Duty Diesel Systems division accounted for approximately 57% and 56% of the total consolidated revenues for the six months ended June&nbsp;30, 2014 and 2013, respectively. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are headquartered, in Oxnard, California and have operations in the United States, Canada, the United Kingdom, France, Japan and Sweden. We
also have an Asian investment. Our proprietary catalyst products are manufactured at our facility in Oxnard, California and our heavy duty diesel systems and products are manufactured at our facilities in Thornhill, Canada and Malm&ouml;, Sweden.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recent Developments </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Sale of Reno Specialty
Exhaust Parts Business </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;20, 2014, we and two of our indirect subsidiaries, ECS Holdings, Inc. (&#147;ECS
Holdings&#148;) and Engine Control Systems Ltd. (&#147;ECS Reno&#148;), entered into and closed the transactions contemplated by an asset purchase agreement with SES USA Inc. (&#147;SES&#148;), an entity affiliated with Shuttleworth Exhaust Systems
Inc. which was divested by ECS Holdings in 2007 and is a distributor of our products. Pursuant to the asset purchase </P>
 <P STYLE="margin-top:0pt;margin-bottom:0pt; font-size:8pt">&nbsp;</P></div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
agreement, we sold certain assets comprising ECS Reno&#146;s business of manufacturing, assembling and supplying custom fabricated exhaust parts and accessories (the &#147;Business&#148;) to SES.
SES paid us approximately $1.3 million in cash, subject to post-closing adjustment, for ECS Reno&#146;s assets comprising the Business and the assumption of specified liabilities. The Business formerly operated as part of our Heavy Duty Diesel
Systems division. For the nine months ended September&nbsp;30, 2014, the Business contributed revenue of approximately $2.8 million and less than $0.2 million of operating profit. The Business sold to SES will be classified as assets held for sale
and discontinued operations in our financial statements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the sale of ECS Reno&#146;s assets comprising the Business,
ECS Reno and Faunus Group International, Inc. (&#147;FGI&#148;), entered into an agreement to terminate a Sale of Accounts and Security Agreement, dated February&nbsp;14, 2011, among ECS Reno and FGI, as amended, pursuant to which we made a final
payment of $350,137 to FGI and FGI agreed to release encumbrances on Reno ECS&#146;s personal property. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Business Strategy Update </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In August 2014, we officially launched our <I>DuraFit</I> product which is intended to address the diesel particular filter (DPF) replacement
market. We believe that demand for <I>DuraFit</I> and retrofit products will be stronger in the fourth quarter ending December&nbsp;31, 2014, but that demand for retrofit products will decline in succeeding quarters. In response to the slowdown in
our retrofit business, we have streamlined staffing to better align our cost structure with the anticipated softening demand. Combined with other measures, we believe these actions will result in an estimated annual reduction in manufacturing and
operating expense of approximately $1.2 million. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Preliminary Financial Results for Continuing Operations for the Third Quarter of 2014 </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our revenue from continuing operations in the third quarter ended September&nbsp;30, 2014 was $9.3 million compared to $13.3 million for the
prior year quarter. Including discontinued operations, revenue was $10.3 million for the third quarter ended September&nbsp;30, 2014 and $14.2 million for the third quarter ended September&nbsp;30, 2013. The lower revenue was largely due to a sharp
downturn in retrofit demand at a time when <I>DuraFit</I> sales had not yet begun to ramp up. As a result, we expect to report a third quarter operating loss from continuing operations of between approximately $2.0 million and $2.5 million,
including approximately of $0.8 million related to severance and other charges. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Vehicle-Exhaust Cleaning Patents </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;30, 2014, we announced that we were awarded two patents by the United States Patent and Trademark Office covering our new
technology that is intended to replace platinum group metals and rare earth metals in catalytic converters. These patents represent the first of what we believe to be a family of patents for our
Spinel<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> technology, a clean emissions exhaust technology intended to reduce the cost of attaining more stringent clean air standards. We anticipate that the new technology will power multiple
catalytic product lines that we believe have the potential to have a significant impact on the traditional platinum-based or rare earth based device industry. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Director Update </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Long-time
director, Charles&nbsp;R. Engles, Phd., has informed the Company that he is considering resigning from the Board of Directors, in light of his association with Stillwater Mining, a company that produces the platinum group precious metals used in
catalytic converters. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Company Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our principal executive offices are located at 1621 Fiske Place, Oxnard, California 93033 and our telephone number at that location is
(805)&nbsp;639-9458. We maintain an Internet website at www.cdti.com. Information contained in or accessible through our website does not constitute part of this prospectus supplement. </P>
 <P STYLE="margin-top:0pt;margin-bottom:0pt; font-size:8pt">&nbsp;</P></div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The Offering </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE="margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Issuer </P></TD>
<TD>Clean Diesel Technologies, Inc. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE="margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Common stock offered </P></TD>
<TD>1,385,000 shares of our common stock, plus 556,964 shares of our common stock underlying the Warrants offered pursuant to this offering. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE="margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Warrants offered </P></TD>
<TD>388,393 Series A Warrants and 168,571 Series B Warrants. Each share of common stock is being sold with 0.28 of one Series A Warrant. The Series A Warrants can be exercised immediately for $3.25 per share until five years from the date of
issuance. The Series B Warrants can be exercised immediately for $0.01 per share until six months from the date of issuance. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">This prospectus supplement also relates to the offering of the shares of common stock issuable upon exercise of the Warrants. There is no established public trading market for the Warrants, and we do not expect a market
to develop. In addition, we do not intend to apply for listing of the Warrants on any national securities exchange or other nationally recognized trading system. See &#147;Description of Securities&#148; on page S-13. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE="margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Common stock to be outstanding immediately following this offering(1) </P></TD>
<TD>13,921,071 shares, or approximately 14,476,349 shares of our common stock if the Warrants offered pursuant to this offering are exercised in full, assuming all of the Series A Warrants are exercised for cash and an average trading price of $1
per share for the five trading days preceding the date of exercise with respect to the Series&nbsp;B Warrants. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE="margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Use of proceeds </P></TD>
<TD>We estimate that the net proceeds from the sale of our securities in this offering will be approximately $3.8&nbsp;million, after deducting placement agent fees and expense reimbursements and our estimated expenses related to this offering and
assuming no exercise of the Series A Warrants. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">We intend to use the net proceeds from this offering for general corporate purposes, which may include working capital, general and administrative expenses, capital expenditures and implementation of our strategic
priorities. See &#147;Use of Proceeds&#148; on page S-9. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE="margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Risk factors </P></TD>
<TD>This investment involves a high degree of risk. See &#147;Risk Factors&#148; for a discussion of factors you should consider carefully before making an investment decision. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE="margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">NASDAQ Capital Market ticker symbol </P></TD>
<TD>CDTI. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">The number of shares outstanding immediately following the offering is based on 12,536,071 shares of common stock outstanding as of October&nbsp;31, 2014 and excludes as of such date unless otherwise noted:
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">452,920 shares of common stock subject to outstanding options with a weighted average exercise price of $9.23 per share; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">392,322 shares subject to unvested restricted stock units with a weighted average grant date fair value of $2.83 per share; </TD></TR></TABLE>
 <P STYLE="margin-top:0pt;margin-bottom:0pt; font-size:8pt">&nbsp;</P></div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">16,667 shares subject to vested and unissued restricted stock units with a weighted average grant date fair value of $2.65 per share; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">1,141,676 shares of common stock issuable upon exercise of outstanding warrants (which does not include the Warrants offered hereby) at an average weighted exercise price of $3.77 per share; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">250,000 shares of common stock potentially issuable upon the conversion of convertible notes; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">152,211 shares reserved for future issuance under our equity incentive plan; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the shares of common stock issuable upon the exercise of the Warrants offered hereby. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Summary Consolidated Financial Data </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth our summary consolidated financial data for the periods indicated. We have derived our summary consolidated
statement of operations data for the years ended December&nbsp;31, 2012 and 2013 and summary consolidated balance sheet data as of December&nbsp;31, 2013 from our audited consolidated financial statements included in our annual report on Form 10-K
for the year ended December&nbsp;31, 2013 and incorporated by reference in this prospectus supplement. The summary consolidated statement of operations data presented below for the six-month periods ended June&nbsp;30, 2013 and 2014 and summary
consolidated balance sheet data as of June&nbsp;30, 2014 have been derived from our unaudited financial statements, which include, in the opinion of management, all adjustments (consisting only of normal recurring adjustments) necessary to present
fairly the information presented. The results for the six months ended June&nbsp;30, 2014 are not necessarily indicative of the results to be expected for the entire fiscal year. You should read this information together with &#147;Management&#146;s
Discussion and Analysis of Financial Condition and Results of Operations&#148; and the financial statements and related notes incorporated by reference into this prospectus supplement. Our historical results are not necessarily indicative of the
results to be expected in any future period. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Consolidated Statement of Operations Data (in thousands, except per share data): </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="59%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended<BR>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Six Months Ended</B><br><B>June&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2012</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2013</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2013</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">60,537</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">55,284</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">25,862</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">25,053</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost of revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,816</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39,880</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,499</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,226</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss from continuing operations(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,694</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,780</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,508</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,985</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss per share:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD COLSPAN="9" VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss from continuing operations per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1.34</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.82</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.48</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.45</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1.34</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.86</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.48</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.46</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Consolidated Balance Sheet Data (in thousands): </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="70%"></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of<BR>December&nbsp;31,<BR>2013</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of<BR>June&nbsp;30,<BR>2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,909</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,558</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Working capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,126</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,190</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indebtedness</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,807</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stockholders&#146; equity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,446</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,596</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">On October&nbsp;1, 2009, the Company sold all significant assets of Applied Utility Systems, Inc., a provider of solutions for the clean and efficient utilization of fossil fuels, for cash and contingent consideration,
which has not yet been earned and will not be paid. The (loss) income, net of tax, of the remaining assets is presented as discontinued operations. </TD></TR></TABLE>
 <P STYLE="margin-top:0pt;margin-bottom:0pt; font-size:8pt">&nbsp;</P></div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suptoc815101_3"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should carefully consider the risk factors set forth below, under the caption &#147;Risk Factors&#148; in the accompanying prospectus and
under the caption &#147;Risk Factors&#148; in our Annual Report on Form 10-K for the fiscal year ended December&nbsp;31, 2013, which is incorporated by reference in this prospectus supplement and the accompanying prospectus. See &#147;Where You Can
Find More Information&#148; and &#147;Incorporation of Certain Documents by Reference.&#148; Before making any investment decision, you should carefully consider these risks as well as other information we include or incorporate by reference in this
prospectus supplement and the accompanying prospectus. The risks and uncertainties we describe are not the only ones facing us. Additional risks and uncertainties that we are unaware of or that we believe are not material at the time could also
materially adversely affect our business, financial condition or results of operations. In any case, the value of our common stock could decline, and you could lose all or part of your investment. See also the information contained under the heading
&#147;Cautionary Statement Regarding Forward-Looking Statements&#148; immediately below. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our ability to achieve profitability and positive cash
flows from operations could depend on reductions in operating costs, which may not be achievable, or increased sales, which may not occur. In addition, we may require additional capital to maintain our operations though there can be no assurance
funding from outside sources will be available on acceptable terms or at all, or, if available, that such funding will not result in dilution to our shareholders. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have incurred losses, have not experienced positive cash flows from operations in the past and our independent registered public accounting
firm expressed substantial doubt about our ability to continue as a going concern in their report on our financial statements for the period ended December&nbsp;31, 2013. Our ability to achieve profitability and positive cash flows from operations,
or finance negative cash flow from operations, could depend on reductions in our operating costs, which may not be achievable, or from increased sales, which may not occur. We have $4.5 million of debt due in 2015 and another $3.0 million of debt
that is callable during 2015, which if not restructured could all be due in 2015. We could require additional working capital to maintain our operations in the form of funding from outside sources which may be limited, difficult to obtain, or
unavailable on acceptable terms or not available at all, or in the case of an offering of common stock or securities convertible into or exercisable for common stock, may result in dilution to our existing stockholders. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>There has been and may continue to be significant volatility in the volume and price of our common stock on the NASDAQ Capital Market. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The market price of our common stock has been and may continue to be highly volatile. Factors, including announcements of new business
initiatives, technological innovations by us or other companies, regulatory matters, new or existing products or procedures, concerns about our financial position, operations results, litigation, government regulation, developments or disputes
relating to agreements, patents or proprietary rights, may have a significant impact on the market volume and price of our stock. Unusual trading volume in our shares occurs from time to time. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We have not paid and do not intend to pay dividends on shares of our common stock. Investors in this offering may never obtain a return on their
investment. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have not paid dividends on our common stock since inception, and do not intend to pay any dividends to our
stockholders in the foreseeable future. We intend to reinvest earnings, if any, in the development and expansion of our business. Accordingly, you will need to rely on sales of your common stock after price appreciation, which may never occur, in
order to realize a return on your investment. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Since we have broad discretion in how we use the proceeds from this offering, we may use the proceeds
in ways with which you disagree. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our management will have significant flexibility in applying the net proceeds of this offering.
You will be relying on the judgment of our management with regard to the use of these net proceeds, and you will not have </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the opportunity, as part of your investment decision, to assess whether the proceeds are being used appropriately. It is possible that the net proceeds will be invested in a way that does not
yield a favorable, or any, return for us. The failure of our management to use such funds effectively could have a material adverse effect on our business, financial condition, prospects, financial condition, operating results and cash flow. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>You will experience immediate dilution in the book value per share of the common stock you purchase. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because the public offering price per share of common stock is expected to be substantially higher than the book value per share of our common
stock, you will suffer substantial dilution in the net tangible book value of the common stock you purchase in this offering. Based on the public offering price of $2.80 per share and corresponding Series A Warrant, if you purchase shares of common
stock and Warrants in this offering, you will suffer immediate and substantial dilution of approximately $2.48 per share in the net tangible book value of the common stock you acquire. In the event that you exercise your Warrants, you will
experience additional dilution to the extent that the exercise price of those Warrants is higher than the book value per share of our common stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We are limited, and may be further limited by this offering, from taking advantage of our significant U.S. federal tax loss carryforwards and tax
credits. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;15, 2010, we completed a business combination with CSI when our wholly-owned subsidiary merged with and
into CSI, which we refer to herein as the Merger. In connection with the Merger, we performed a study to evaluate the status of net operating loss carryforwards as a result of the Merger. Because the Merger caused an &#147;ownership change&#148; (as
defined for U.S.&nbsp;federal income tax purposes) as of the date of the Merger, our ability to use our net operating losses and credits in future tax years has been significantly limited. In addition, due to the &#147;ownership change,&#148; our
federal research and development credits have also been limited and, consequently, we do not anticipate being able to use any of these credits that existed as of the date of the Merger in future tax years. In addition, this offering, alone or in
combination with other previous offerings of our equity securities, may further limit our ability to use our net operating losses and credits in future tax years. Our limited ability to use these net operating losses and tax credits could have an
adverse effect on our results of operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Anti-takeover provisions could negatively impact our stockholders. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Provisions of Delaware law and provisions of our restated certificate of incorporation, as amended, and by-laws could make it more difficult
for a third party to acquire control of us or have the effect of discouraging a third party from attempting to acquire control of us. Additionally, our restated certificate of incorporation, as amended, authorizes our board of directors to issue
series of preferred stock and such preferred stock could be issued as a defensive measure in response to a takeover proposal. These provisions could make it more difficult for a third party to acquire us even if an acquisition might be in the best
interest of our stockholders. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>There is no public market for the Warrants to purchase common stock in this offering. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There is no established public trading market for the Warrants being offered in this offering, and we do not expect a market to develop. In
addition, we do not intend to apply to list the Warrants on any securities exchange. Without an active market, the liquidity of the Warrants will be limited. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Holders of our Warrants will have no rights as a common stockholder until such holders exercise their Warrants and acquire our common stock.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Until holders of the Warrants acquire shares of our common stock upon exercise of the Warrants, holders of the Warrants will have
no rights with respect to the shares of our common stock underlying such Warrants. Upon exercise of the Warrants, the holders thereof will be entitled to exercise the rights of a common stockholder only as to matters for which the record date occurs
after the exercise date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suptoc815101_4"></A>CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus supplement and the information incorporated by reference in this prospectus supplement include &#147;forward-looking statements&#148; within
the meaning of Section&nbsp;27A of the Securities Act of 1933, as amended, (the &#147;Securities Act&#148;), and Section&nbsp;21E of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;). Without limiting the foregoing, the
words &#147;may,&#148; &#147;believe,&#148; &#147;may,&#148; &#147;could,&#148; &#147;might,&#148; &#147;possible,&#148; &#147;potential,&#148; &#147;project,&#148; &#147;will,&#148; &#147;should,&#148; &#147;expect,&#148; &#147;intend,&#148;
&#147;plan,&#148; &#147;predict,&#148; &#147;anticipate,&#148; &#147;estimate,&#148; &#147;approximate,&#148; &#147;contemplate&#148; or &#147;continue&#148;&nbsp;&#147;target,&#148; &#147;goal&#148; and similar expressions are intended to identify
forward-looking statements, although not all forward-looking statements contain these words. All forward-looking statements included in this prospectus supplement are based on information available to us up to, and including, the date of this
document, and we assume no obligation to update any such forward-looking statements to reflect events or circumstances that arise after the date hereof. Our actual results could differ materially from those anticipated in these forward-looking
statements as a result of certain important factors, including those contained in or incorporated by reference into this prospectus supplement. You should carefully review those factors and also carefully review the risks outlined in other documents
that we file from time to time with the SEC. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suptoc815101_5"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We estimate that the net proceeds from the sale of the Shares of our common stock and Warrants to purchase shares of common stock in this
offering will be approximately $3.8 million, after deducting the placement agent&#146;s fees and our estimated expenses related to this offering. In addition, we may receive proceeds of up to $1.2&nbsp;million if the Series A Warrants issued in this
offering are exercised for cash. We intend to use the net proceeds from this offering for general corporate purposes, which may include working capital, general and administrative expenses, capital expenditures and implementation of our strategic
priorities. We may also use a portion of the net proceeds to acquire or invest in businesses, products and technologies that are complementary to our current business, although we have no present commitments or agreements for any such transactions.
Pending the application of the net proceeds, we may invest the proceeds in short-term, interest bearing, investment-grade marketable securities or money market obligations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of the date of this prospectus supplement, we cannot specify with certainty all of the particular uses of the proceeds from this offering.
Accordingly, we will retain broad discretion over the use of such proceeds. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suptoc815101_6"></A>CAPITALIZATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth our cash and cash equivalents and our consolidated capitalization as of June&nbsp;30, 2014 (i)&nbsp;on an
actual basis, and (ii)&nbsp;on an as adjusted basis to give effect to the issuance of the securities offered hereby, assuming no exercise of the Warrants. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should read the following table in conjunction with the section entitled &#147;Management&#146;s Discussion and Analysis of Financial
Condition and Results of Operations&#148; and our financial statements and notes included in our Annual Report on Form 10-K for the year ended December&nbsp;31, 2013 and our Quarterly Reports on <FONT STYLE="white-space:nowrap">Form&nbsp;10-Q</FONT>
for the periods ended March&nbsp;31, 2014 and June&nbsp;30, 2014, which are incorporated by reference in this prospectus supplement and the accompanying prospectus. See &#147;Incorporation of Certain Documents by Reference&#148; and &#147;Where You
Can Find More Information.&#148; </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="78%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As&nbsp;of&nbsp;June 30,&nbsp;2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Actual</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As&nbsp;Adjusted(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(In thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,558</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">12,348</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Borrowings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Line of credit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,432</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,432</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8% shareholder note due 2015</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,607</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,607</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8% subordinated convertible shareholder notes due 2016</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8% shareholder note due 2015</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,975</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,975</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total borrowings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stockholders&#146; equity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preferred stock, par value $0.01 per share: authorized 100,000; no shares issued and outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock, par value $0.01 per share: authorized 24,000,000; 12,412,336 shares issued and outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">124</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">138</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional paid-in capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">197,107</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,883</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated other comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(891</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(891</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(186,744</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(186,744</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stockholders&#146; equity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,596</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,386</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total capitalization</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">20,610</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">24,400</TD>
<TD NOWRAP VALIGN="bottom">(2)&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Assumes that 1,385,000 shares of our common stock and Series A Warrants to purchase 388,393 shares of common stock are sold in this offering at $2.80 per share and corresponding Series A Warrant and Series B Warrants to
purchase up to 168,571 shares of common stock are sold in this offering at $2.79 per Series B Warrant and that the net proceeds thereof are approximately $3.8&nbsp;million after deducting placement agent fees and expense reimbursements and our
estimated expenses. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Assuming the exercise of all of the Series A Warrants issued in this offering for cash, total capitalization would increase by $1.2&nbsp;million, resulting in total capitalization of $25.6&nbsp;million as of
June&nbsp;30, 2014, on an as adjusted basis. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suptoc815101_7"></A>DILUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you invest in our common stock and Warrants, your ownership interest will be diluted to the extent of the difference between the public
offering price per share of common stock that you pay and the as adjusted net tangible book value per share of our common stock immediately after this offering. Net tangible book value per share represents the amount of our total tangible assets
less total liabilities, divided by the number of shares of common stock outstanding. Dilution in the as adjusted net tangible book value per share represents the difference between the amount per share of common stock paid by purchasers in this
offering and the as adjusted net tangible book value per share of common stock immediately after the consummation of this offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of
June&nbsp;30, 2014, our historical net tangible book value was approximately $576 thousand, or $0.05 per share. After giving effect to this offering and the receipt of $3.8&nbsp;million of estimated net proceeds from this offering, our as adjusted
net tangible book value as of June&nbsp;30, 2014 would have been approximately $4.3&nbsp;million, or approximately $0.32 per share. This represents an immediate increase in net tangible book value of $0.27 per share to existing stockholders and an
immediate and substantial dilution in net tangible book value of $2.48 per share to new investors participating in this offering. The following table illustrates this per share dilution: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="91%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Public offering price per share of common stock and corresponding Series A Warrant</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Historical net tangible book value per share as of June&nbsp;30, 2014</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.05</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Increase in net tangible book value per share attributable to this offering</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjusted net tangible book value per share after giving effect to this offering</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dilution per share to new investors</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The discussion and table above exclude, as of June&nbsp;30, 2014, unless otherwise noted: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">538,036 shares of common stock subject to outstanding options with a weighted average exercise price of $8.59 per share; </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">462,883 shares subject to unvested restricted stock units and vested and unsettled restricted stock units with a weighted average grant date fair value of $2.87 per share; </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">1,151,535 shares of common stock issuable upon exercise of outstanding warrants (which does not include the Warrants offered hereby) at an average weighted exercise price of $3.76 per share; </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">250,000 shares of common stock potentially issuable upon the conversion of convertible notes; </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">136,936&nbsp;shares of common stock reserved for future issuance under our Stock Incentive Plan; and </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the shares of common stock issuable upon the exercise of the Warrants offered hereby. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-11 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suptoc815101_8"></A>MARKET PRICE AND DIVIDEND INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Market Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our common stock is
traded on the NASDAQ Capital Market under the symbol &#147;CDTI.&#148; The following table sets forth the high and low trading prices of our common stock on the NASDAQ Capital Market for each of the periods listed. Prices indicated below with
respect to our share price include inter-dealer prices, without retail mark up, mark down or commission and may not necessarily represent actual transactions. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="72%"></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>NASDAQ&nbsp;Capital&nbsp;Market</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>&nbsp;&nbsp;&nbsp;&nbsp;High&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>&nbsp;&nbsp;&nbsp;&nbsp;Low&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><U>2012</U></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1<SUP STYLE="font-size:85%; vertical-align:top">st</SUP> Quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5.28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2<SUP STYLE="font-size:85%; vertical-align:top">nd</SUP> Quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4.20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.93</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3<SUP STYLE="font-size:85%; vertical-align:top">rd</SUP> Quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3.35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> Quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3.04</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><U>2013</U></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1<SUP STYLE="font-size:85%; vertical-align:top">st</SUP> Quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3.05</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2<SUP STYLE="font-size:85%; vertical-align:top">nd</SUP> Quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3<SUP STYLE="font-size:85%; vertical-align:top">rd</SUP> Quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.08</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> Quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><U>2014</U></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1<SUP STYLE="font-size:85%; vertical-align:top">st</SUP> Quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7.39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2<SUP STYLE="font-size:85%; vertical-align:top">nd</SUP> Quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3.48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3<SUP STYLE="font-size:85%; vertical-align:top">rd</SUP> Quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.81</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> Quarter (through November 3, 2014)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3.97</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On November&nbsp;3, 2014 the last reported sale price for our common stock as quoted on the NASDAQ Capital
Market was $3.17 per share. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Dividends </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We plan to retain any earnings for the foreseeable future for our operations. We have never paid any dividends on our common stock and do not
anticipate paying any cash dividends in the foreseeable future. Any future determination to pay cash dividends will be at the discretion of our board of directors and will depend on our financial condition, operating results, capital requirements
and such other factors as our board of directors deems relevant. In addition, our credit facility restricts our ability to pay dividends. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-12 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suptoc815101_9"></A>DESCRIPTION OF SECURITIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are offering 1,385,000 shares of our common stock, Series A Warrants to purchase up to 388,393 shares of common stock, and Series B
Warrants to purchase up to 168,571 shares of common stock. Each share of common stock is being sold together as a unit with 0.28 of one Series A Warrant to purchase one share of common stock. Each Series A Warrant is immediately exercisable to
purchase one share of common stock at an exercise price of $3.25 per share for five years from the date of issuance. Each Series B Warrant is immediately exercisable to purchase one share of common stock at an exercise price of $0.01 per share for
six months from the date of issuance. The shares of common stock and Warrants will be issued separately. This prospectus supplement also relates to the offering of shares of our common stock upon exercise, if any, of the Warrants. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The material terms and
provisions of our common stock are described under the caption &#147;Description of Common Stock&#148; starting on page 4 of the accompanying prospectus. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Warrants </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>The following summary of
certain terms and provisions of Warrants that are being offered hereby is not complete and is subject to, and qualified in its entirety by the provisions of the Warrants, the forms of which will be included as exhibits to a Current Report on Form
8-K to be filed by us with the SEC in connection with this offering. Prospective investors should carefully review the terms and provisions of the form of Warrants for a complete description of the terms and conditions of the Warrants</I>. <I>
</I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Duration and Exercise Price </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Series A Warrants offered hereby will entitle the holder thereof to purchase up to an aggregate of 388,393 shares of common stock at an
initial exercise price per share of $3.25, commencing upon the date of issuance, and will expire five years from the date of issuance. The Series B Warrants offered hereby will entitle the holder thereof to purchase up to an aggregate of 168,571
shares of common stock at an initial exercise price per share of $0.01, commending upon the date of issuance, and will expire six months from the date of issuance. The Warrants will be issued separately from the common stock, and may be transferred
separately immediately thereafter. Warrants will be issued in certificated form only. The exercise price is subject to appropriate adjustment in the event of (1)&nbsp;payment of a common stock dividend or other distribution on any class of capital
stock that is payable in shares of common stock; (2)&nbsp;subdivisions of outstanding shares of common stock into a larger number of shares; or (3)&nbsp;combinations of outstanding shares of common stock into a smaller number of shares. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Exercisability </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Series A
Warrants will be exercisable, at the option of each holder, in whole or in part, by delivering to us a duly executed exercise notice accompanied by payment in full for the number of shares of common stock purchased upon such exercise. Only if the
registration statement of which this prospectus forms a part, or other applicable registration statement, covering the issuance of the shares of common stock issuable upon exercise of the Series A Warrants is not available for such issuance, the
holder may exercise the Series A Warrant in whole or in part on a cashless basis. The Series B Warrants may only be exercised on a cashless basis. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Transferability </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to
applicable laws and any restrictions on transfer set forth in the Warrant, Warrants may be transferred at the option of the holder upon surrender of the Warrants to us together with the appropriate instruments of transfer. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Exchange Listing </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There is no
established public trading market for the Warrants, and we do not expect a market to develop. We do not intend to apply to list the Warrants on any securities exchange. Without an active market, the liquidity
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-13 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of the Warrants will be limited. In addition, in the event the price of our common stock does not exceed the per share exercise price of the Warrants during the period when the Warrants are
exercisable, the Warrants will not have any value. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Pro Rata Distributions </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If, at any time while the Warrants are outstanding, we distribute to our common stockholders for no consideration (1)&nbsp;evidences of our
indebtedness, (2)&nbsp;any security (other than payment of a common stock dividend or other distribution on any class of capital stock that is payable in shares of common stock), (3)&nbsp;rights or warrants to subscribe for or purchase any security,
or (4)&nbsp;any other asset (including cash) (in each case, &#147;Distributed Property&#148;), then each holder of a Warrant shall receive with respect to the shares of common stock issuable upon exercise of such Warrant the Distributed Property
that such holder would have been entitled to receive had the holder been the record holder of such number of shares of common stock issuable upon exercise of the Warrant immediately prior to the record date for such Distributed Property. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Fundamental Transactions </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If, at
any time while the Warrants are outstanding, (1)&nbsp;we consolidate or merge with or into another entity in which the Company is not the surviving entity; (2)&nbsp;we sell all or substantially all of our assets, other than a sale of our engine
control systems division or catalyst division or components thereof; (3)&nbsp;any tender offer or exchange offer (whether completed by us or a third party) is completed pursuant to which holders of a majority of the outstanding shares of our common
stock tender or exchange their shares for securities, cash or other property; (4)&nbsp;we effect any reclassification of our common stock or compulsory share exchange pursuant to which outstanding common stock is effectively converted or exchange
for other securities, cash or property or (5)&nbsp;any transaction is consummated whereby any person or entity acquires more than 50% of the Company&#146;s outstanding common stock (each, a &#147;Fundamental Transaction&#148;), then upon any
subsequent exercise of a Warrant, the holder thereof will have the right to receive the same amount and kind of securities, cash or other property as it would have been entitled to receive upon the occurrence of such Fundamental Transaction if it
had been, immediately prior to such Fundamental Transaction, the holder of the number of shares then issuable upon exercise of the Warrant (the &#147;Alternate Consideration&#148;). The Company shall not effect any such Fundamental Transaction
unless any successor to the Company, surviving entity or the corporation purchasing or otherwise acquiring such assets or other appropriate corporation or entity shall assume the obligation to deliver to the holders of the Warrants such Alternate
Consideration as the holders of the Warrants may be entitled to purchase. However, each Warrant holder may require the Company or any successor entity to pay the Warrant holder within 90 days of the Fundamental Transaction an amount of cash equal to
the Black Scholes Option Pricing Model obtained from the &#147;OV&#148; function on Bloomberg as of the day immediately following the public announcement of the applicable Fundamental Transaction. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Exercise Limitation </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A holder may
not exercise its Warrants if, after giving effect to the exercise, the holder and certain related parties would beneficially own more than 9.99% of our common stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Right as a Shareholder </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The holder
of a Warrant does not generally have the rights or privileges of a holder of our common stock, including any voting rights, until it exercises his, her or its Warrants. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Waivers and Amendments </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as
otherwise provided in the Warrants, we may not may amend or fail to observe the terms of the Warrants without the consent of the applicable holder of each such Warrant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-14 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suptoc815101_10"></A>PLAN OF DISTRIBUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cowen and Company, LLC, which we refer to as the placement agent, has agreed to act as the exclusive placement agents in connection with this
offering subject to the terms and conditions of a placement agent agreement, dated November&nbsp;4, 2014. The placement agent may engage selected dealers to assist in the placement of the shares and Warrants. The placement agent is not purchasing or
selling any shares and Warrants offered by this prospectus supplement and the related prospectus, nor is it required to arrange the purchase or sale of any specific number or dollar amount of the shares and Warrants, but has agreed to use its
commercially reasonable &#147;best efforts&#148; to arrange for the sale of all of the shares and Warrants offered hereby. We will enter into a subscription agreement directly with each investor in connection with this offering and we may not sell
the entire amount of shares or Warrants offered pursuant to this prospectus supplement and the related prospectus. The public offering price of the shares and Warrants offered hereby has been determined based upon arm&#146;s-length negotiations
between each purchaser and us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The placement agent proposes to arrange for the sale to one or more purchasers of the shares and Warrants
offered pursuant to this prospectus supplement and the related prospectus through direct subscription agreements between each purchaser and us. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Commissions and Expenses </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have agreed
to pay the placement agent an aggregate cash placement fee equal to 7% of the gross proceeds in this offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table shows
the combined per share and total cash placement agent&#146;s fees we will pay to the placement agent in connection with the sale of the shares and Warrants offered pursuant to this prospectus supplement and the related prospectus assuming the
purchase of all of the shares and Warrants offered hereby: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="78%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Per Share of Common Stock and Corresponding Series A Warrant</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.1960</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Per Series B Warrant</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.1953</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">304,381.9163</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because there is no minimum offering amount required as a condition to closing in this offering, the actual
total placement agent fees, if any, are not presently determinable and may be substantially less than the maximum amount set forth above. Regardless of whether this offering is consummated, we have agreed to reimburse the placement agent for its
reasonable out-of-pocket expenses, including the fees and disbursements of the placement agent&#146;s counsel, up to an amount not to exceed $80,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our obligation to issue and sell shares and Warrants to each purchaser is subject to the conditions set forth in a subscription agreement,
which may be waived by us at our discretion. A purchaser&#146;s obligation to purchase shares and Warrants is subject to the conditions set forth in his, her or its subscription agreement as well, which may also be waived. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently anticipate that the sale of the shares and Warrants will be completed on or about November&nbsp;7, 2014. We estimate the total
offering expenses of this offering that will be payable by us, excluding the placement agent&#146;s fees, will be approximately $254,036, which includes legal and printing costs, various other fees and reimbursement of the placements agent&#146;s
expenses. At the closing, The Depository Trust Company will credit the shares of common stock to the respective accounts of each purchaser. We will mail Warrants directly to each investor at the respective addresses set forth in his, her or its
subscription agreement with us. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Indemnification </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have agreed to indemnify the placement agent against liabilities under the Securities Act and certain other specified liabilities, or to
contribute to payments that the placement agent may be required to make in respect of those liabilities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-15 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Lock-up Agreement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We, and our executive officers and directors have agreed, subject to certain exceptions, for a period of 90 days after the date of this
prospectus supplement, not to offer, sell, assign, transfer, pledge, contract to sell, enter into any swap, hedge or similar agreement or arrangement, engage in any short selling, establish an open &#147;put equivalent position&#148; within the
meaning of Rule 16a-1(h) under the Exchange Act, or otherwise dispose of, or announce the offering of, file or exercise any right with respect to any registration statement under the Securities Act in respect of any shares of common stock or any
securities convertible into or exchangeable for shares of our common stock without the prior written consent of Cowen and Company, LLC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This 90-day period may be extended if (1)&nbsp;during the last 17 days of the 90-day period, we issue an earnings release or material news or
a material event regarding us occurs or (2)&nbsp;prior to the expiration of the 90-day period, we announce that we will release earnings results during the 16-day period beginning on the last day of the 90-day period, then the period of such
extension will be 18 days, beginning on the issuance of the earnings release or the occurrence of the material news or material event, subject to certain exceptions, unless Cowen and Company, LLC waives such extension in writing. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Electronic Distribution </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus
supplement and the related prospectus may be made available in electronic format on websites or through other online services maintained by the placement agent, or by an affiliate. Other than this prospectus supplement and the related prospectus,
the information on the placement agent&#146;s website and any information contained in any other website maintained by the placement agent is not part of this prospectus supplement and the related prospectus or the registration statement of which
this prospectus supplement and the related prospectus forms a part, has not been approved and/or endorsed by us or the placement agent, and should not be relied upon by investors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing does not purport to be a complete statement of the terms and conditions of the placement agency agreement and subscription
agreement. A copy of the placement agent agreement and the form of subscription agreement with each purchaser are included as exhibits to our current report on Form 8-K that will be filed with the SEC and incorporated by reference into the
Registration Statement of which this prospectus supplement forms a part. See &#147;Where You Can Find Additional Information.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Regulation M
Restrictions </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The placement agent may be deemed to be an underwriter within the meaning of Section&nbsp;2(a)(11) of the Securities Act,
and any commissions received by it and any profit realized on the resale of the shares and Warrants sold by it while acting as a principal might be deemed to be underwriting discounts or commissions under the Securities Act. As an underwriter, the
placement agent would be required to comply with the requirements of the Securities Act and the Securities Exchange Act of 1934, as amended, including, without limitation, Rule 415(a)(4) under the Securities Act and Rule 10b-5 and Regulation M under
the Exchange Act. These rules and regulations may limit the timing of purchases and sales of shares and Warrants by the placement agent acting as a principal. Under these rules and regulations, the placement agent: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">must not engage in any stabilization activity in connection with our securities; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">must not bid for or purchase any of our securities or attempt to induce any person to purchase any of our securities, other than as permitted under the Exchange Act, until it has completed their participation in the
distribution. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Listing and Transfer Agent </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our common stock is listed on the NASDAQ Capital Market and trades under the symbol &#147;CDTI&#148; The transfer agent of our common stock is
American Stock Transfer&nbsp;&amp; Trust Company, LLC. The transfer agent&#146;s address is 6201 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> Avenue, Third Floor, Brooklyn, New York 11219, and its telephone number is:
(800)&nbsp;937-5449. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-16 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There is no established public trading market for the Warrants and we do not expect a market to
develop. In addition, we do not intend to apply for listing of the Warrants on any national securities exchange. The Company will act as warrant agent with respect to the Warrants offered hereby. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Other Relationships </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The placement agent
and its affiliates have provided and/or may in the future provide various investment banking, commercial banking and other financial services for us and our affiliates for which they have received and/or may in the future receive customary fees.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-17 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suptoc815101_11"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The validity of the shares of common stock and Warrants offered hereby will be passed upon for us by DLA Piper LLP (US), Phoenix, Arizona. The
placement agent been represented in connection with this offering by Loeb&nbsp;
&amp; Loeb LLP, New York, New York. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suptoc815101_12"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consolidated financial statements of the Company as of and for the years ended December&nbsp;31, 2013 and 2012 have been incorporated by
reference in this prospectus supplement in reliance upon the report of BDO USA, LLP, independent registered public accounting firm, incorporated by reference herein, and upon the authority of said firm as an expert in accounting and auditing. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suptoc815101_13"></A>WHERE YOU CAN FIND MORE INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We file annual, quarterly and current reports, proxy statements and other information with the SEC. You may read and copy any document we file
at the SEC&#146;s Public Reference Room&nbsp;at 100 F Street, N.E., Room&nbsp;1580, Washington, D.C. 20549. You can request copies of these documents by writing to the SEC and paying a fee for the copying cost. Please call the SEC at 1-800-SEC-0330
for more information about the operation of the public reference room. Our SEC filings are also available to the public at the SEC&#146;s web site at <U>http://www.sec.gov</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon request, we will provide each person to whom this prospectus supplement is delivered a copy of all of the information that has been
incorporated by reference in this prospectus supplement or the accompanying prospectus but not delivered with this prospectus supplement and the accompanying prospectus. You may obtain copies of these documents from us, without charge (other than
exhibits, unless the exhibits are specifically incorporated by reference), by requesting them in writing or by telephone at the following address: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Investor Relations Manager </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Clean Diesel Technologies, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>1621 Fiske Place </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Oxnard,
CA 93033 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(805) 639-9555 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Internet Website: <U>www.cdti.com </U> </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-18 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suptoc815101_14"></A>INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The SEC allows us to &#147;incorporate by reference&#148; into this prospectus supplement the information contained in the documents we file
with the SEC, which means that we can disclose important information to you by referring you to those documents. The information incorporated by reference is considered to be part of this prospectus supplement and the accompanying prospectus, and
later information that we file with the SEC will update and supersede this information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus supplement incorporates by
reference the documents listed below that we have previously filed with the SEC. These documents contain important information about us: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2013 filed on March&nbsp;31, 2014; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">portions of our definitive proxy statement on Schedule 14A filed on April&nbsp;7, 2014, as updated by Amendment No.&nbsp;1 to Schedule 14A filed on May&nbsp;14, 2014, that are incorporated by reference into Part III of
our Annual Report on Form 10-K for the fiscal year ended December&nbsp;31, 2013; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our Quarterly Reports on Form 10-Q filed on May&nbsp;8, 2014 and August&nbsp;8, 2014; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our Current Reports on Form 8-K filed on March&nbsp;14, 2014, March&nbsp;27, 2014, April&nbsp;1, 2014, April&nbsp;4, 2014, as amended by our Current Report on Form 8-K/A filed on April&nbsp;4, 2014, April&nbsp;7, 2014,
April&nbsp;24, 2014, May&nbsp;14, 2014, May&nbsp;16, 2014, May&nbsp;27, 2014, July&nbsp;7, 2014, July&nbsp;31, 2014, September&nbsp;10, 2014, September&nbsp;16, 2014, September&nbsp;30, 2014, and October&nbsp;21, 2014 (other than the information
furnished therein under Item&nbsp;2.02 and Exhibit 99.1); and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the description of our Common Stock, $0.01 par value per share, contained in our Registration Statement on Form&nbsp;8-A filed on September&nbsp;27, 2007, including any amendments or reports filed for the purpose of
updating such description. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we incorporate by reference any additional documents that we may file with the SEC
under Section&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act (other than those furnished pursuant to Item&nbsp;2.02 or Item&nbsp;7.01 of Form 8-K or other information &#147;furnished&#148; to the SEC), until the offering of all the securities by
this prospectus supplement is completed, including all filings made after the date of this prospectus supplement. These documents may include annual, quarterly and current reports, as well as proxy statements. Any material that we later file with
the SEC will automatically update and replace the information previously filed with the SEC. These documents are available to you without charge. See &#147;Where You Can Find More Information.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this prospectus supplement, any statement contained in a document incorporated or deemed to be incorporated herein by
reference shall be deemed to be modified or superseded to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated herein by reference modifies or supersedes such
statement in such document. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-19 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PROSPECTUS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="4"><B>CLEAN DIESEL TECHNOLOGIES, INC. </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g815101g81r82.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>$50,000,000 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>Common Stock </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Preferred Stock </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Warrants </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Units </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">By this
prospectus, we may offer and sell from time to time up to $50,000,000 in total of any combination of the securities described in this prospectus, either individually or in units. We may also offer common stock upon conversion of preferred stock or
common stock or preferred stock upon the exercise of warrants. This prospectus provides a general description of securities we may offer. Each time we offer securities, we will provide a prospectus supplement containing more information about the
particular offering together with this prospectus. The prospectus supplement also may add, update or change information contained in this prospectus. This prospectus may not be used to offer and sell securities without a prospectus supplement.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The securities may be sold directly by us to investors, through agents designated from time to time or to or through
underwriters or dealers, on a delayed or continuous basis. For additional information on the methods of sale, you should refer to the section entitled &#147;Plan of Distribution&#148; in this prospectus. If any agents or underwriters are involved in
the sale of any securities, the names of such agents or underwriters and any applicable fees, commissions, discounts and over-allotment options will be set forth in the applicable prospectus supplement. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our common stock is listed on the NASDAQ Capital Market under the symbol &#147;CDTI.&#148; On May&nbsp;11, 2012, the last reported sale
price of our common stock was $2.57 per share. Pursuant to General Instruction I.B.6 of Form S-3, as long as the aggregate market value of our common stock held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> remains below $75.0 million,
we will not, during any 12 calendar month period, sell the securities in a public primary offering with a value exceeding more than one-third of the aggregate market value of our common stock held by non-affiliates. As of March&nbsp;31,
2012,&nbsp;the aggregate market value of our outstanding common stock held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> was approximately $14,420,866, which was calculated based on 5,611,232 shares of outstanding common stock held by <FONT
STYLE="white-space:nowrap">non-affiliates</FONT> and a price per share of $2.57, the last reported sale price per share of our common stock on the NASDAQ Capital Market on May&nbsp;11, 2012. As of the date hereof, we have not offered any securities
pursuant to General Instruction I.B.6 of Form <FONT STYLE="white-space:nowrap">S-3</FONT> during the prior 12 calendar month period that ends on and includes the date hereof. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Investing in our securities involves a high degree of risk. We refer you to the section entitled &#147;<A HREF="#tx815101_3">Risk Factors</A>&#148; on page 3 of this prospectus and in the applicable
prospectus supplement and under similar sections in the documents we incorporate by reference into this prospectus. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or
determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense. </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">The date of this
prospectus is&nbsp;May 21, 2012</FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>TABLE OF CONTENTS</B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="96%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#tx815101_1">ABOUT THIS PROSPECTUS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#tx815101_2">ABOUT OUR COMPANY</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#tx815101_3">RISK FACTORS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#tx815101_4">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#tx815101_5">USE OF PROCEEDS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#tx815101_6">DILUTION</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#tx815101_7">RATIO OF EARNINGS TO FIXED CHARGES</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#tx815101_8">DESCRIPTION OF COMMON STOCK</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#tx815101_9">DESCRIPTION OF PREFERRED STOCK</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#tx815101_10">DESCRIPTION OF WARRANTS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#tx815101_11">DESCRIPTION OF UNITS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#tx815101_12">PLAN OF DISTRIBUTION</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#tx815101_13">LEGAL MATTERS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#tx815101_14">EXPERTS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#tx815101_15">WHERE YOU CAN FIND MORE INFORMATION</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#tx815101_16">INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">16</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">i </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="tx815101_1"></A>ABOUT THIS PROSPECTUS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">This prospectus is part of a registration statement that we filed with the Securities and Exchange Commission (&#147;SEC&#148;) using a
&#147;shelf&#148; registration process. Under this shelf registration process, we may offer to sell any one or more or a combination of the securities described in this prospectus in one or more offerings up to a total dollar amount of $50,000,000
(or its equivalent based on the applicable exchange rate at the time of the sale in one or more foreign currencies, currency units or composite currencies that we may designate). We have provided to you in this prospectus a general description of
the securities we may offer. Each time we sell securities, we will provide a prospectus supplement that will contain specific information about the terms of that offering. We also may add, update or change in the prospectus supplement any of the
information contained in this prospectus. If there is an inconsistency between the information in this prospectus and a prospectus supplement, you should rely on the information in the prospectus supplement. You should read carefully both this
prospectus and the applicable prospectus supplement together with the documents we incorporate by reference into this prospectus as described under the heading &#147;Incorporation of Certain Documents By Reference&#148; before making an investment
decision. THIS PROSPECTUS MAY NOT BE USED TO OFFER AND SELL SECURITIES WITHOUT A PROSPECTUS SUPPLEMENT. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The registration
statement that contains this prospectus, including the exhibits to the registration statement and the information incorporated by reference, provides additional information about the securities offered under this prospectus. That registration
statement can be read at the SEC web site or at the SEC public reference room as discussed under the heading &#147;Where You Can Find More Information.&#148; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">You should rely only on the information provided in this prospectus and in any prospectus supplement, including the information incorporated by reference. We have not authorized anyone to provide you with
different information. You should not assume that the information in this prospectus or any supplement to this prospectus is accurate at any date other than the date indicated on the cover page&nbsp;of these documents. We are not making an offer to
sell these securities in any jurisdiction where the offer or sale is not permitted. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In this prospectus, references to
&#147;Clean Diesel Technologies,&#148; &#147;Clean Diesel,&#148; &#147;CDTI,&#148; the &#147;company,&#148; &#147;we,&#148; &#147;our&#148; or &#147;us,&#148; unless the context otherwise requires, refer to Clean Diesel Technologies, Inc.
</FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="tx815101_2"></A>ABOUT OUR COMPANY </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We are a Delaware corporation formed in 1994 as a wholly-owned subsidiary of Fuel Tech, Inc., a Delaware corporation (formerly known as Fuel-Tech N.V., a Netherlands Antilles limited liability company)
(&#147;Fuel Tech&#148;), and were spun off by Fuel Tech in a rights offering in December&nbsp;1995. Since inception, and as set forth below, we have developed a substantial portfolio of patents and related proprietary rights and extensive
technological know-how. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We currently conduct our operations primarily through our wholly-owned subsidiary, Catalytic
Solutions, Inc. (&#147;CSI&#148;). CSI is a California corporation formed in 1996 and, through its Heavy Duty Diesel Systems division, has over 30&nbsp;years of experience in the heavy duty diesel systems market and has proven technical and
manufacturing competence in the light duty vehicle catalyst market meeting auto makers&#146; most stringent requirements. From November&nbsp;22, 2006 through the Merger, CSI&#146;s common stock was listed on the AIM of the London Stock Exchange
(AIM: CTS and CTSU). </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We completed a business combination with CSI on October&nbsp;15, 2010 when our wholly-owned subsidiary,
CDTI Merger Sub, Inc., merged with and into CSI. We refer to this transaction as the &#147;Merger.&#148; The Merger was accounted for as a reverse acquisition and, as a result, our company&#146;s (the legal acquirer) consolidated financial
statements are now those of CSI (the accounting acquirer), with the assets and liabilities and revenues and expenses of CDTI being included effective from October&nbsp;15, 2010, the date of the closing of the Merger. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">1 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are headquartered in Ventura, California and have operations in the United States,
Canada, the United Kingdom, France, Japan and Sweden as well as an Asian investment. Our proprietary Catalyst division products are manufactured at our facility in Oxnard, California, while our Heavy Duty Diesel Systems division products are
manufactured at our facilities in Reno, Nevada; Thornhill, Canada; Malm&ouml;, Sweden; and South Godstone, United Kingdom. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We
are a leading global manufacturer and distributor of heavy duty diesel and light duty vehicle emissions control systems and products to major automakers and retrofitters. Our business is driven by increasingly stringent global emission standards for
internal combustion engines, which are major sources of a variety of harmful pollutants. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Our Divisions </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We operate in two primary divisions: our Heavy Duty Diesel Systems division and our Catalyst division. We have included all of the
operations of CDTI in our Heavy Duty Diesel Systems division. </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I><U>Heavy Duty Diesel Systems</U></I>: Our Heavy Duty Diesel Systems division specializes in the design and manufacture of verified exhaust emissions
control solutions. This division offers a full range of products for the verified retrofit and original equipment manufacturer, or OEM, markets through its distribution/dealer network and direct sales. These Engine Control Systems (&#147;ECS&#148;)
and Clean Diesel Technologies-brand products, such as Purifilter<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>, Purifier&#153;, Platinum Plus<FONT
STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> and ARIS<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>, along with our exhaust gas recirculation with selective catalytic reduction technologies, are used to reduce exhaust emissions created by <FONT
STYLE="white-space:nowrap">on-road,</FONT> <FONT STYLE="white-space:nowrap">off-road</FONT> and stationary diesel and alternative fuel engines including propane and natural gas. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Sales of emission control systems by our Heavy Duty Diesel Systems division are being driven by increased regulation of diesel emissions,
particularly in the State of California and Europe&#146;s Low Emission Zones, or LEZs. The U.S.&nbsp;Environmental Protection Agency, or EPA, estimated in a 2010 report that more than 11&nbsp;million diesel engines operating today do not meet its
new clean diesel standards, yet the engines can operate for 20 to 30 years. In California, government mandates could lead to the long-term retrofitting of nearly one million diesel vehicles at an estimated cost of over $2&nbsp;billion, according to
a California Air Resources Board, or CARB, 2010 report. According to 2011 data received from Transport for London, we believe the London LEZ regulations will have resulted in the retrofitting of up to 20,000 heavy duty diesel vehicles during 2011
and through early 2012. </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I><U>Catalyst</U></I>: Our Catalyst division produces catalyst formulations to reduce emissions from gasoline, diesel and natural gas combustion
engines. Using our proprietary MPC<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> technology, we have developed a family of unique high-performance catalysts
&#151; with base-metals or low platinum group metal and zero-platinum group metal content &#151; to provide increased catalytic function and value for technology-driven automotive industry customers. Our technical and manufacturing competence in the
light duty vehicle market is aimed at meeting auto makers&#146; most stringent requirements, and we have supplied over ten million parts to light duty vehicle customers since 1996. Our Catalyst division also provides catalyst formulations for our
Heavy Duty Diesel Systems division. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Globally, the catalyst market is estimated to exceed $7&nbsp;billion by
2015, according to a report issued by Global Industry Analysts, Inc. in 2011. We expect growth in this business division to be driven by increased sales to existing customers, including Honda, and catalyst sales internally to our Heavy Duty Diesel
Systems division. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">With over 30&nbsp;years experience in vehicle emissions control technologies, we believe we offer one of
the industry&#146;s most comprehensive portfolios of evaluated and <FONT STYLE="white-space:nowrap">EPA-</FONT> and CARB-verified systems for use in engine retrofit programs, as well as by regulators in several European countries. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">2 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="tx815101_3"></A>RISK FACTORS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">An investment in our securities involves a high degree of risk. You should carefully consider the risk factors described in Part I,
Item&nbsp;1A, &#147;Risk Factors&#148; in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2011, as well as the risks, uncertainties and additional information set forth in the other
documents incorporated by reference in this prospectus. For a description of these reports and documents, and information about where you can find them, see &#147;Where You Can Find More Information&#148; and &#147;Incorporation of Certain Documents
by Reference.&#148; Before making any investment decision, you should carefully consider these risks as well as other information we include or incorporate by reference in this prospectus or in any applicable prospectus supplement. The risks and
uncertainties described in the prospectus supplement and the documents we incorporate by reference into this prospectus are not the only ones we face. Additional risks and uncertainties that we are unaware of or that we believe are not material at
the time could also materially adversely affect our business, financial condition or results of operations. In any case, the value of our securities could decline, and you could lose all or part of your investment. See also the information contained
under the heading &#147;Cautionary Statement Regarding Forward-Looking Statements&#148; immediately below. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="tx815101_4">
</A>CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">This prospectus and the information incorporated by
reference in this prospectus include &#147;forward-looking statements&#148; within the meaning of Section&nbsp;27A of the Securities Act of 1933, as amended, (the &#147;Securities Act&#148;), and Section&nbsp;21E of the Securities Exchange Act of
1934, as amended (the &#147;Exchange Act&#148;). Without limiting the foregoing, the words &#147;may,&#148; &#147;believe,&#148; &#147;may,&#148; &#147;could,&#148; &#147;might,&#148; &#147;possible,&#148; &#147;potential,&#148; &#147;project,&#148;
&#147;will,&#148; &#147;should,&#148; &#147;expect,&#148; &#147;intend,&#148; &#147;plan,&#148; &#147;predict,&#148; &#147;anticipate,&#148; &#147;estimate,&#148; &#147;approximate,&#148; &#147;contemplate&#148; or
&#147;continue&#148;&nbsp;&#147;target,&#148; &#147;goal&#148; and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these words. All forward-looking statements included in
this prospectus are based on information available to us up to, and including, the date of this document, and we assume no obligation to update any such forward-looking statements to reflect events or circumstances that arise after the date hereof.
Our actual results could differ materially from those anticipated in these forward-looking statements as a result of certain important factors, including those contained in or incorporated by reference into this prospectus. You should carefully
review those factors and also carefully review the risks outlined in other documents that we file from time to time with the SEC. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="tx815101_5"></A>USE OF PROCEEDS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We will retain broad discretion
over the use of net proceeds to us from the sale of our securities offered hereby. Except as may be otherwise described in a prospectus supplement, we currently anticipate using any net proceeds to us for general corporate purposes, which may
include working capital, general and administrative expenses, and capital expenditures. We may also use a portion of the net proceeds to acquire or invest in businesses, products and technologies that are complementary to our current business,
although we have no present commitments or agreements for any such transactions. The amounts and timing of our actual expenditures for each purpose may vary significantly depending upon numerous factors, including the actual amount of proceeds we
receive, competition and economic or other conditions. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We cannot guarantee that we will receive any proceeds in connection
with any offering hereunder because we may choose not to issue any of the securities covered by this prospectus.&nbsp;If we choose to issue securities, we will provide a prospectus supplement that will contain information about how we intend to use
the proceeds from each such offering. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pending the application of such proceeds, we may invest the proceeds in short-term,
interest bearing, investment-grade marketable securities or money market obligations. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">3 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="tx815101_6"></A>DILUTION </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If there is a material dilution of the purchasers&#146; equity interest from the sale of common equity securities offered under this
prospectus, we will set forth in any prospectus supplement the following information regarding any such material dilution: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the net tangible book value per share of our equity securities before and after the offering; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the amount of the increase in such net tangible book value per share attributable to the cash payments made by the purchasers in the offering; and
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the amount of the immediate dilution from the public offering price which will be absorbed by such purchasers. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="tx815101_7"></A>RATIO OF EARNINGS TO FIXED CHARGES </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Because we have no preferred stock issued (and have not had any issued during the last five fiscal years), a ratio of earnings to
combined fixed charges and preferred dividends is not presented. If we issue preferred stock in the future, we will set forth in any prospectus supplement the ratio of earnings to combined fixed charges and preferred dividends for the last five
fiscal years. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="tx815101_8"></A>DESCRIPTION OF COMMON STOCK </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following description of our common stock, together with the additional information we include in any applicable prospectus
supplement, summarizes the material terms and provisions of our common stock that we may offer under this prospectus. For the complete terms of our common stock, please refer to our Amended and Restated Certificate of Incorporation, as amended
(&#147;Certificate of Incorporation&#148;) and Bylaws. The description herein does not contain all of the information that you may find useful or that may be important to you. You should refer to the provisions of our Certificate of Incorporation
and Bylaws because they, and not the summary, define the rights of holders of shares of our common stock. You can obtain copies of our Certificate of Incorporation and Bylaws by following the directions under the heading &#147;Where You Can Find
More Information.&#148; The terms of our common stock also may be affected by Delaware law. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Authorized and Outstanding Capital Stock
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are authorized to issue 12,000,000 shares of common stock, $0.01 par value per share.&nbsp;As of May&nbsp;11, 2012, we
had 7,218,807 shares of common stock outstanding.&nbsp;In addition, we had 934,914 shares of common stock reserved for issuance under outstanding warrants; 1,783,330 shares reserved for issuance to Lincoln Park Capital Fund, LLC under a purchase
agreement; 369,853 shares reserved for issuance to Kanis S.A. upon conversion of our subordinated convertible notes; 176,676 shares reserved for issuance upon the exercise of outstanding stock options and an additional 58,892 shares reserved for
issuance pertaining to outstanding restricted stock units under inducement awards; and 577,214 shares reserved for issuance upon the exercise of outstanding stock options and an additional 119,225 shares reserved for issuance pertaining to
outstanding restricted stock units under our 1994 Incentive Plan.&nbsp;As of the date of this prospectus, we do not have any shares of preferred stock outstanding. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Voting Rights </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">For all matters submitted to a vote of stockholders, each
holder of common stock is entitled to one vote for each share registered in the holder&#146;s name on our books. Our common stock does not have cumulative voting rights. The holders of a plurality of the shares of our common stock entitled to vote
in any election of directors, voting together as a single class, can elect all of the directors standing for election, if they so choose. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">4 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Dividends </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Subject to limitations under Delaware law and preferences that may be applicable to any then outstanding preferred stock, holders of common stock are entitled to receive ratably those dividends, if any,
as may be declared by our Board of Directors out of legally available funds. We have never paid any cash dividends on our Common Stock and do not anticipate paying dividends in the near future. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Liquidation </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Upon our
liquidation, dissolution or winding up, the holders of common stock will be entitled to share ratably in the net assets legally available for distribution to stockholders after the payment of all of our debts and other liabilities of our company,
subject to the prior rights of any preferred stock then outstanding. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Fully Paid and Nonassessable </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">All shares of our outstanding common stock are fully paid and nonassessable and any additional shares of common stock that we issue will
be fully paid and nonassessable. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Anti-Takeover Effects of Certain Charter and Bylaw Provisions and Delaware Law </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our Certificate of Incorporation and Bylaws and Delaware law contain provisions that could make the following transactions more difficult:
acquisition of us by means of a tender offer; acquisition of us by means of a proxy contest or otherwise; or removal of our incumbent officers and directors. It is possible that these provisions could make it more difficult to accomplish or could
deter transactions that stockholders may otherwise consider to be in their best interest or in our best interests, including transactions that might result in a premium over the market price for our shares. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The provisions of our Certificate of Incorporation and Bylaws and Delaware law summarized below may have the effect of deterring hostile
takeovers or delaying changes in control or management of us. They are designed to encourage persons seeking to acquire control of us to first negotiate with our Board of Directors. We believe that the benefits of increased protection of our
potential ability to negotiate with the proponent of an unfriendly or unsolicited proposal to acquire or restructure us outweigh the disadvantages of discouraging these proposals because negotiation of these proposals could result in an improvement
of their terms. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Charter and Bylaw Provisions </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Our Certificate of Incorporation and Bylaws contain provisions relating to corporate governance and to the rights of stockholders. Our Bylaws provide that special meetings of stockholders may only be
called by our Board of Directors, our Chairman of the Board or our Chief Executive Officer and shall be called by our Chairman, Chief Executive Officer or Secretary at the request in writing of stockholders owning at least <FONT
STYLE="white-space:nowrap">one-fourth</FONT> of the outstanding shares of capital stock entitled to vote. In addition, our Certificate of Incorporation provides that our Board of Directors may authorize the issuance of preferred stock without
further stockholder approval and upon those terms and conditions, and having those rights, privileges and preferences, as our Board of Directors may determine. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Since the terms of our Certificate of Incorporation and Bylaws may differ from the general information we are providing, you should only rely on the actual provisions of our Certificate of Incorporation
and Bylaws. If you would like to read our Certificate of Incorporation and Bylaws, they are available as described under the heading &#147;Where You Can Find More Information.&#148; </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Delaware Anti-Takeover Law </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are subject to the provisions of
Section&nbsp;203 of the Delaware General Corporation Law. (&#147;DGCL&#148;). In general, this section prohibits a publicly held Delaware corporation from engaging in a business combination </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">5 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
with an interested stockholder for a period of three years after the date of the transaction in which the person becomes an interested stockholder, unless: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">before the date on which the stockholder became an interested stockholder, the corporation&#146;s Board of Directors approved either the business
combination or the transaction in which the person became an interested stockholder; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the stockholder acquires more than 85% of the outstanding voting stock of the corporation, excluding shares held by directors who are officers or held
in certain employee stock plans, upon consummation of the transaction in which the stockholder becomes an interested stockholder; or </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the business combination is approved by the Board of Directors and by <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the outstanding voting
stock of the corporation that is not held by the interested stockholder, at a meeting of the stockholders held on or after the date of the business combination. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Section&nbsp;203 defines &#147;business combination&#148; to include: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">any merger or consolidation involving the corporation and the interested stockholder; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">any sale, transfer, pledge or other disposition of 10% or more of our assets involving the interested stockholder; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">in general, any transaction that results in the issuance or transfer by us of any of our stock to the interested stockholder; or
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits provided by or through
the corporation. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">An interested stockholder is a person who, together with affiliates and associates, owns,
or at any time within the prior three years did own, 15% or more of the corporation&#146;s voting stock. Business combinations include, without limitation, mergers, consolidations, stock sales, asset sales or other transactions resulting in a
financial benefit to interested stockholders. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Other Rights and Restrictions </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Holders of our common stock do not have preemptive or subscription rights, and they have no right to convert their common stock into any
other securities. There are no redemption or sinking fund provisions applicable to the common stock. The rights, preferences and privileges of common stockholders are subject to the rights of the stockholders of any series of preferred stock which
we may designate in the future. Our Certificate of Incorporation and Bylaws do not restrict the ability of a holder of common stock to transfer the holder&#146;s shares of common stock. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Listing </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our common stock is listed on the NASDAQ Capital Market under the
symbol &#147;CDTI.&#148; </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Transfer Agent and Registrar </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The transfer agent and registrar for our common stock is American Stock Transfer&nbsp;&amp; Trust Company, LLC. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="tx815101_9"></A>DESCRIPTION OF PREFERRED STOCK </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following
description of our preferred stock, together with the additional information we include in any applicable prospectus supplement, summarizes the material terms and provisions of our preferred stock that we
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">6 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
may offer under this prospectus. For the complete terms of our preferred stock, please refer to our Certificate of Incorporation and Bylaws, and the applicable certificate of designation to our
Certificate of Incorporation (&#147;Certificate of Designation&#148;) establishing the terms of the related series of preferred stock. See &#147;Where You Can Find More Information.&#148; The descriptions herein and in the applicable prospectus
supplement do not contain all of the information that you may find useful or that may be important to you. You should refer to the provisions of our Certificate of Incorporation, the applicable Certificate of Designation and our Bylaws because they,
and not the summaries, define your rights as holders of shares of our preferred stock. The terms of our preferred stock also may be affected by Delaware law. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Authorized and Outstanding Shares </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We currently have authorized 100,000
shares of preferred stock, $0.01 par value per share, none of which have been issued. The Board of Directors has the right, without shareholder approval, to issue preferred stock and to establish its terms and conditions. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Designations, Powers, Preferences, Rights, Qualifications, Limitations and Restrictions </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Prior to issuance of shares of each series of our undesignated preferred stock, our Board of Directors is required by the DGCL and our
Certificate of Incorporation to adopt resolutions and file a Certificate of Designations with the Secretary of State of the State of Delaware, fixing for each such series the designations, powers, preferences, rights, qualifications, limitations and
restrictions of the shares of such series. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our Board of Directors could authorize the issuance of shares of preferred stock
with terms and conditions which could have the effect of discouraging a takeover or other transaction which holders of some, or a majority, of such shares might believe to be in their best interests or in which holders of some, or a majority, of
such shares might receive a premium for their shares over the then-market price of such shares. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Subject to limitations
prescribed by the DGCL, our Certificate of Incorporation and our Bylaws, our Board of Directors is authorized to fix the number of shares constituting each series of preferred stock and the designations, powers, preferences, rights, qualifications,
limitations and restrictions of the shares of such series, including such provisions as may be desired concerning voting, redemption, dividends, dissolution or the distribution of assets, conversion or exchange, and such other subjects or matters as
may be fixed by resolution of the Board of Directors. Each series of preferred stock that we offer under this prospectus will, when issued, be fully paid and nonassessable and will not have, or be subject to, any preemptive or similar rights.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The applicable prospectus supplement will describe the following terms of the series of preferred stock in respect of which
this prospectus is being delivered: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the title and stated value of the preferred stock; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the number of shares of the preferred stock offered, the liquidation preference per share and the purchase price of the preferred stock;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the dividend rate(s), period(s)&nbsp;and/or payment date(s)&nbsp;or the method(s)&nbsp;of calculation for dividends; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">whether dividends shall be cumulative or <FONT STYLE="white-space:nowrap">non-cumulative</FONT> and, if cumulative, the date from which dividends on
the preferred stock shall accumulate; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the procedures for any auction and remarketing, if any, for the preferred stock; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the provisions for a sinking fund, if any, for the preferred stock; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the provisions for redemption, if applicable, of the preferred stock; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">any listing of the preferred stock on any securities exchange or market; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the terms and conditions, if applicable, upon which the preferred stock will be convertible into common stock, including the conversion price (or its
manner of calculation) and conversion period; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">7 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">voting rights, if any, of the preferred stock; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">a discussion of any material and/or special U.S. federal income tax considerations applicable to the preferred stock; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">whether interests in the preferred stock will be represented by depositary shares; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the relative ranking and preferences of the preferred stock as to dividend rights and rights upon liquidation, dissolution or winding up of our
affairs; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">any limitations on issuance of any class or series of preferred stock ranking senior to or on a parity with the preferred stock as to dividend rights
and rights upon liquidation, dissolution or winding up of our affairs; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">any other specific terms, preferences, rights, limitations or restrictions on the preferred stock. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Transfer Agent and Registrar </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The transfer agent and registrar for our preferred stock will be set forth in the applicable prospectus supplement. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="tx815101_10"></A>DESCRIPTION OF WARRANTS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following
description, together with the additional information we may include in any applicable prospectus supplement, summarizes the material terms and provisions of the warrants that we may offer under this prospectus and the related warrant agreements and
warrant certificates. While the terms summarized below will apply generally to any warrants that we may offer, we will describe the particular terms of any series of warrants in more detail in the applicable prospectus supplement. If we indicate in
the prospectus supplement, the terms of any warrants offered under that prospectus supplement may differ from the terms described below. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We will file as exhibits to the registration statement of which this prospectus is a part, or will incorporate by reference from reports that we file with the SEC, the form of warrant agreement, including
a form of warrant certificate, that describes the terms of the series of warrants we are offering, and any supplemental agreements, before the issuance of the related series of warrants. The following summaries of material terms and provisions of
the warrant agreements and warrant certificate are subject to, and qualified in their entirety by reference to, all the provisions of the warrant agreement and warrant certificate applicable to the particular series of warrants that we may offer
under this prospectus. We urge you to read the applicable prospectus supplements related to the particular series of warrants that we may offer under this prospectus and the complete warrant agreements and warrant certificates that contain the terms
of the warrants. For more information, please review the forms of these documents, which will be filed with the SEC and will be available as described under the heading &#147;Where You Can Find More Information.&#148; </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following is a summary of our outstanding warrants as of May&nbsp;11, 2012: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="56%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Shares</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Weighted</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Average</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Exercise</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Price</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Range of<BR>Exercise&nbsp;Prices</B></FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Outstanding at December&nbsp;31, 2011</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">929,914</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15.13</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="white-space:nowrap">$2.80&nbsp;-&nbsp;$169.47</FONT></FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Warrants issued</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.80</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">$3.80</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Outstanding at May 11, 2012</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">934,914</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15.07</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="white-space:nowrap">$2.80&nbsp;-&nbsp;$169.47</FONT></FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Warrants exercisable at May 11, 2012</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">904,914</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15.26</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="white-space:nowrap">$2.80&nbsp;-&nbsp;$169.47</FONT></FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Aggregate intrinsic value</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">8 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>General </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We may issue warrants for the purchase of common stock or preferred stock in one or more series. We may issue warrants independently or together with common stock or preferred stock, and the warrants may
be attached to or separate from these securities. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We will evidence each series of warrants by warrant certificates that we
will issue under a separate agreement. We may enter into a warrant agreement with a warrant agent. If we elect to do so, the warrant agent will act solely as our agent in connection with the warrants and will not assume any obligation or
relationship of agency or trust for or with any registered holders of warrants or beneficial owners of warrants. We will indicate the name and address and other information regarding the warrant agent in the applicable prospectus supplement relating
to a particular series of warrants if we elect to use a warrant agent. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We will describe in the applicable prospectus
supplement the terms of the series of warrants, including: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the offering price and aggregate number of warrants offered; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the currency or currencies (including composite currencies), and/or the securities (if any), in which the exercise price of the warrants may be
payable; and, if the exercise price is payable in whole or in part with securities, the basis for determining the amount or number of such securities to be provided as such payment; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">if applicable, the designation and terms of the securities with which the warrants are issued and the number of warrants issued with each such security
or each principal amount of such security; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">if applicable, the date on and after which the warrants and the related securities will be separately transferable; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the number of shares of common stock or preferred stock, as the case may be, purchasable upon the exercise of one warrant and the price at which these
shares may be purchased upon such exercise; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the effect of any merger, consolidation, sale or other disposition of our business on the warrant agreement and the warrants;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the terms of any rights to redeem or call the warrants; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">any provisions for changes to or adjustments in the exercise price or number of securities issuable upon exercise of the warrants;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">if applicable, the minimum or maximum amount of such warrants that may be exercised at any one time; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the dates on which the right to exercise the warrants will commence and expire; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the manner in which the warrant agreement and warrants may be modified; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">if applicable, material U.S. federal income tax consequences of holding or exercising the warrants; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the terms of the securities issuable upon exercise of the warrants; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the identity of the warrant agent for the warrants and of any other depositaries, execution or paying agents, transfer agents, registrars or other
agents; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the proposed listing, if any, of the warrants or any securities purchasable upon exercise of the warrants on any securities exchange;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the anti-dilution provisions of the warrants, if any; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">any redemption or call provisions; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">any other specific terms, preferences, rights or limitations of or restrictions on the warrants. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Before exercising their warrants, holders of warrants will not have any of the rights of holders of the securities purchasable upon such
exercise, including the right to receive dividends, if any, or, payments upon our liquidation, dissolution or winding up or to exercise voting rights, if any. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">9 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Exercise of Warrants </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Each warrant will entitle the holder to purchase the securities that we specify in the applicable prospectus supplement at the exercise price that we describe in the applicable prospectus supplement.
Unless we otherwise specify in the applicable prospectus supplement, holders of the warrants may exercise the warrants at any time up to 5:00&nbsp;p.m., Pacific Standard Time, on the expiration date that we set forth in the applicable prospectus
supplement. After the close of business on the expiration date, unexercised warrants will become void. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Holders of warrants
may exercise their respective warrants in the manner set forth in the applicable prospectus supplement relating to such warrants. We will set forth on the reverse side of the warrant certificate and in the applicable prospectus supplement the
information that the holder of the warrant will be required to deliver to the warrant agent. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Upon receipt of the required
payment and the warrant certificate properly completed and duly executed at the corporate trust office of the warrant agent or any other office indicated in the applicable prospectus supplement, we will issue and deliver the securities purchasable
upon such exercise. If fewer than all of the warrants represented by the warrant certificate are exercised, then we will issue a new warrant certificate for the remaining amount of warrants. If we so indicate in the applicable prospectus supplement,
holders of the warrants may surrender securities as all or part of the exercise price for warrants. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Enforceability of Rights by Holders of
Warrants </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each warrant agent will act solely as our agent under the applicable warrant agreement and will not assume any
obligation or relationship of agency or trust with any holder of any warrant. A single bank or trust company may act as warrant agent for more than one issue of warrants. A warrant agent will have no duty or responsibility in case of any default by
us under the applicable warrant agreement or warrant, including any duty or responsibility to initiate any proceedings at law or otherwise, or to make any demand upon us. Any holder of a warrant may, without the consent of the related warrant agent
or the holder of any other warrant, enforce by appropriate legal action its right to exercise, and receive the securities purchasable upon exercise of, its warrants. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="tx815101_11"></A>DESCRIPTION OF UNITS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following description,
together with the additional information we may include in any applicable prospectus supplements, summarizes the material terms and provisions of the units that we may offer under this prospectus and any related unit agreements and unit
certificates. While the terms summarized below will apply generally to any units that we may offer, we will describe the particular terms of any series of units in more detail in the applicable prospectus supplement. If we indicate in the prospectus
supplement, the terms of any units offered under that prospectus supplement may differ from the terms described below. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We
will file as exhibits to the registration statement of which this prospectus is a part, or will incorporate by reference from reports that we file with the SEC, any form of unit agreement that describes the terms of the series of units we are
offering, and any supplemental agreements, before the issuance of the related series of units. The following summaries of material terms and provisions of the units are subject to, and qualified in their entirety by reference to, all the provisions
of such unit agreements and any supplemental agreements applicable to a particular series of units. We urge you to read the applicable prospectus supplements related to the particular series of units that we may offer under this prospectus and the
complete unit agreement and any supplemental agreements that contain the terms of the units. For more information, please review the forms of these documents, which will be filed with the SEC and will be available as described under the heading
&#147;Where You Can Find More Information.&#148; </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">10 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>General </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We may issue, in one or more series, units comprised of shares of our common stock or preferred stock and warrants to purchase common stock or preferred stock or any combination. Each unit will be issued
so that the holder of the unit is also the holder of each security included in the unit. Thus, the holder of a unit will have the rights and obligations of a holder of each included security. The unit agreement under which a unit is issued may
provide that the securities included in the unit may not be held or transferred separately, at any time or at any time before a specified date. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We may evidence units by unit certificates that we issue under a separate agreement. We may issue the units under a unit agreement between us and one or more unit agents. If we elect to enter into a unit
agreement with a unit agent, the unit agent will act solely as our agent in connection with the units and will not assume any obligation or relationship of agency or trust for or with any registered holders of units or beneficial owners of units. We
will indicate the name and address and other information regarding the unit agent in the applicable prospectus supplement relating to a particular series of units if we elect to use a unit agent. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We will describe in the applicable prospectus supplement the terms of the series of units being offered, including: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the designation and terms of the units and of the securities comprising the units, including whether and under what circumstances those securities may
be held or transferred separately; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">any provisions of the governing unit agreement that differ from those described below; and any provisions for the issuance, payment, settlement,
transfer or exchange of the units or of the securities comprising the units. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The other provisions regarding
our common stock, preferred stock and warrants as described in this section will apply to each unit to the extent such unit consists of shares of our common stock and preferred stock and warrants to purchase our common stock. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Enforceability of Rights by Holders of Units </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Each unit agent will act solely as our agent under the applicable unit agreement and will not assume any obligation or relationship of agency or trust with any holder of any unit. A single bank or trust
company may act as unit agent for more than one series of units. A unit agent will have no duty or responsibility in case of any default by us under the applicable unit agreement or unit, including any duty or responsibility to initiate any
proceedings at law or otherwise, or to make any demand upon us. Any holder of a unit may, without the consent of the related unit agent or the holder of any other unit, enforce by appropriate legal action its rights as holder under any security
included in the unit. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="tx815101_12"></A>PLAN OF DISTRIBUTION </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We may sell the securities offered by this prospectus in one or more of the following ways from time to time: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">to or through underwriters or dealers; or </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">directly to purchasers, including our affiliates, or to a single purchaser; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">through one or more agents; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">through a block trade in which the broker or dealer engaged to handle the block will attempt to sell the securities as agent, but may position and
resell a portion of the block as principal to facilitate the transaction; or </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">through a combination of any of these methods of sale. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">11 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition, we may issue the securities being offered by this prospectus as a dividend or
distribution. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We may effect the distribution of the securities from time to time in one or more transactions at a fixed price
or prices, which may be changed from time to time, at market prices prevailing at the time of sale, at prices related to prevailing market prices or at negotiated prices. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We will set forth in a prospectus supplement the terms of the offering of our securities, including: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the type and amount of securities we are offering; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the purchase price of our securities being offered and the net proceeds we will receive from the sale; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the method of distribution of the securities we are offering; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the name or names of any agents, underwriters or dealers; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">any over-allotment options under which underwriters may purchase additional securities from us; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">any underwriting discounts and commissions or agency fees and commissions and other items constituting underwriters&#146; or agents&#146; compensation;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">any discounts or concessions allowed or <FONT STYLE="white-space:nowrap">re-allowed</FONT> or paid to dealers; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">any securities exchanges on which such securities may be listed. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Sale through Underwriters and Dealers </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If we use an underwriter or
underwriters in the sale of securities offered by this prospectus, the underwriters will acquire the securities for their own account, including through underwriting, purchase, security lending or repurchase agreements with us. The underwriters may
resell the securities from time to time in one or more transactions, including negotiated transactions. Underwriters may sell the securities in order to facilitate transactions in any of our other securities (described in this prospectus or
otherwise), including other public or private transactions and short sales. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Underwriters may offer securities to the public
either through underwriting syndicates represented by one or more managing underwriters or directly by one or more firms acting as underwriters. Unless otherwise indicated in the prospectus supplement, the obligations of the underwriters to purchase
the securities will be subject to certain conditions, and the underwriters will be obligated to purchase all the offered securities if they purchase any of them. The underwriters may change from time to time any public offering price and any
discounts or concessions allowed or <FONT STYLE="white-space:nowrap">re-allowed</FONT> or paid to dealers. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If we use an
underwriter or underwriters in the sale of securities, we will execute an underwriting agreement with the underwriter or underwriters at the time we reach an agreement for sale. We will set forth in the applicable prospectus supplement the names of
the specific managing underwriter or underwriters, as well as any other underwriters, and the terms of the transactions, including compensation of the underwriters and dealers. This compensation may be in the form of discounts, concessions or
commissions. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In compliance with the guidelines of the Financial Industry Regulatory Authority, or FINRA, the aggregate
maximum discount, commission, agency fees, or other items constituting underwriting compensation to be received by any FINRA member or independent broker-dealer will not exceed 8% of any offering pursuant to this prospectus and any applicable
prospectus supplement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We may grant to the underwriters options to purchase additional securities to cover over-allotments,
if any, at the public offering price with additional underwriting discounts or commissions. If we grant any over-allotment option, the terms of any over-allotment option will be set forth in the prospectus supplement relating to those securities.
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">12 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Sale Through Dealers </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">If we use dealers in the sale of the securities offered by this prospectus, we or an underwriter will sell the securities to them as principals. The dealers may then resell those securities to the public
at varying prices to be determined by the dealers at the time of resale. The applicable prospectus supplement will set forth the names of the dealers and the terms of the transactions. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Direct Sales </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We may directly solicit offers to purchase the securities
offered by this prospectus. In this case, no underwriters or agents would be involved. We may sell the securities directly to institutional investors or others who may be deemed to be underwriters within the meaning of the Securities Act with
respect to any sale of those securities. The terms of any such sales will be described in the prospectus supplement. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Sale Through Agents
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Securities also may be offered and sold through agents designated from time to time. The prospectus supplement will name
any agent involved in the offer or sale of the securities and will describe any commissions payable to the agent. Unless otherwise indicated in the applicable prospectus supplement, any agent will agree to use its reasonable best efforts to solicit
purchases for the period of its appointment. Any agent may be deemed to be an underwriter within the meaning of the Securities Act with respect to any sale of those securities. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Delayed Delivery Contracts </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If the applicable prospectus supplement
indicates, we may authorize agents, underwriters or dealers to solicit offers from institutions to purchase securities at the public offering price under delayed delivery contracts. These contracts would provide for payment and delivery on a
specified date in the future. Institutions with which contracts of this type may be made include commercial and savings banks, insurance companies, pension funds, investment companies, educational and charitable institutions, but in all cases those
institutions must be approved by us. The obligations of any purchaser under any contract of this type will be subject to the condition that the purchase of the securities shall not at the time of delivery be prohibited under the laws of the
jurisdiction to which the purchaser is subject. The applicable prospectus supplement will describe the commission payable for solicitation of those contracts. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Market Making, Stabilization and Other Transactions </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our common stock is
listed on the NASDAQ Capital Market. Any common stock sold pursuant to a prospectus supplement will be eligible for listing and trading on the NASDAQ Capital Market, subject to official notice of issuance. Unless the applicable prospectus supplement
states otherwise, each other class or series of securities issued will be a new issue and will have no established trading market. We may elect to list any other class or series of securities on an exchange, but we are not currently obligated to do
so. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Any underwriters that we use in the sale of offered securities may make a market in such securities, but may discontinue
such market making at any time without notice. Therefore, we cannot assure you that the securities will have a liquid trading market. Any underwriter may also engage in stabilizing transactions, syndicate covering transactions and penalty bids in
accordance with Regulation M under the Securities Exchange Act of 1934, as amended. Stabilizing transactions involve bids to purchase the underlying security in the open market for the purpose of pegging, fixing or maintaining the price of the
securities. Syndicate covering transactions involve purchases of the securities in the open market after the distribution has been completed in order to cover syndicate short positions. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Penalty bids permit the underwriters to reclaim a selling concession from a syndicate member when the securities originally sold by the
syndicate member are purchased in a syndicate covering transaction to cover </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">13 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
syndicate short positions. Stabilizing transactions, syndicate covering transactions and penalty bids may cause the price of the securities to be higher than it would be in the absence of the
transactions. The underwriters may, if they commence these transactions, discontinue them at any time. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The effect of these
transactions may be to stabilize or maintain the market price of the securities at a level above that which might otherwise prevail in the open market. Such transactions, if commenced, may be discontinued at any time. We make no representation or
prediction as to the direction or magnitude of any effect that the transactions described above, if implemented, may have on the price of our securities. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Derivative Transactions and Hedging </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We, the underwriters or other agents
may engage in derivative transactions involving the securities. These derivatives may consist of short sale transactions and other hedging activities. The underwriters or agents may acquire a long or short position in the securities, hold or resell
securities acquired and purchase options or futures on the securities and other derivative instruments with returns linked to or related to changes in the price of the securities. In order to facilitate these derivative transactions, we may enter
into security lending or repurchase agreements with the underwriters or agents. The underwriters or agents may effect the derivative transactions through sales of the securities to the public, including short sales, or by lending the securities in
order to facilitate short sale transactions by others. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The underwriters or agents may also use the securities purchased or
borrowed from us or others (or, in the case of derivatives, securities received from us in settlement of those derivatives) to directly or indirectly settle sales of the securities or close out any related open borrowings of the securities.
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Electronic Auctions </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We also may make sales through the Internet or through other electronic means. Since we may from time to time elect to offer securities directly to the public, with or without the involvement of agents,
underwriters or dealers, utilizing the Internet or other forms of electronic bidding or ordering systems for the pricing and allocation of such securities, you will want to pay particular attention to the description of that system we will provide
in a prospectus supplement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Such electronic system may allow bidders to directly participate, through electronic access to an
auction site, by submitting conditional offers to buy that are subject to acceptance by us, and which may directly affect the price or other terms and conditions at which such securities are sold. These bidding or ordering systems may present to
each bidder, on a <FONT STYLE="white-space:nowrap">so-called</FONT> &#147;real-time&#148; basis, relevant information to assist in making a bid, such as the clearing spread at which the offering would be sold, based on the bids submitted, and
whether a bidder&#146;s individual bids would be accepted, prorated or rejected. Of course, many pricing methods can and may also be used. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Upon completion of such an electronic auction process, securities will be allocated based on prices bid, terms of bid or other factors. The final offering price at which securities would be sold and the
allocation of securities among bidders would be based in whole or in part on the results of the Internet or other electronic bidding process or auction. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>General Information </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Agents, underwriters, and dealers may be entitled,
under agreements entered into with us, to indemnification by us against specified liabilities, including liabilities under the Securities Act of 1933, or to contribution by us to payments they may be required to make in respect to such liabilities.
The applicable prospectus supplement will describe the terms and conditions of indemnification or contribution. Some of our agents, underwriters, and dealers, or their affiliates, may be customers of, engage in transactions with or perform services
for us, in the </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">14 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
ordinary course of business. We will describe in the prospectus supplement the nature of any such relationship and the name of the parties involved. Any lockup arrangements will be set forth in
the applicable prospectus supplement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under <FONT STYLE="white-space:nowrap">Rule&nbsp;15c6-1</FONT> of the Exchange Act,
trades in the secondary market generally are required to settle in three business days, unless the parties to any such trade expressly agree otherwise. The applicable prospectus supplement may provide that the original issue date for your securities
may be more than three scheduled business days after the trade date for your securities. Accordingly, in such a case, if you wish to trade securities on any date prior to the third business day before the original issue date for your securities, you
will be required, by virtue of the fact that your securities initially are expected to settle in more than three scheduled business days after the trade date for your securities, to make alternative settlement arrangements to prevent a failed
settlement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The securities may be new issues of securities and may have no established trading market. The securities may or
may not be listed on a national securities exchange. We can make no assurance as to the liquidity of or the existence of trading markets for any of the securities. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="tx815101_13"></A>LEGAL MATTERS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Unless the applicable prospectus
supplement indicates otherwise, certain legal matters with respect to the validity of the securities offered under this prospectus and any prospectus supplement will be passed upon for us by DLA Piper LLP (US), Phoenix, Arizona. Counsel for any
underwriter or agent will be noted in the applicable prospectus supplement. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="tx815101_14"></A>EXPERTS
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The consolidated financial statements of Clean Diesel Technologies, Inc. as of December&nbsp;31, 2011 and 2010, and for
the years then ended, have been incorporated by reference herein and in the registration statement in reliance upon the report of KPMG LLP, independent registered public accounting firm, incorporated by reference herein, and upon the authority of
such firm as experts in accounting and auditing. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="tx815101_15"></A>WHERE YOU CAN FIND MORE INFORMATION
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We file annual, quarterly and current reports, proxy statements and other information with the SEC. You may read and copy
any document we file at the SEC&#146;s Public Reference Room&nbsp;at 100 F Street, N.E., Room&nbsp;1580, Washington, D.C. 20549. You can request copies of these documents by writing to the SEC and paying a fee for the copying cost. Please call the
SEC at <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-800-SEC-0330</FONT></FONT></FONT> for more information about the operation of the public reference room. Our SEC filings are also available
to the public at the SEC&#146;s web site at http://www.sec.gov. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">15 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have filed with the SEC a registration statement on
<FONT STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> under the Securities Act relating to the securities covered by this prospectus. The registration statement, including the attached exhibits and schedules, contains additional relevant information
about us and the securities. This prospectus does not include all of the information contained in the registration statement. Whenever a reference is made in this prospectus to a contract or other document, the reference is only a summary and you
should refer to the exhibits that form a part of the registration statement for a copy of the contract or other document. You can get a copy of the registration statement, at prescribed rates, from the sources listed above. You can also obtain these
documents from us, without charge (other than exhibits, unless the exhibits are specifically incorporated by reference), by requesting them in writing or by telephone at the following address: </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Investor Relations Manager </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Clean Diesel Technologies, Inc. </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>4567 Telephone Road, Suite&nbsp;100
</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Ventura, CA 93003 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(805) <FONT STYLE="white-space:nowrap">639-9460</FONT> </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Internet Website:
www.cdti.com </B></FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="tx815101_16"></A>INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The SEC allows us to &#147;incorporate by reference&#148; into this prospectus the information contained in the documents we file with
the SEC, which means that we can disclose important information to you by referring you to those documents. The information incorporated by reference is considered to be part of this prospectus, and later information that we file with the SEC will
update and supersede this information. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">This prospectus incorporates by reference the documents listed below that we have
previously filed with the SEC. These documents contain important information about us: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">our Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarter ending March&nbsp;31, 2012, which was filed on May&nbsp;10,
2012; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">our Annual Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT> for the year ended December&nbsp;31, 2011 (including information
specifically incorporated by reference into our <FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT> from our definitive proxy statement for our 2012 annual meeting of stockholders, which was filed on April&nbsp;23, 2012 and amended on
April&nbsp;23, 2012) filed on March&nbsp;29, 2012; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">our Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed on February&nbsp;17, 2012,&nbsp;February&nbsp;28,
2012,&nbsp;March&nbsp;14, 2012 and May&nbsp;7, 2012; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the description of our Common Stock, $0.01 par value per share, contained in our Registration Statement on
<FONT STYLE="white-space:nowrap">Form&nbsp;8-A</FONT> filed on September&nbsp;27, 2007, including any amendments or reports filed for the purpose of updating such description. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">All filings that we may file pursuant to the Exchange Act subsequent to the date hereof and prior to effectiveness of this registration
statement shall be deemed to be incorporated in this registration statement and to be a part hereof from the date of filing of such documents or reports. In addition, we incorporate by reference any additional documents that we may file with the SEC
under Section&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act (other than those furnished pursuant to Item&nbsp;2.02 or Item&nbsp;7.01 of Form <FONT STYLE="white-space:nowrap">8-K</FONT> or other information &#147;furnished&#148; to the SEC),
from the date of the registration statement of which this prospectus is part until the termination of the offering of the securities. These documents may include annual, quarterly and current reports, as well as proxy statements. Any material that
we later file with the SEC will automatically update and replace the information previously filed with the SEC. These documents are available to you without charge. See &#147;Where You Can Find More Information.&#148; </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">16 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">For purposes of this prospectus, any statement contained in a document incorporated or
deemed to be incorporated herein by reference shall be deemed to be modified or superseded to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated herein by reference
modifies or supersedes such statement in such document. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">17 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g815101g16o58.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>CLEAN DIESEL TECHNOLOGIES, INC. </B></P>
<P STYLE="margin-top:36pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>1,385,000 Shares of Common Stock </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>388,393 Series A Warrants </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>168,571 Series B Warrants </B></P> <P STYLE="font-size:48pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PROSPECTUS
SUPPLEMENT </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:119pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>Cowen and Company </B></P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>November&nbsp;4, 2014 </B></P> <P STYLE="font-size:30pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:4.5pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g815101g16o58.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g815101g16o58.jpg
M_]C_X``02D9)1@`!`@$`8`!@``#_[0SJ4&AO=&]S:&]P(#,N,``X0DE-`^T`
M`````!``8`````$``0!@`````0`!.$))300-```````$````'CA"24T$&0``
M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X
M0DE-)Q````````H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`&
M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4`
M```!`"T````&```````!.$))30/X``````!P``#_____________________
M________`^@`````_____________________________P/H`````/______
M______________________\#Z`````#_____________________________
M`^@``#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0`
M````.$))300:``````!M````!@``````````````20```+L````&`&<`,0`V
M`&\`-0`X`````0`````````````````````````!``````````````"[````
M20`````````````````````````````````````````````X0DE-!!$`````
M``$!`#A"24T$%```````!`````(X0DE-!`P`````"DX````!````<````"P`
M``%0```YP```"C(`&``!_]C_X``02D9)1@`!`@$`2`!(``#_[@`.061O8F4`
M9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.
M%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`S_P``1"``L`'`#`2(``A$!`Q$!_]T`!``'_\0!/P```04!`0$!`0$`
M`````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)
M"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$`
M`@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D
M8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4
MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1
M`Q$`/P#T3K'6<3I&*,C)W/+W"O'QZQNMNM=_-X^/7^?8]<QU#-S[;JZNMYE^
M-??[J?J]T;WY.WG=F9M?Z3Z/\YM?BXO_``BCE=0R+\N[KM+1=F79#ND?5FE^
MK&&759O4G?UWTWO?9M_HV/Z'^&6RSZOOZ7T'.HZ9^L]7RZG^IF6D-LNO>TM]
M:VT[MC&.=^BJ^A6I0!`"]SI_+]UC),KKH\Z,#HV=3T*["PG8]_5<Z9NN?=:<
M?&-E][G66V6?SS,=G_;BO]0SG-ZW:*.H9G0^H6V%E%74&A_3LG8/3;]GU=75
MZ[6,_FKJ,CW_`,SZBTL#H.5C=6Z67-;]@Z1TTX]+@[W'(>:J[3L_<^ST?3_X
M1;.=@XN?BV8F92S(Q[1MLJL$M(_\E^XY&637>QK_`%OF*(PT/0Z>#G=&Z[9E
MY+^F=2H^P]8QVA]F-.YEE<[1EX5W^&QG._ZY19^BM6RN%R<#J%%K^BLM=9U/
MI3#U'ZM9MFMCZF_H\CIF0_3U.?LUON_346TV_P""77]*ZC3U3IV-U&B17E5M
ML#3RW</<QW\JMWL<F3B!J-BOC*]#NW$EG=9Z[T[HM#;LVP@V$MIJ8-UEA'TA
M56W]W\Y_\VQ8E'^,?HC[-M].3C5D_P`\]C7-`\7^A9=8W_,0CCG(6(DCNHY(
M`T9`%ZQ)4.I=8Q.G=+?U6PNNQ6!C@:(>7-L<RNM]7N:Q[?TC7?3^@L+_`,<C
MHG_<?,\_T;/_`$JE''.0N,252R0B:E(!ZQ)9?3OK'TKJ>)=E85IL&,TNOI+2
MVUD`O]U3]KO?M_1_X-ZQF_XRNAN8UPQ\R'`$?HV=_P#KR0QS)($3IN@Y(``F
M0UV>M27,8G^,#H^5E48M=&6U^38RIA=6T-#GG8W?%KO8C97UUZ5B=4=TJRO)
M.0RVN@O;6"S=9LV>_?\`1_3-_-1]K)MPFZOZ*]V&_$-Z^K__T.AZ%17^T?JU
M3'LQND6Y5?\`QMQQF6N_S;;/\];7UFQ[<O"9BMZ6>KUV6!UE/V@8P:&>]EAL
MW-<[])_@VKFL;(?TVC`S+I+_`*LY5W3.IB-1B7D-Q\S;]/T6,^Q9'T?]+^XN
M\:]KFM<TAS7"6D000>'`J7)8D)>?Y_\`H7$QP`,3'R?/;^DX&+9BMS?JKZ#<
MO(KQ:W_M!S_?8=/;4]SO:QK[$2_HO2WYV;C=)^K)ZA7@V"E]_P!O=2#9L9<Z
MO;=9^9ZNQ;W5GLR?K7TC&<0*L"G(ZC?/`T;AX[O[+KKG*7U):YW06Y]@VV]4
MONSK!_QUCG5?^R[:DXY)"/%K_C2_[[^JM$!Q5I7E'_O4?5<3'Z?F_5C[-6*A
MCY+L6NL$NVU68]PLKWN]S_YFO_,1?J:WT^EY&,S2K%S\RFK^H+[2T?\`35/J
MW4\:SZP?:K'?Y/\`JO1;DYE@X.3<PU48C9^E=7CFU_M_PEU-?TUI_5/"R,/H
M&*W*&W+NWY.2#H19D/=E6,=_*K]7TTV7R"]]/^ZDN'SZ?RV>)^L#7=5^O#L.
M]SFU&^C#!&A;5M9=:VO]WU766^Y=5U?ZD]%RL5C,-E?3+J7#;D5L&K?SJ[AN
M9ZV_]ZQ^_>LKZY_5CJ+NH#KG2F/M<[TW7UT_SK+:OYG+H;_A?:VMME?\Y^C_
M`,)^D61U'J/UL^L=-?3;\%]C6O#G,KQ[*0][?H.R;<H^E6QKO=^8IA<HXS"8
M@(CU:_++^ZP:1ED$X&1D?3I\WU=[J_23T?Z@Y?3QE?:V56,-;PT,VM?D56>E
MM:ZSZ#G.57ZD]`Z/U;I63;U#%9?:W*=6VPR'AH92X-8]A8YNUSW*WF_5Z[I?
MU!NZ716<G+<:[;68["[=8^^JVWTF-&]S*F^WZ/\`-U^HN?Z9F?7#I.-9B]/P
M<BNNUYM<YV'8]P>0UGL<X;/HUM^DQ"-RQR$9B^.[O@3*HY(F437!55QK]&I'
M3OKJ,!KC;3Z]V"_<9-E+ZWV-9=&W?LV5;_\`BUH_7?H?2.E8.$_IN)7BNLOV
M/=6():*K7;/ZNYK47ZG?5CJ;>ICK75F/I->]U5=I!MLMMEMF3>&[O3;M?9L9
M_.;W_P""]/\`27O\86)EY.#@LQ<>W)<S)+GBECK"!Z5K=SA6';6[G(F8]^%2
MV`$ST)0('V9W'<W$>"OJ=T#HV1T7IW4KL.I^</TOV@CW;V6.V63^\W:L?JW4
M<)GUMLH?TC$MM&9CL^U/+_4)<<?;;[?;ZE>[VKJOJ;3?1]6L"J^I]-K6.#Z[
M&ECVG>_Z;'^YJX_K'3>IO^N-N17@Y+Z#FXSQ<VEY86M^S[W^H&[=C-KMSDV!
M!R9.(])5JNF",>/A'[MZ/__1[/KW3,NC+/6^ET#)M=7Z'4^G.C;EXXG@.]CL
MO'W/]'?_`#M?Z!9_U=R<FG8SH%C>I]$-C:WX%[_2S>G;CMLJ=ZWNMQ\?W?H+
MOT^S^8LO78E8>5_S5_YRX?K>E^W_`'>AZ>[UMOINW?:?0_P7H[MGVO\`1_Z-
M26>'U#2M/V,9`O0]7$ZG=D7N^M?4,:M]UC:ZND8@K:Y[P[;^L;&5![_;=G;_
M`/K2L'/ZP>EUXN#3^P.EXM3*K.K=2VLL;6QHK_5L$N=ML_<LR[*_^+6?B_;-
MV;^Q_P!M_9_M=_VCT_V?_2-Y^U1Z_P"G^E]%&PO^:7VVK]O?;OM^[]6_;^[;
MN_[KS_DS=_43S5#Z</\`BK=;^V_M2=%Z31U=F/3BTOJ^K&)8,@/O!];J62#O
M^V9.\->_%]3]-^E_I+]GZ/T*]E?:B4P4E'.^HIDC735:$DZ28N62U3I)*6('
M*4:ITDE+0E"=))3_`/_9.$))300A``````!5`````0$````/`$$`9`!O`&(`
M90`@`%``:`!O`'0`;P!S`&@`;P!P````$P!!`&0`;P!B`&4`(`!0`&@`;P!T
M`&\`<P!H`&\`<``@`#8`+@`P`````0`X0DE-!`8```````<`"``!``$!`/_N
M``Y!9&]B90!D0`````'_VP"$``$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$"`@("`@("`@("`@,#`P,#`P,#`P,!`0$!`0$!
M`0$!`0("`0("`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#`__``!$(`$D`NP,!$0`"$0$#$0'_W0`$`!C_Q`#:```"
M`@$%`0$`````````````"0@*!@(#!`4'`0L!``("`P$!`0`````````````'
M!08!`P0""`D0```%`P(#!`8&!04+#0````$"`P4&$00'``@A$@DQ$Q0505$B
M%A<*87&!D3(8<B,S)1GPH=%")+'!4F*R@S1$*'@I\4-38W.$-59GAS@Y61$`
M`0,"!`,$!`H$"@4-`````1$"`P`$(1(%!C$3!T%1<2)A@3(4\)&AL<%"4B,S
M%6)#)!;1\7*"HK+2H[,7DE,T)3;"<X/#TV24-<4F1H8(_]H`#`,!``(1`Q$`
M/P"_&JJFB0AC`7NA*7\`4%3EH-.(=@CK@8R6[DY,(_W;7F1\=NS/)^/7@VX7
M<CA?:OC2_P`H9XFC7"8JB)4+)"^4$SF^N)ZK(L\?9B!<O3^_\A>84D$SF`O&
M@``B$_I.UKC=-V-OZ?;`L/:2`U.\D^G@F))P7&H;6-?M]`LAJM[G=*[!L3&E
MSW%%1K0.**220UH!S$8*D`F^SJ=]0>\NVCI]8/L,!X.56*WDW(9EM+3S>Z)S
M)`=X93.1+F.C;`9(Y3H-+-)%2#VJ%'@#?=L+973S27C>6NF_UD-^[C8",P['
M!D>4I]E[ONSBC3QI8_O=NK>SA#MJQ-I%F/,R21N$1#AY)KC*]H>$.:"(<]H(
MS2,.%<%UZ2CO)GZ,QW?'U5\KSN>SEQ2MH_C)IG[7#_/W$1`R+9&V/)#],O>K
MFK^R394Q,`]FM$/4"*#1'6^D[4,%F/UP0-7@00(D(\7D_%6Q^Q9[AONNJ:]'
M+?O02`DRRG@01(]S2UQ[Q&QJ8(5J%69>G3@7`?4^V'[6<"ON2Y1<29Y:\M98
MN)_*F5W<K*-Q=_._`5%2,1B'D:`/',?N7$`J8W*!:#VW';_4;<]QL/<5SJSA
M[ORG<HIE!*!H52<<P`"''$(:J&M[%V[;;OT73=,>X/;)".]S"9'/>&Y0`G+S
M.=F!(P=F'"GF;[MON_7*628SDW8]NU:L3N..(R#&\X@?%C^ZLBD%TZJO9GB2
M)J6LM8%+VZ9;FW213<65:B!0$#@4^D_LN_V+INGW\&XMORR3S3N/,'`A&\'!
MP<T\4(S''$8!&KN_3MX7]Y!+MW5VQ11L:@#PUS'*[,2QT;V2M(+26/='["-<
M,Q6'V->KWF[;?.VG"'5=V^..$'V_76LV3/<%;U';'#XG2V13<')O8;F46AT$
MP.)[EP:')7D$X`9N0`*A8+OIS9:[:7.K['N#[L3^&5RYL"F8^R4X"X13VBH3
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MV2EJ<P\I1'4CMS1KO=%S;6.B#`XGP&'B5.`:%))``Q6H?7=8MM!A9/J0+I7O
MRQM':47B<&AK07/>XAC&M))"57NPY@9PWDJW75/ZNDB;(GM\C;0K,,)X'>KM
MYL8(PP3Q)#,#N[,)JJW$=DRPIBTM8%7=YDI<(F5*<BJ=@HU[V_L-.T^VV=L_
M2UW#F1]P$7`(24("GBKOP6=H)(8KK>RNM2N_WKW3?Y=OY"6QH?.2[,QC55&,
M&4(TK-*3ES!C9),Z;]R_4#ZISG=P786WALMV8Q.\]WASTY6RD>E\C;&8P6]N
MW1-:/DYV*X+;HE(1HC_+Y7R=W>N90,5'6O\`=W:FQK6VGWI=B_UJ5%B"$N!/
MU02T)Q&:1"$(RD@BM_YYN?=.LR:?MNU=:Z1`#YQY&,<%`$S\I+B<'"*WS!P<
MUQE#"U]1WV+;-(KCWK=/&.V>:2C+R.U3&[G/)ODB=_VEV?LD2&%,+"J'?B8Y
MQN;1YR&)B<YCF`6PU3F$`-JS[UW1I^J=.M.Y>BLMI9(TC5PD(^^P*H`"Z%I+
MD`0H`!A51VCHFJV/4FZLY-2BGM89W2/Y;,GLVZ92KWO+8I96,9G<YS@7%SCV
M3!VGHV^Y/KG[W<Z&2-?1+;=`++$$;5`]$+:7I>10:Z.`>R(EN58S)J=H>UQX
MZIVY#J.V.F6CQRA&728'T_M!0<<"6`]RIVBKEH@T_<G4"]NP6E]L97`M[0P^
MZMS>/WA'?B?#V[=ITAG?).8Y]NQVN[K,M;?-RLL6;'5QN+R3.5[!G^X86"U8
M&5G56C@V<FCK*=G:R)FJ+U;@2H%;Z!R#$:'OPVUA#IVH;?AEM2GK0)B#F805
M[FXXD*E2>N[$==74U[9ZW)%=,S$9ABTN<'%)(\DH(R@`JXH"P(TD&*[/O9D;
M6_FZ?770PG%?*9E_8X/N,*U@7&4S(%PE;-3X\.C"*-M'%C*+`H$G:O)_)C&(
M5TL&JBBI9U^@:DZ[.XNFDI-D26OC:IQQ/*Y;ES>4'V\"F8`*P5"2:UIGNKM`
MZBQ#-&&O9)(6B0#,U@ES,3+YW-QC+D#LCG29)'#%FV\RWT*LY,30YO4IROTM
MLZRHEHUNMT7SMWP3)W\IK@%`"W+WB%PGW1C'`H=V^-A3&*4[HG37N2/2]\6'
M*$'(W5"4Q*`$*`TE%+"OE.#FR]KLQS9AN=3V?>AA9S]LS-S![,>8"`7.#%.2
M5H&9P"LDC<H$63*VSVS/K')F9KD,<=;%X8'YL:WAE=FU<M[87[6[H%59G-L6
M*8]J>WNDU"G(<H"!BB`Z3#HY(WW$<H(IQ1R1S1Q2PD.C(4=WP[^T<*R37OU8
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M6+<-J=%`REU<-=\ULRA.8K8RV=[?HF*HX))ZZ[9L?3_:QW'.XOW%?DX.\W$@
MICB0SC,,$ER@\6N&=1(WSKMMM^U?RM(M/,'1DL<QH#F%!Y4,@)9%@X<L/1"R
M1CK*$*C<7@4688?"(^WQ*%1)BM&6-Q1DL+9M:F=I:[84;-K:K&W*0J*%J@A0
MH``5[?7I'W<NJ7NNNO+W41*9PI7M/>?@@`0``)3<LVV=KIK8+2S,<,+<`%P'
M=QQQ[3B25*DK21^E)@W/V.,C=0S=?N`P_+(ID#-F4+]WAT.>Q:CR5TBS(>3R
MFS;V0R!Q`R5Z,ALFM$3"!#&;0"E0III[YU+1)[#;^F6&H0\B-ZR'B&`-:V,D
MCM`7#C@J]R[V3I.H6VH:IJ5W#(9I(@`'-R>9TLCY!B2H4M.8(!F(11CF71(V
MT9DPKB'/F2-Q<%>X!FW.^?I/,GIED(-Q7)*.)6:*[(=5.V,8"":1/[L:@B`B
M`A[(>GAZ@[A_-KBPBANA-;QQ$X$?6.`X#@`WX<>K8&@_E45U+-;.9*L<:$$$
MB-N)Q)P+W/."?&H#N2\P?B*(FK6I4P#^>HU'2Z8RXR))<#-X4PB6AV$9J(V[
M3:GBW>EAE[PQF1ILU+!P,>\BLB;DB+/T'DR*0E;).Q72H'+;7R`J"`A02G*(
ME,`A7DDM#W?:[1U6SGM'CD$`%IX''#AB"#BUPQ!3'C4'KFV;G<>FW$%TYL%X
MU3$\!2THAP)1[7-5KV'RO:2#Q`I*.QI1ZR$S;B>A[OU.M(9#CJ-.2>')?<@9
M5Q?L8V2I+A@<&!T.-17AY+JQ=H[S&$R#2(MY@(5N,EIP;EM;?3X='ZB[<N01
M.Y98R1B'*U2`B*YKFO`&!RE"<Q"TV]</OI+S8NM0\N*,EL*`K%+"DA:UQ+LS
M,CXY(G.<7.;S`<K#&VO;.BMF"<P"ZW`=-?/-\93*&SZ9NGN'>WACH%D>(%W=
M-%%5D3N027.Q1J]N+*_MSG[6>2MY0"A=5S?]C'=7-MNJSQM+J)H5.S(,H*#B
M&H#W>5<34UL;5A'<7NUKA&WEN2[*I)S`ALQ"N)R&12T\'.,@;@VGXI%215`"
M#S"H6@"/I$H!Z*5+_1I/#]DU1T2?BA::A<)FF7TURE"@(@(#2H^BOV=GKIKI
MEMN<\.@('>:\!X:$=2W-R?5=V/[4WQPAV1,LJ2/(;:!5'3'&-F9><R5F,"12
MF2?#-')'HVL(&`>[=G*V/V"'"FKOH&P=R:O'EL[=&HJRE,#X*0,/:.'IJGZI
MOO;^F/2:X<Y^8CR`'$`>4.):U[\1Y&$O]%1HA'7^Z>DL=DF=X<LL8VM;E8;<
MK[D/'?=QT3@%:&NHF^2]5.H_X2)0X\1#4[=]&]TZ7$X&&V/8G,(4]P+HPU?7
M45;]4-MW3F&.292%P#791WN:R1S@!VJ*;YC_`"#C_*$3:YYC.51Z<1!\M!NV
MB519WL9`S.*'.8!6L76S7N;6Y*)@$!$##Q`0TN]1M+S0I.3>6Q"8I]*JA'I&
M%7JPU6WUJ#/978=&J8=A[B,"".X@&O$MU>\/!&R^"Q[(6?9$YQN*RB5(PQIN
MFV/O4G4-(EVEYD":2MNR6US<<@VK`MZ`'F#AP$:2&A:;?;ADY=G",WC]*>/8
M>%1FN:Y8;<B9+=2.1Q*(%)[RBCO"A>VH.'Z\G35$*ER[*!*`=OP@RR';0>`>
MY?H^[5NFZ2[BDCYTT#4\7?V:I)ZO;;;)DR3KX,_MK65P_K:],R3WJ+0CN(!C
M6.7F3NICCS*$9;Q&O%,'1]AUK:@/Z1P`=<UQTYW-&SGC30X'@%`/])/GJ5T_
MJ+MJX9Y;J1C1Q);F`\2PO3UBF6PN8Q#(,?;IGCV3LLRB[S:^):I%%7EK?HZY
M(U$O?6;NTK7%M=D$>P4C#V#]E+O=.N+.0PRAT+QQ"(?'LP]-6_3;NSU!@N+6
MX:^(]H((7NPX'$8%*7[GGJR[']M.89/A'+V1Y"R9(A:;*:2-S?C:<R)N;_>)
MDMI,SE*]1V,N-JI^Y'8IN`5H-!"H#JXZ'L+6-?LQ/9VT/N_<57X@"`J+BGJX
M56-?WQHFA7+V7$LA>W##(W$)P+W!2,P4#-Q'$8UY4'7BZ:!:@.7Y>`B%!KA_
M*U`^T(EK<.DNX["?"V:'^+O[-1'^;6UY6$'G>",^A]:/X[_33,8!0R]*!#TB
MIA[*Q:?=#%!X?W-=!Z-;GGDYKK:'X?\`1'YZS<=5]M6;<OWQ'\SZ9!4PMIF^
M';1O=L9VMMYD[M*4,=W<>MI<#K&'^,K6"DB*\G92HHOUK:+W)5BL=Q40"A0#
MB/'A7MP[9U?;,EM%>N@+GK[)+A@BX$!#B/X:M>A[FTO=]N^>U<_*T`HX93BI
M!P)&./#NX5&][ZV/3=87AVC]_GI=)R8'AT9'>V-B[*X!:.#$ZF:70@#[EB`]
MU<)FY:=H<?6&IJTZ8;GOK/FMM&B%.!<%"<0?6@/%%JOW_4C;MA<B$\]Q+FH6
MQN+3F4A#WEH);@%0X5F_\5G8S[G^_P!\:R>ZGPH^-_C_`'!GM?AS\=/RT^\W
M<^6=[R?&C]V^$Y/%4_6\G=_K=5O_`"^ON;RO)F]XY/M_7Y?,[N&7M^1,:E?W
MYTCD\[E3Y/=^=^']7F\I./MYNS@G:N%?_])H>P>9N.VOI&[Y]^EY>K!F/.DS
MR8\-TI/0;\'RX=PQW`+HW8//8Y0F#FY#Q#F!?Z`T^]W6<>XNI&E[9RY=-A<Y
MP;W`9I$3@`1&T#N6D3LM[](V#>:Z)&G5+EL,1?Q\Q$<9/826ND>X\%RBFB]%
M3;_8X$V"8BO5[=1.5YLL2YFE]W=F$UVX7<W);GCZRO&I.6*E;B#Z1$!$>-=4
M#J-JTNIZZVR80;&S;R_%Q\SSAVDG'N`"5=>G&E1VFEW6J$)=7TID`^S"Q60L
M"XY0P+Z2XD\5J>^=W'--AAK(UYMW8(](,W6L7=0QBWS2^)8Q6[DQD*-/FRB9
MT"^6$4"H`)R@(\!$`$1U3=.BT>XO;9U_./=QX]V'!2,>U"@X=E7'4KK5&6EP
MVQLC[P"!]50`<2`X@$HN!<U2@)%)H3F_S%O*'?8;VAF/Z:.3%R=GH#XJ@;39
M;:]&I;8MN+E_/[\ET?H(I57!ZM"60VYFR=@RZ>GRO#OCK;]^/F-0'V<-[/1*
M%.!W5G$P_:7*=!^_7)/'TJ,WW$\@A\+GZ6UVQOZF@XQREOZ0L5_HOKZ,Y^8T
M$/9PUL_`?^L=&6GH_P"CRJ(\=;)X^DQ;]S-)G\+GZ17B%_4_F?>13Y/3^7_\
MERUW,9EGS!]W)XNA+<7;3V2+KR*.VDK=+)P:W!6PC97E$'YUM[!')YU;BX\H
M`X]VF3F&OL@`]FU[>C[M/$,<<@N2?^\'#M0D`<$0%<25485J:WJ?',^Z?+<.
M"81GW!K%0(J%SDS%Q<X."M#0@.9QP7K.,YMN^XG8!U$XJ*K8^P#+=CBG)EU:
M4(=Z@+TBN_EL;L![$ACEM)&\1'A1U]=`'3TWM9]R.OMJS3_LAC>`?LYR`J>A
MP!'I-9ZARVF@&TW3&C-0):\!#YW0,<\-4<"6*'=[6]XK?W56OY=NN9LBS@QB
M:S8=U,+<\-S8$AJ@^NY")Q-J7.:HU'Q#_'1]5+$/6.L:1'+K/3[5K28>2P$I
M^))6@^O..S#PKFU-C=*ZE6%Y;R>2]?`].*F1CK:4CT%K(.*^;AQJPHK<DM[\
M4BE]I9!9<H\:<R)#":M?6(#I12,B=$;YWZK#X=U.)C\MXRU1.9C2/.N!OIDF
MU[#\/P_B5Y58<QYX%W3&6V*Z7F<#QXQ%1!\>6816!1*3R"Z=`;F<U`_UHY#`
M=$NFCTEVDW6M3$MT0+6!./?W^D@>R$*N([C2IZM[H.D63=.M@XW,H+G`9@<H
MP:"F(:]R\UP(+8FO`Q<VJGFTO:%F/>5E"ZQ=AAO:5[]NL!E$ZFLKNE+*,Q)N
M4/1)R>79)&XN5KBY,:A44D3&,;T=HA]2ZSOK0.GML8>1AQ)[5[$`13\0`KYL
MT/:FN[RN&&U*RHC6J@#0?-F)7*T$E"5)."&IP[Q.B_N@VBXJ=LU7<IQSEN`1
M&S\;/!A@/+3(X<T\Y;<7H[/($B6[VQ)"8.\3*L)R]HD`*B%"T?K-8;BU>*UE
MMS'G'ZP#$IBGF*^AI1>PU=M6Z0:UM[3Y+Q\\<C'/`S!Y<UJN`!>3&PMQ(61J
MHN+0M8?T@]Z4GVL;LL:0%&2W%Q@_<),&R`SN$+W`K-MG*)+2.PB8M-N)@39W
MU.3^!)<'IQ:!,41$0*)=_67:NA7^E,U"QDB]Z7#'@1CA_*'U3@F5P`-:^F6]
M+_1]8-I?1R9"`'$`^=KBA+RJ'DN4&5HS9\['%P1'D_,A('_*5AM4YA.D?<A&
MTP((?A../\F&#L'L`HTTJNB$EN[<%PV8?585_G.ID=<(KC\LTJ6*1`))/ZG\
M55B=J.U+).\_+RF$\..</9Y>E#7*;#>3R\>6MG\I9#L"9@&XC\:E9RGYY`6@
M<M!J-1#T_2&]-Z:=MVP,\\'EP\<2$0<$QQQ]5(#:VT[[7[J.SA<L[G%!]7`/
M+R22'`C*$&0@XJ0F,C=TG2<WF[2X5>Y*R/"XI-\:L1@]X99B*1+R5**-O*8Q
MG:0-%U&XK)DV>V$@@=Q%/E3X"<2@/&N;8ZM[;W%*W3%/O!'>CD12@09D`)*.
MS(,`:L.M])]Q;>MC>YP'9DX9HR5`"NSOR%[B&M#HQ&2<7#&N5TM=\LRV6[BX
MFTW$E<#[?<MR1KA^4(E>7HFC#"9]N+9F8LF-8'$097F,'02,L6E5V(!#MY1+
M!]0.G#-;MY]0L@KVX-'!"F`![`4`+3AE1W$5U=.]\WFAWI9=3+%-YI"5)>%\
MQ*G%S5+A($)DSQE0X4V;J$=%S=SN@WB97S]C&6X.L(;-;.")-MI,9)-&N2E6
MC,+CL8N>=*/1"_MT"]XQ5*/?<2B'V+;8_4O3]MVD-K*'-#/T2<54E6N"`G^*
MF9O#ICJVMZE=7\22%SE;YV`(&AH!:^-RD)CP''QI`^ZO:MD?91F!+"68W"&/
M$O5AS9-O%P5W>G5G!H>U)`D%#OT;BAN]YX\>H<H``4XC7@_ML;UT[=,7OL-N
M4Q[<5"JH0!,`F.-(7<NS=2VY.^TNW#FM<`4`+4(86$.4N).8J,H`P0E4'O.S
M;IA[BM]L$EV1<'2/#S3'HA.%H.ZVN1I)(&UP,[V[(PR,XE+'HI+@`@)/Y>)A
M+QJ%-0VZ.J>C[?ECM[BV+G.5``N``53P!4\*E]J]-]8W;;22VS@&L`S.<0T*
MXN`R@H2"UH*H,01W59HZ.W3XSQL*;\^6^;WO&3PIDQV@-^Q?#AX?W8ML2/-L
MA3<?.%'V+10Y%16?BB7E2/P`1X<-?-_47>=ENB:UEA"<K-V(BH"O>I"KW'&O
MH?I?LK5=J>_MOW@B1C`/,78MSD`#ZH#7AN4\",%4HG.=?+[[Z9#.)Y)&^:[9
M0L)5-I@_6AKJ93L7`MB_O;LZH"H;X6`0%!3NBB8.:H"/T#IRV'7/1+?3#;.L
M`)RP_J04+B2B@]Y[B/DI6W_1/<$]VV8R!SF!C`1.@<(VM8'%I:"I:S'$%2I'
M%)'_`,%G=A\!OAS[SX:]Y?R9?ETY_-'3P'O;_$D_-3XSO/+:^YWPE]CEIW_F
M7L=U3VM*[]^K+WWWGDA/S+F^R?8]UY'S_4[L:8/^7-_[E[OS)%_*>3^*/;][
MY_=[2?K>"X(N-?_38CD.I?EFX'Y6-2>\%GYI3C0"[HY+WE>/LT6*B.OH&XG=
M:]8=8>T8.MD'@;:,GYB*^=67$7^4N@W4PXZBKOY1NI@/ERU95VH+6"6UC;(1
MO#]WJ;?\1#:]SZ$B0&-"`!6G;S:2NY&2LW9KO,&+;B?X^:?H2GAMUL8T#0H(
M/9-M$!ZHPOTUY/O/PGN6SSBYGA6V?<@.VZ5VTX:7F1SBUC]S>.5U%V]F?T[A
MC:5+-0JPK+OEU8K"/,4O+9B%:\!Y-JZMM*RN;R:^V^YX1,`#V@JA"$X(/F-:
M]P:9N:[9;^X:RR/*Y7!S'`.P(`+F$.`4K@A.&-+7_AI]5T`#FZNDR[>WW:DX
M^JG#WF"NF?\`OMTW9&KMF?T(_P"&J7^ZN]7._P#/!_XJZ_LU$)1FZAN&.I9M
M&VAS#J#9+S8;(5RSY1G5JT&NXTTV./(VYR.1/S(\IA<+G61DT7@%^4?:+4!H
M`#4!&6;)M._VSK.X8]O11-"B+,QB*$#4RH,7%`!Q((PJFS'?UGO;3="?JS"Q
MSXR<DL[CD<XF0%DN;,YC&*2<`'M)4H!)'?'D3=QGWJB0G9#M2W)R;;FW1K!@
M3J>R*-D-?-3>[G!^E)[M_9TA0-<&NFI1AL2")P`OF=1J'`87;>F:#I6RK[7]
M5TX37$DF9@RM<HYW*(\R@(0I*8@H,<:GMQW^[-3ZAVNB:9=EEF(`T+)(QH>&
M&5SW"/&0EK@QC20&N:I5I2I+[3-C'4!Q)N!B>1-P/4/EV=,;QFRE*;UC4S'?
M-+;,7%UCRS(Q'>U5'"Z1&W;+I8KG02"/B$P`!J(CJO[CW%HU]M^"RM=*ABN>
MU_(@&&':T!W8>U,3V)5JT#0=9L=<FNKN_>ZW5?Q9GEV+L"U[C&!BW@U?*,02
MY<*^8C6M2]/@"J_Z1\<,:*-_J\6%E+"EK_FC'^_4STADR;FFN1V6<B?RLT:?
M*E:.I3@-%M8G>R;D9OY'*ES_`-%:\6ZJ'C39TZ)*8\GO0.<HKPN*_LSO."P?
M>;TUJ4M=6'8\G+T;J--A^(/\.[7Y*JN^09=4V;&%QM"<._WBQR^K,E6->X_M
M0*?XG*/U=X(:0C`/=.3VYO\`K*=1:?>!)Z/HJEC\P]<.J^_/'MK=%5*U6>VB
M+*-0E_"<RT^R1YN-*`/X2%#^?7UAT&TZ&ZM_3F<J=Z_V4KY3ZY&3\[;([L;&
MUJ]R$A/YV;&F`_+9-#(AA+=`^$13-)[K+\<97A;CXE1G8X4@I'^\+7L[YZ<`
M#Z:ZJ7_Z%=+9ZG:EPP:9O$D<H8^`RGUTP.B`BFTR]+2H/+([@'<PD#T9B\>J
MK$4P1AU_$9-;Y&L8Y=X_O&EQ1F%M,4FU>++,`HKF=/>)!\$68S*%KS=]WX"0
M2@/,%-(*WFFFN(/=`?5Q^'PX4ZIY6M@>;LM$(P*H/C/Q=O'AC4+&;&O2X0=F
MB\88;L7M7VW=6\L9.SM6"$'('P@JBRBS'01(N#]0![GN?U_JU:[B3=HMP)_?
M^1W_`'J?P54K?3]D7EUS(X]/=<X8CEN*+@>TD]_J6EY?,??K-HV%"A_6W+,9
M>/;4,>9&)PK33)Z"GE[DU!WZ#?ZRTN>O<@AT;1B?]9)\L8I1WR_I1'J&K$$:
M4P%DLWK&A'_'AON$0I]&K]UDFS[9O/3)&/[YM43HZ.9N6V/V5/\`<SU=*R.S
M,;_CW(<>DUM;7,7?(9(FB06=U[-K<-CNU.=J]$6-2O=W%G<F`1J';7AKY<T=
MSCK.GF`*_GQ$`]IYF'QI7U#KQ:-$U0W#D9[K(I[AD(^2OR[55!MH[=>'6$Q$
M5@\+<<:F`"CV\*]FOT#;>75KM<Y'(1%@:^"9;:VN]<8+B/,PN\S>_C7ZB\"N
MG"[AT)N7$/WI=0:,W5_V!2_6:$%+H*</]9,/T:_/;4SEO94'ZZ7^*OOZQ0QV
MZ\.3&M4L_F`Q_P"(<3M&FW?&5.'9219$]'V:^JN@^%E;=RN_K.KY+ZR._P#>
M,R!3Y/\`"CIJ?RW!A_*UGL1[/S%WOI_].<=>C2YZ[?=ZW;'M27YXZ9O0P'\N
MU<+VQ_-)5C`E>?\`S)*^CC4WHTE&_P"SL\/H%._]8[P'SFOS(<JR*6%R_F1)
M*92WN2Y7R0(B,F=3"<1F#V)E%1,_4544[1,/-S"/:.OO_0[2)MYMYHC9E+7_
M`%R.TX#S8`=@"5\"Z[?22N;*YK<X8#P:5):TDN6-'.*JXG,IQ4U.WSR3?E%Y
M_/I)WO\`"V\?WGG"_?>9?QP/#^-[SG_T[P7ZKOOQ]Q[%=+KEO_-T^\_XQ3BW
MC^6*O#VNU>%7?WRS_=[-R;7_`(97V9/P_P`ZRY?:_"_1]M>U*__4:'L+A[IN
M4Z1>^_87?VBP9>P7,,E,MK'%.Z\61Y2=@R1`+=0P^R!KG)T*=&\?4%L/'CIZ
M;]?'8]2M/U-DJVDQ0.'`@N<T%>!:`]OJ"TAMK1_G'2VYTAD(;<VT<4I;^DTL
MN'!.(<Y[7J.]U-#Z+N>F_.VP##R"MP>XE6$K9QPI,+)43>,L;J%(I^[Z*M?:
M$MQ#KMN,`^NH>@=4+JWILVG[[@FB:EM=_>$)B'\LAX\<X<>[S"F'T^U-EWM]
M[0CGVKBUC@I#HG@20N!/?&]H[2"T@TVDQA-P,B4?K5+Z_2`:H_-ACP]X^'JJ
MY$/=QAP\:U$Y2FY`(!/J$H_1]?8&O!GB<\1B=7]U>FM("\M!5=#9P!MQO7)W
MT9S,3OHQMOB-GA:+KH\H6J3T1%I@MR!:4J<ZD7D'#L]L?HTW-<.JZ)T_T?2K
MFV,=M=Y7!>U2)_G<WXJ2^B\S6^I]]J)N@ZVMVRRM`'%RFR9F/=E9*X<%)6MC
MI0".X/J,]33>/<J$68K.<FPM!+W@5.Z84W<R1S``T'V8U`&%3_O7KUC>\VLZ
M3M_1-K7,`$+2!AV.B;CXJ7KXE:][*L1?;SUW=+GY8S&XM7M$LB-/\UL19ZA5
MB\JZ@@H82U*!"FI^F'WB`#_,&DVWFNU*>`_[-E'S4YLR6[92//5=;K/N`[CM
MR>P?IZQA0SB[Y`R\T97R/:V@@HNPP)F%5D/>7J0B4JB0Q=62./*(A4&L/6&G
M+T\_W7H>NZ[*"`(AW8AG$+V9B6@=[FFE)O\`(U+7M%TM@:YV?*`I!#YL&N`'
M'(QKRX]C7_%S]UBZ6XOKD;),'LH*7S)M7A;CF:<=V4/#,#M<)#*VE`Q!H%%5
MX_&R#3V0\>`=H"&NC1Q[CTPUZZD/WES,>SO+8V$GO7F>I3VUJUE\=WU%T6U8
MP?=R11M4CA''-<2AHQ\H')!P"N0=E6%5#B1553T47I]/=(`;L'MXAI*S.RW6
MFQKB>8?IIOL'DO).P)\E5P?F$]I#[D''6.]VD"9;AT>,)D>(ODRR;;,+N_#%
MSSWSZ255$0Y4X6^6QSC0*4=#&_JCIX]&]V,T;53:$*V92._AB!^D@#@!W&DQ
MU;VY^8Z<;\,`0-C.)`!S$L<X_8)<YCR2`,P./"D4=.?J$3'8%DF3RMKC(9$Q
M=DEO;+'(\"1=4FQXN_(CJ*,LK9'Q2VNTBN[!YQ>I+$$O(H4X@/+P,5U;]V0W
MJ#'S1A=C@[B0<,>(#A]H*N`(*@4C>G^^+G9^I(7_`+.X`/:Y0QP\Q#4`)8XX
M&(Y4\Y#O*JL.W\=<EOW18`E^W_!^&Y9`;+*#0M'IY,L@NC,1PM(Y>%$'IE9F
M&/J7QS^?VH=P1R.N5("F$`)4:A0MI='7:;JAO-1O3.(01PY*8H3B5Q'LD#*O
M$G"K_O3K#'J>G"SL86QM+F.=Y^87@8AH.3(T-<`9&.<)$\H`QI;'2PVN7VY+
M?%A1E86(JD:Q/*&G,^2GCPI3M;$QP1T+(&1M5*H(%,$GD:5DV"%!_&)J"!1U
M<.I%]HNV=%F9`/VCE)$40B4J@;X+F)Q0,.%5?IWI.N[EU$22W<QM!*PD9BA:
MTM,CGD<%#"QH[72X'`U8E^8]5_V0<)JC4HCN5CPT]0?#O(XB-:\.S2KZ%-7=
M-PT_9;_6(II];H6W6BZ2UPP+Y3_=U7`Z?V\&VV*;@SY\7Q[<Y+2-`9#!_=>R
MDB4>43*]W$?N!>!=[J,75J)?W!2G+_6'CPXOCJ3M1VI[4NX1(6G[KAC^M&)P
M;\_9ZZ2&S-R?NUK]C<B)KP"5!):H<Q[4!#GIESJF3%>([6)[L^O;FK/^,Y1B
M/%.&F;!;7.&F_CTGFEY,QG4P"//=HM9OC;'@]V8FPL!UT+@0\S55N.4``2@4
MWM:6^W^A<VD:E:7=]=*6XC`8.QQ3$*.PER+CB@J^;AZS_G6F75E:0M9$\HX*
MXES?LEV#D<<'-;&'D8*%-+1V&;49!O&W/8MPM'6RXNXDW.;=+\P/]M;'!JB^
M,V)Q&XD";NL`"!5)2"(-C.(B(BI>EJ`A6C(ZD[RL-GZ/'9P']IY01,/!J=N9
M"F&#5-+_`&3M+4-WZH]V/(?+F)*NX@+(""`#'F!>,RNER-RE2GZ,IJA>%(``
M!"I!R$X`7V1YZE`.!1"E/^77PI(V1Q;(#PK[?:6B7E\`E4AOF`1_XAQ/]WC&
M@=H?^8LB^L*=@Z^L^A`)LK;Q=_6=7R+UC(&\9L>UG^%'36/EN_\`XK9[_P!X
MQQ&G_MQCJGWTTNNO0)U>S'I^F*F7T)_V'5<>V+YI*L5)=H?]F'^6?23B_`B\
M!\PIZ._$/\D5^8?E$0^+F9@X<,JY$X5X4]\'K^;7Z&:%'^W;<(^S)_4-?GQN
M"-)2T_ZJ/_"94[:_[(7X@_\`JNYO3_\`N1]79_*FEUR_]^?_`'#_`-(JX\H_
MN^B?_$$]?YTM?__5<[G1R'I:]5AJW0N"2S=M-WRH!$<NWUJBJ9J@V3.5!49$
MYE(8B*2R4C3!W!0XF4%MOWWD((DXN;27P;]Z9163F)NRQRMC5$"8-!Q5P<TE
M@`0-(+CV4F]2N!LS?#[FZD32[C/(P!271N`,X`#0UIBD:V4DN+Y&N9&P8.7$
MLIW;UT;]\;CN+86AU>>GWO4>V_XAH1FCLT8[R`Z*W+V9P;1MRJVO>-]VZN#L
MQ)AW9'1DN[UO3*<U@FH7IM[BSZE[!;HNYG9-^Z?C$2<`>8A4\4=@'E'.+\I>
M`T-8[@NI=5V+O&+5;"5LFP;AJ-:WS!S'1AQ:#YO-&09(0'1L$(<V/F/?+)'9
M(BDFBV18LQ3:`/S/*8=*6BT=HY)6*[3<&EV:KP#*)7[5<)=\0UNJ"E0$HC7Z
M!#2`O;35K+7UN;9.4`""BJF(P7O]:X4[+.\L=3TAD^F7.:SF4M(5$)]('<5!
M`0C@*ZW(4U:<4XWR%DEV$I8_CF%2:9WYRA4XV$:8KI\O3B7F"HA:VYO5V_4.
MI73(':WKUM:'!QG$/^D0#\_R5IU&>'2="N;JU;FE9`YZ'@2`2T'Q*>JJY_2@
MD;E@3IA[W]\TL$;>692E68,EVKJO4?,[B*,5PT1\W)[514R<[.B(?X0FIIV;
M_A;J6[]N[=@1K8P7%>(S'S-/@R$?'W4H=J33Z5MG=>M2NYL@RP,R#VC&W*'#
M'ZTLSB?!!C4Q^@9B\<;]/N+RIP`#/&;)[/,EWJH!52YMB.Q(6U&5'UJ-\;1,
M'Z>JKU6O&2[DM-+CN5?;08^G,2[#P:Z('O(2K#TPLN1HNJ:H(R(I;K*U2I2)
MHA7UR,D/K6F";N]V6*-E>'9#F;+CRDBWM286<;CEJLB$CF4EN$S"TQ5@MS"0
MJEU<E3$PB80*!"F,8>`\]-V]M[5-QZL+2%PATT)S)45%P"^GL:T>9SB```IJ
MT[AU^RT"Q?/(>?JS\W)AS!I<0%./8UH\SWN1K&`EQQI(VQVS=\;,&X_KA;]"
MJ-4IR/%W%?"D,O#`+C'L6*J%3C]HP)*$/RGFXH-[3'!Y`YFDHWQA,1R$P,S<
M;HM2FL=C;4M<MO"$E*#`-Q1S@JH5<Y"`20,#F:*!H##I\#MW[DGYES(\\D*]
M9)9?)F9&4R@M#61M+<S6AREP#'GVKHEX=G$Q/G?J2YQL36N3MX4KO3P2WO#7
M2GN_B!-Y\4E:LUQ=+F7".2EYM[%-I(J`_N5D;A(82F#4)U`U&W=)9:39E;2"
M&-`2"0@`:I'%0KNPHYJ]M2/3[3'Q&_U>;"6XD*N1P#G$ETARD#*0YS6("YN9
MDA;@15@;LTMP`QJ#@*9]=2LC;WMK=65S;IJVJA/#KVZR`GMET3`)5$NZK6E:
M@-:_T8,C;%PFC)!48CL\/CK2X>^-EBF;F:>(/;2&]R'0`VPY=?W29X1FDDVU
MR![5+=WC"R,S1,\9A?G(`F6;(0[*V*T?-P"A6QSMTB\>4NF[M?K;KNA-,;7B
M4DC$8'`$<'-<U3VE@:32GU[HSHVJ/#H$C8UKO*X/(&8@GS1R1290B!LKY6A2
MC5J,,2^6G:$71);(6[F122/T_M;9"<6L\/=;X/24S\^RN;\H?7;&^C5CN^NU
MY=L'*LR&]RA#XG*XKZZKMOT0BMPYKKN+.JAP:\EOH:W.QB>+33\=K6TC!.S7
M'8XYP7#;2,M5W<^82!U6.+A))2ZD(HEYO*G]0!N7IP+;CRE%3@0.!0`.Q'[G
MW/J.L7#;B\FYAQ]2XD^DDXDG$TYMO;?LM#MS%!F+G(KG%20%#6X(UK6M0-:T
M!K0,!@*\BZ@^Q>-]0#%<-Q=+LA2/&K7#\@M^1+9YC;>S.%_?.-HP26.)-@@]
M51027)(A'F#C4H!3LU+[1W;=;/NC>QM_:R!BJ<#X'O[JC=U;79NV"*U>\"!@
M=@6YES!#@'-/8$*A./9BI\/EJL1F*!/S6Y:)P'\$-A)A]0_BI3CIG7G7+4-0
MBY9TUY'_`#S?^PI:Q="=)C=G=?A/1&_Z9S\U9%&?ENMMUJXEN9KN!SG+FZV3
M&K2UH0>(>*'CP7=4(]?KF+^CRB%:U]<;<=;-9EA,5O`2Y,%F4+Z0T,)_TA73
M:]$-(M9.8Z]1JJ0V,JG<#))*UOCD6G1;;-KF!]HT&)C[;_CMI@K+=J%<G=6T
M`]X_R1P*B-N1WF+\\W"TA?;HH<"JK*B)0X!0!H*LW#N.]U68W%Y<<VY[NP=Y
M0=YQ).)[Z:VC:);Z/%R+>$XX%QQ<40`$]@:,`UH#0,$J3(F$I0`Q!'LK]_T!
MJ'DNI&X\@I4TUN`\^-)?WT=&W'>^+/89\D6>IYCIU-`V&%)Q]ACT5=FSP;%<
M/RY7$JKP3OQ.J,@&H<0"GX@J%&1M?J'>;?L!9VUKF`7ZP'$D\"UW?\WA2RW7
MTQL-V7LE[/<(793[+CP`&!;)&4(:,"OH0XU);I[[!XUT_,<33'$6R%(\AMLX
MGUUD"Y=Y0WL]A?6%Y<QZ/Q\6TA60$4KE`J$>1-4>%1I2G;$;IW)-NN5LTX[2
MN(/'U#N'94KM/:@VDV6-LP=G#?JD(&K@A<XXEQ)Q1<:82B1-/G$!"IA`3?97
MU\:<=4^&+W9A$I&-7ATO-0`\*KB2?Y<C"4FDLME-UN8S):7$PD4AD5Y:ILT+
M`EF=]=S/:ENG^[Q$_AUC4K0M:=FG?%UKU*T8YAM'ASB2?OTXXD@<H]M)"7HC
MI\LD7)U(9&96@&$.P:"UH)SA<"G#N[J]6_@;8@^&GPP^/^1/+_RV_EP\P\HA
MOB_=K\VWYO\`WK[GP_=^:^\W[L[O]AX+];^/57_S3F]Z]Z]S&;WCG\1[7N_N
M_=]G%?D[:G_\KH_=O=_?79?=O=_8^KS^?]KAFPRKF7ZR85__UKKFZ;;9C#=Y
MA*7X"RS:%.P2>V,+4ZV0$.ZQ:2MZ:X,$L855*I)/T=N3=Z0IPY3@(E-[)C!J
M4V]KUSMZ]@U>%#-%^(.P]X48@X`M<,6D`BHC7-*MM;M7Z=>@L+G9HW#O0A4/
ME<""X.8Y6N:2T@@FJ_.(,\W^S.Y=NEEU;HHWS+;G*&T8MA+/CS:NU[CU_P`?
MJK69&EH>'E1)!>U8XJIW8INI%T':%W0)%5$MN"3@BVM9L+?>HFZ@;.<8KN,_
M>,/$E"<>+3,C2N8>9N)))<YRJL]4EVJV7:6\;)AT-WF#F'RQ^=K0YC?+(V%[
MGM+1$O+D!`:T!D<??)[:^H'TK5W.=["Y`.\W9/+KWWF5P3?W1WR6Q1O=E@N$
MG6%E8#*"]JGME2'\T8JE=P$#7[88"E6UP1ZKM[>%Q#;ZY:-M=5P5Z\M.!\I<
M,>TB-^)4C-F)EK?-I>XMKQ/FV_=-FT9X<5'G:7%<9&,.`P#0^`!H:T`QY3RZ
MEGU/-U;HMT?WS)UY#W_%4OW)PB!PE#'TB7$\ABWQ640&3,3THFBD);A*&%<:
M@)"B-0`0#B`0NS="9^_+[>*<RF`%#AQ*-`P)0@NQ*G%I2IO>>MENT;"2V8#-
M<RLPQ0M;FE>0'`$AS8SE#LJAPJ&G4"_V2^A-MOV[(JD;)'E6PP_&'ZS,!;4X
MWCTLKF?()A"H&(",G3Y!$>T#\1U9=O13;AZCZIJ3T`A?EXICY;<)ZE-0>X)Q
MI6Q-'T[E.=/<ATI:!F4-#KAP=WJXL;C@55<*[W'/6*BD)PIA[:QT]]NF4=UN
M2\?8OAD#LW,L6>F&#VEY'V*U9'5\42[LDL>K<CQ;G[XIT&HE1$07]>-5Z?3Z
ME<ZONO4-2B]S9<'S-"`1+E'F<&M!#0F5N8GNP4\^A[ZBTO3M%V[:V;FW+[=N
M#WATCY'#.XMBC+Y"'%RA[Q&P*`JE!V##LFE#B^'ZB/7,S-%SV$%7*[PK;XFZ
M@?&4%$]R55F8'AL83*6,A.!T0*2+-7G/G7=E%TOG8!50'BGUWG0C:6Q+!.82
M9)%088*'G$!"5+\`2BN\A$A:Z&Z!]UNC>EQF:]C6B,MS2$9@X,(;A@X-RMC:
MW,&YRV,NF#\5:F_+_7:STTR-Z:9+B?IDX0DY3LS9=B5I=LX29EYTE.0B0@*M
MS<&,)%#D$$F-K$2$,#D<1"5=?:5TPTJ>&*83;HF<N<HA'8X@XAC45@/F>_S$
M-3R\(MM3ZAZF9LY@TF$92YA*P\,\<;@@=/(N660>2.(9&F3.2^S6PQUEBK2V
MQJ/MELTLC,W-[8TM;;;EL6]N;FI,J3.UM:12(VQ+:VMB@F!2T*`4#AZ$7?7L
MMS<CGN5TO$^GYOAA3BL;**Q@;#;-#8FM``[@.`[_`!)Q)QXUD21N"H?17[N&
MO5T1R23\,:VV_M$>%<@">OB/\O537*VW^V<?AX5OS)PKCF,O6E4R!7T"(^CT
M@`"/&NMYN+2#`UIR3OX$"N0F!`#V/MT-A$?C6TR9\5H$!K^TX&KZ0[/\7CZ-
M;,[$'!:\Y'*<2E<<ZUNK0@F&O&@=E1`!]=`&FM$D<=RPPYOGK(EY16M2J8D(
M/=J`F(C^(:!7MH`"-./:.LVUM%;\*).;($9QK3;E.0![Y0AA]`@(<`#Z0]==
M#;:"/V036&\XKS*Y"ATR%$5#`!?KI_?#6T$'ZPK)=DQKB%+;W"`I$.)BUI[0
MA6M*<>76MES$24=6)09P2:UH(E1`0$X'+3ZQ[0^_^G7I[(B,16(XWL*=E;I4
M0`AB"83`;U\1^W6NWAY"H<:V2.YO$)6E.W*D02@/`>(_13CVC76RY;SP`E:H
MF")<:$4R<@EY@.%>WB`\?7V<->)8(IAYL:V-:^+`UJY$O6';3T>JE.SL_E77
MCW*-$R_53Y5K/./>*__7OY?\V`_7Z?I]>M%WP!HBQ`J/&X?;5A7==CN_Q=G.
M`L\^AUU0$"7X@5U8[_BFB[Q]Z)R/<?D-N`@`+HJ@80J`B("(#*:3JUQIY,]C
M<8GCV@^(/=Q[_3Q6)U?2(-3:R.\MRC<6N!1P7M:1CCP(*M/<J4D)GZ?O4IZ?
M$P:E=@N?V3-^W>[DC<+G@_/2Y;=QBK4Z/)[A[.PK$&VC:900,)CJ,YV4RAU!
M_=YQH;5_O=V:5NFR$-_:PQ77'F8G@7<)`IRA<&'RM.`"XTO+3:6K[7OA=6-[
M++;(0C<H+E#0#)&1D<]05E"R/XO/`5C?S"TTN;RZV;X\>(;D)_P\VY(><KY?
M<8U$W)QL`:H^#"P)-:#YW9H^B^J1J0/O(FL:A:@(B!1&L[T:L;6SOM1O9Y@'
MA$4%P*+[2(@*A2,2`4"I4/UANIKJSM;:"-<D;R%=D.=X`:6X$.+2TX8-S$9G
M90ZON6^METK<X6\2MLE;4<HYMO(7?W%]"V::86Q3)B,CL5$$5%V1"1SY<@&.
M@D',/(%0*%0J`"'+:=.-U0/N'C688A*2OM%Q150%@Q_G>L5TW74K:4XMFLT=
M\LC(01C&&M:Y$!+7DIVXMX*4KMX]U'MZ>26$(/T[>E&^8U9'!0Z;/.<E1PT$
M@-@!@XN/D=M'H'#E3AV_^.'"H4H;6+K:>A6+VOUW=AF=C@XEA3ORJ]Y]"95K
M;;;IUR5KV:+M%D0+6G[D"97+[)?]S$U.TDN2N^QKT?,W;BYVRYIZJN>K_.+N
MU+FO8]@.#.-PTXP8*$MU0L'==CMHM;K'7*"I;BQ:FU/G$H&%Q7J.HF\W;:16
MON>C6_*;\G`!1]OQE)/C75IVS;^:Y%YK,V:0\?K./F)RER_=C'!L(`+</*:L
M$12+Q^#1MIBD49V:,1E@L2-+"QQYOMVIH9F^U2,5)O:FJS1);6R5MW7`H%I0
M.`:7=Y/)<2.GD*W)Q4XD\/@@`%,ZQM&VL++:!@$+0@`P0?.JXDDDE>-9AK77
M71HHHT44:**-%%&BBC111HHHT44:**-%%&BBC111HHHT44:**__0OX$_8%^K
M^_K3=>S\/16(>#:U%[/N_P`D-<3.'JK::VS_`+'[1_N&UUZ?^&W^4:U7'`UN
M(?L4_P!$-=!XFL,]EM;VBO5;:GX!URW?X)\?X:]L]H5N:Z3P]=>*T:XS[5>J
JUZ[:\T:**-%%&BBC111HHHT44:**-%%&BBC111HHHT44:**-%%&BBO_9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g815101g81r82.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g815101g81r82.jpg
M_]C_X``02D9)1@`!`@$`8`!@``#_[0D84&AO=&]S:&]P(#,N,``X0DE-`^T`
M`````!``8`````$``0!@`````0`!.$))300-```````$````'CA"24T$&0``
M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X
M0DE-)Q````````H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`&
M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4`
M```!`"T````&```````!.$))30/X``````!P``#_____________________
M________`^@`````_____________________________P/H`````/______
M______________________\#Z`````#_____________________________
M`^@``#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0`
M````.$))300:``````!M````!@``````````````;0```7P````&`&<`.``Q
M`'(`.``R`````0`````````````````````````!``````````````%\````
M;0`````````````````````````````````````````````X0DE-!!$`````
M``$!`#A"24T$%```````!`````(X0DE-!`P`````!GP````!````<````"``
M``%0```J````!F``&``!_]C_X``02D9)1@`!`@$`2`!(``#_[@`.061O8F4`
M9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.
M%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`S_P``1"``@`'`#`2(``A$!`Q$!_]T`!``'_\0!/P```04!`0$!`0$`
M`````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)
M"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$`
M`@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D
M8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4
MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1
M`Q$`/P"ME?TO(_XZW_SX]1IINO?Z=%;K7@26L!=`_>?'T&?RWJ>2USLV]C!+
MWWV-8/%SK'-:/\Y:SGLP,C&Z?54VQ@>++0[:0]M;WM]9S;=U+K\QU%C_`%;]
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MV.$[_I[O\&D,D#^D$G',?HG['-26E5T+)NLR**;:[,K&O.,<>'`O>/4=N9:X
M>BUCJ\>^SWO_`,%_+K4F_5OJ[G.K=4RNP,WM8ZQLN][<=K6N#MC?4>[]%N=^
MD2]R'[P'FCVY](D^3EI+1_YO]7`#C0`W23O88EOJ[-H=N]1M(];T_P#1J=GU
M;ZRQ[VB@/#"X;P]K0=I:WA[@YOJ[ZWUM_<2]R'[P^U7MS_=/V.6DM6SZK]:9
M8&-H%C7N+:W[V-W0"_2M[_4;]%_^8LI$2C+8@H,9#<$/_]"OD/?7G76,C?7D
M6/9/&YMKGM_Z35?ZH'9`;U/%?^8^&-=M>*VFR_\`1F6^I9B,L=BYE+/T]?H5
MY7I_9LGU52RJ;OM>1%5A_36_F._TC_Y*C7]LK8]E;;6LMCU&;'%KMIW,+F.:
MYFYD>U_TUIU?"1N.[F75CNZ^?C=0?C48H-C&[A3;DO+]D45LQ_1<[Z>39]MN
MZELQ*_5NML]C*E1ZQ97ZS,>H%K<>9;()8Z*J:Z7/9[77T8^+C_:/3=_2_7K_
M`,$FLS^J6%[MIJ?:7&RRF@5V.+SNL_3LK]9GJ._G/2L9O5047``"IX`T`V._
M\BA")%$D:=O%,Y`W0.O=9UECBYSK'N<Z=Q+G$F=7;I/NW)%]CIW/>Z>=SG&?
MCN*?T;_]%9_F._\`(I>C?_HK/\QW_D4_19JMZEA=N-CR[3W;W3I]'W;OS9]J
M;<^(WN@#:!N=]$_F<_0_DJ7HW_Z*S_,=_P"12]&__16?YCO_`"*6BM6.]\SN
M=,[IW&9'Y^Z?I_RTXLM``%CP`20`]T`D[G$>[\YR?T;_`/16?YCO_(I>C?\`
MZ*S_`#'?^12T1JQWOU][_<(/N=J-#M=K_)1*<O+H>7TWV5N+75[@XD[7G=8P
M;MVW>[W/VJ/HW_Z*S_,=_P"12]&__16?YCO_`"*6B=6(?8V-KWB.(>[2=#^<
MF4_1O_T5G^8[_P`BEZ-_^BL_S'?^12T1J__9.$))300A``````!5`````0$`
M```/`$$`9`!O`&(`90`@`%``:`!O`'0`;P!S`&@`;P!P````$P!!`&0`;P!B
M`&4`(`!0`&@`;P!T`&\`<P!H`&\`<``@`#8`+@`P`````0`X0DE-!`8`````
M``<`"``!``$!`/_N``Y!9&]B90!D0`````'_VP"$``$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$"`@("`@("`@("`@,#`P,#
M`P,#`P,!`0$!`0$!`0$!`0("`0("`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`__``!$(`&T!?`,!$0`"$0$#$0'_
MW0`$`##_Q`#E```"`04!`0$``````````````0(#!@<("04$"@$!``$%`0$`
M``````````````$#!`4&!P(($``!`04&`P,(`PL)!`4-```!$2$Q`@4&`$$#
M!`<(46$2<8$BD:&Q,A,5%@E"%%?PP='A4B,G&"@X2/%B<B4W6&AXF((SMA<D
M-$0FN)*BPF,V1E9F=H:6R-@1``$"!`,#!@@("`L(`@,```$"`P`1!`4A$@8Q
M%`=!46'1(A-Q@3*BI%755O"Q0K(S5)25D<'A4B-S%36A8G*"PE-C--06)I+2
M0X,D)747=#:CLPC_V@`,`P$``A$#$0`_`+<W7?O5[FO\P>L;RG_O_.;?<G#G
M]Q4'ZAOYHCX)U[^_*_\`7+^<8U\"M:2H/'CZ56VWL_3N1K#GT"(DY;U#DX*?
MI`@OYIY[5H0F(TE"%8TB\E7KU,:!9"$H1JHO5VE#Q8G"R)B1()(-Y("%2A1@
M%_5SL^*(@+E1&M:A+.'(Q(MD!"!8;V]I0A.",)8+(F``B_B20U0&<&EMD(=\
M3_RD+G/YPA+(B$KR"Q""J.YO526V1,!(N%Q>7`<"2BH;(07-9_1:2&@]5R]O
MX;/BB(`2K85:2C%4HH<219"$$<.#D!X$<%+[/!$Q+GU`!3T@M#%56M/.R(A1
M$MX*&%$5P:H=Y+(F&@`O/4C!<`A:%>%LV1$"@-1&<2I`XE%,*&[A9"#ON4@(
MH!`"`A4;RLA">6!A41%@8JOX,LB8""I8&`.`+^9#"`760P@5XB7@A#4!4("1
M=Q5MD1X(!Q`)"<D0A";FLX60@)4E.#"6!"`2MY=WV1,-`I*J;V@!JA%+4A`-
MD1XH14EP4(`5"$!C0K!R2R)AD7-#B$52U!ZH0=(+;(B$[B$^D6E6$._FV1,+
M@&MX1*CD)>!ZO'T60@12(0.)YA;HF*@OX60B30&$`O4(C[N06R(A`%4>A`:T
M!051&=UD3$E)"/8]@>YY>4YH;(B(\2YY0<C=P1/P61,`"@D")MZB%3Y"]>/X
MD1#(1@+"%#`/$"P$<&WV0B-S0TN*O/Y1ZG+9$PP4B#'N",N5$X\KK(0B]+U#
M5)#U3BQ6O;9"&P%J.51XE/4&J.8Y<+(B'>XHWI)[UY)R<ED(054O0(XE7DHB
M*O$MLA`$]`:X`$`N7UN^SEZ(F`A&W*4,)!(4L4DL=9$0&]`0Q?*Q"`Q&61,,
M,0KQ"JJAJ?S0^R$/I*.OZEZHE5.+E[WV=,1'_]"V]UR_K5[FO\P>L?;_`.W\
MZ5]]ON3AU^XK?^H;^:(^"M>_ONO/]LOYQC7T%5%W-#>.2VV]GZ=R-8<^@1$D
M(*-Y$=32```4>J=UJT1"!*+>480PA[`58$Y<K(0QQ`'%ZE0H,2'JO[;.F$(W
M!.E41K%Y@AZ&R)AJ0;VIX80@4/`1I>PBR(@!+@50@!K_`!/<P@E.RR$)&W(I
M#&D*PJ7*1QN%D3`PM/>K``@"AA2)0E]D1!#$G!`I')[6E6N\ED(;GM5RM16(
M2@:4-D3"A#P0U.2W@H`\'TV1$-6`O41!M_$L*CR60Z(05H4<`1XGO8%4L\ED
M3"54<J*2TE`CFAOH%D(:$MO:Q6JJ1(5=9"&A!52K1Q)`1'PD!"^R(VP$%2I"
M\2C%8U@5GELB818`(06EZ1!A-Z>3C9"!3"H567@E$#+R@A)LB(/*%57CJO"$
M@@$_<ED(:A5``>'Q`E2X,7R60@#(E7R/"I"TJR+ERLB=L)+T#58%1OA4"'J8
M!9RQ$"!8E)!16\6BXHK+(F!B`%H*(E]PA40J$\Y%D1`40ABJUL(O+'(%LB8$
M9"3>2]6"Y08G$V1$1')H4/`N"AC;(F)7`("`U%XO0*&*.-_&R$1X\&CI*@N:
M4#'BR$2?>UR<5<@1B?>LA!<L2-/)H%T+4"%_&R(@"!5()*%H1MZ,1X?9"'>$
M0<B>T`(`2O?RLA"5$!%YO8.IQ01$AALB8850Z$M0$JPA`PE@`LB(%0,`0HJ-
M>&JCF,LA"O:WJ<YX8OA)<+(F$26^MRX!&HUJCB^R$/[UY+1Q"H0P=ED(0N:H
M:J$`A@(4$("$_'9"&T$$JEP0B[I16HCK(B&P-B)8!>H)*D-14(+[(0!Y`#%(
M1>"%0C0]>VSXHF`!I#";@Q%`3B2".7EM,1TPFN:Y/5'%$7@OFM$3'__1MO=;
M^]9N:7^\%K&U?_G^=?>]-ON3AU^XK?\`J&_FB/@K7O[[K_UR_G&-?@W@&'@6
M`J2@?;;V?IW(UASZ!,(H_N`B0H`@0H%4*T<+5H0U50@145"51P3N\C[(15AZ
M(A^?]<A;_P#T2B);WW=%<C_J?"Z;$^5LY/HI(V`;8H.N55*9Z>/_`&[:=FWE
M^EFK;/9$,)(\7`P!A''Q<R`,IE<J"/KK_P`@$EJ,-JA<I;6VH:D?E;)23V2?
M_P!4U\HVQ=42*FM6%6)K-<?E3(')_:23LGLC;W3G85O(U5R\.9I#;]7D4LQ`
M8L"8U3A2?3S)9L*P]%<&EB&A$0FVA5W$#1])IDVMRM;0^/D3<*A^DS^3D*L1
M\<;-;-#ZFNC:+A8Z53+:L)R0L'DP4XL"72,(S;./E([[9')LW.\_IS1V4EV2
MR^>FF.1JS24?U7(RJ`XL,,(*Q$Q00D\$#;8+_P!O:5;TRJTH="WQR?IA_P`3
M/M[B6SI_AC,N\+-3--KN5]9+S:&RI6+*)!(Q/Z-_D\&,:(T]IIJ#5U/3ZJZ3
MT]K*J*6I#-2[*59/Z7IZ<U#+I$9T%'ODR*&(!7VZ(Q?-+4?=TI=32/N3RB;C
MA.`*@!+M9>66P8QIM#8-3ZA8=NU"._HVSC]$W*1D!-2DJ$Y;9<D6,,&.`#$A
M/7`?58(2Q0%6)J+PMD:>AJ'U*J;:]O#?@#>&'YQ_%&,=NM'<G#:5,;O5H)!.
M93FS$B4@GDYX3"6WHAMDW*9+GDXGX=,4.^*/*&$0(-Z`<.\N:JDFV*<!84`/
MA\)Q4![T0BKD5./!6=1)!!*.O%D5H"'$JU@:X(6J&%1VV0@0AS7>+J9ZK`]X
M6R(@\5[6(51%[B6_BLB8%"Q,)*DH$0M?>A`-D(;0$0&\W%$+RB-!>STV1$*\
M`H$!*@WL<2JEG=W60AEA'A;ZW`E27>(JSMLA`WM*%UZE5A0%X';9$P@7!7=*
MH"00P-+W,<ALB(%;$TM5H[Q<C@C"ED3`70L"HQI""%0'D($%D1SPPH^DUH4@
MHB%RDJWSV0@4?B4!"4,)502YK5LA"!`0O12`L0N"%.^R)AD(G;U(6(UH6X0^
M1;-D1``48T($NO07#J+!9$PR$[2U%5;P"I:E[+(B(O*(WATJ;@#<`$-[K(0U
M0*5($08PN`>H\([.-@A"*M',!BPDM+/%<GGLB8:7=3V.%[`P=B+Z+-L1"'"Y
M3$A!/$J]H060@0E%8@8B,1"]4*!O&R)A//<2PPL"J]GB%D(88A![^`)84\IX
M+9"&CEO",!:`@:G+R60A%@`:$!5C6.4H7Q"R$`<8B>PEQ)9$Q%2ZR(@8`A+2
M/Z32>PN1OHLA`+P@"])%Q'W[^XW61,"O4E``/$"B%$+!$UED1``PD(!P>X/<
MJ(5YISLA`T!0O86H4)^BB)>KK(F`(BE0"I80$#F7H2/19"&GT>76O)SG>I9R
M1'3'_]*V]UW[U>YKEN"UC_X_G27V^Y.'7[BH/U#?S1'P7KW]]UWZY?SC&OT+
M_+R*]7-C;;@Q].Y&KN?0)@1'$$W$`&]@[?PVJP@5I8R+FP`E0\!GILA&WNU/
M9MJ5NQJ*:^XH\C1VF]*_])U$U:J&+!$DD&1$$>*<'+C'Q<OEY]47LX3$>J.&
M""$&***&$+;1M5ZOH+6P4WEM2[VI)[M"9E2CALRI[O`2*BHR`Z<(VS1^F*^[
M.!=J(_923^D49!*1CMS*[S$@A(2"2>B-_P"1[A-O&VJ=X6D/RX=`,?<-KSBP
M1Y28[B*PE/Q3F\SG8L$PXDWI"7CV6*)'AF,_G<,R240]((^O-)YPC3FI]4I%
MPU;6II[&@YQVF$H"3(Y7%I6VH[`F9D)XIQG/I=3J+3>DANFFJ4NWI22F92\5
M%6R;:%)<3C.<@"9>5A(Q?NI^W#YHU4:4UUK=N4W0_P#*RB:4HS/UO,]/*:JR
M8Y"8Q2^5RN&=^[L24:5XE*T]*S%'$<E%&)MB1Q(8HE)4V-HN^@QJ9BU45K"V
MEK",[>?`?*4I9*7%!,BHE)7,)PG%:^676E1PZ?N>HWU4RT@J`6&EYIN=D!+>
M9`*DD`(4D2*@D@&8C$6T:IJOTR^7EOIW!SNI)_GLY7>!+]!Z6SL_J"93,09V
M<8'N6:^Y!4'5&L68KB`^`=7]7EH;:KJ"U:6J]<V>UL`FD!4MS%W&38+8[2LP
M!6<LQSSG@8IZ>K]3VGA77U]F(?<3*0DTV)&H"73V@1-+4R!RG``F4>9LPTR^
M9'IGHYD-=]G]44I4%*5?G)A-)]I%E\[2=13TQR6:1R6*"<4A/L+V(B.')0%E
M4V$WBZA#"3$H&>XAWS2NI;VS1ZQ2:3(E,E*#JP9@>2IE*)RP*A.0)`Q((&`T
M/9=;4M&Y>^%:^_LBEE+DBPCR,TPH5I*QF(7EDF9`FD2*5&]<YJ9M%WJSV8:;
M[O=+,+9=NHCS7NS+ZN4M)X9'3TPJ$08A,KU$D<Z`CD>)'&0>B:@@@)#,H+\-
M=K7Q#T59E5W"&[.7"A4@+`+5,%I3A/+O`4I84)D)2@G9D!)QSC=XX:\0;@Y:
M=6THHM2H)0LA54L=X#(S#0::!!F"<V!\HQS(W+[7-5-J-=BB]39;@9B7S$_6
M:-KB20F"DJPR0@$6)GY=,XX8<3+YC#ZAU2J-(H5%Q!/4M*:M;O+27&U83DH'
M!2589DJ&495`\FSE!((,<\U/II5K6MM:<93!&(4F?94DYI%)'RMHV&1PC7J)
MH',>@]HXVW>KRD)6.7\D:&Q-*U"$%1EZO^B>(*)ZMJ47$1*O`1I1MUS%(#O1
MWHF&&I<``JM8]KPP`"R(AL(*J"`UY<TDF]7V1,)H"$7`*0H"HJW?R60@0@%`
MB(U&&YBF(L/"R$`4`&Y>F\<"K;BED(&A@7UFH;T*0D\DXV0@(N+>)A!8>]'K
M9"&I<0T>*XN:U"'GM[[(B!%*EK2&-:(4<`%1+N-D(1`+R"P.'B;<%)4J/39"
M`J`P\2P`*[R(&K9$P`EC`02Q20\EA-Z$KRLB(`%("`!H15!2_AZUG-$P$=W>
M%>P,"DIVOLA#%Q5@<S^=#U$$HI/9?9$0@_UCVJ226D*CB0.VR$!9P<TJ%:CQ
M"JA;F_@0@1'%WY+BP*>H\Q9"!W,=3^#0`CF`!UD3##6(2!Y(F(C^EP>MD1`T
M%>!A#2.P%0I';9"$T(7,<6OZGO5ILB8.I"BF$`%C"A%S47T^FR(ADAA!"AZ7
MJBA1V*660@_VKR^(%A8AA#$%_*R'BA*%:6J+G7GF.D\+(0+$"CS?P8%XA6/N
MLA`MX=X6%0HA!O"!4LB8?!%>JE.9N>"4LB(7,DHQC2I;"6@^)./=9"`%`7@M
MNX$*3$K5LA`86HT7(];GHT>BR)@0%PX,)3BT]2@DEUD(%:^%41?$CD>G4OF2
MR$?_T[;W7?O5[FA_B#UB+/\`Z_G7"WW)PZ_<5!^H;^:(^"M>_ORN_7+^<8U_
M@)6Y@(%Q?Z&OMM[/]X7T1J[N+"1#)/3[)&7\7]0=SM+]/^VZUNI2)(3M_!X4
M\W-%9AM3]T7>U>2G\2,G1LV^3&PNUW;O5NZ;6JBM%J2/U;&GF;.<J.?_`%1E
M*T1)3#%.YT>)*@`7S>V#UYJUBP6U84K!M,^F>Q($TG:J0$S*>W`1E]'V9W6>
MKTI/T>'X,LB2,R-B03SE.&TQUAU2F,XW.Z@4]\LW8Q'!26VG2K$^J:F5EEX<
M,RZJHZ?FF)\:U554XPR(9](\.>^TB\1,4ZG*E1"(!#R*P-6JCT^]Q7UNZHZS
M4Z>Z029S&9A"$=R0RHN-IG)31RA)F!)2HZE?M_U/?!P9TDH#2M*$%6Q6TIJ5
MN*[[*\.Z?69)2])1*2D$%`C&^K^\?2S9I))IMK^7OD91AS26PF4ZK;JIEE)7
M/JMKFI3#APSJ"CX"8?;>SB@(AFD4,,H'4?=D+IA:YT[IBYZ[><U_KQ`-N!DA
M!"""`KNTYNY4A1RG+,*;&;Y79V>=0ZLMFA:9.G=%R-93]EQR2IS.)`[]#B0D
MGD2I7)+9C].<J2J*%^4155:5K/I[4E=;P=<\27Q5%4<VFF>G\SIB0S7!PX<"
M'/SHA,.&"A<\`0!#",ZG9E;9:F[GQMK;8P\E%);Z=)1E;"$I[VD0`D)&0`%)
M)$I@2V"8EC[C=C;N#UOKU,*545SZ@HE943W52LE15)<R%``["9SQD9VUNEQX
MM%OEB[*M"X8(<K.-6IS,-=*K$.)[0QY&+#,_E6#%A]/YL005O+P6Q*<B7):R
MT'2?M7B#J#6)KAN]&I"4JR;<[1;V`@C*$X@H5/ED1./6MKH;5H33^E!1D5-6
M%K(S[,CJ5@^20<Q5/!8P'*#*.66G^I5?Z7U-@5=IK754Z>U+EP09I2\VF\NS
MZ-6`B'IAGD,08A46ZU76ISB#3&FN380P!*6"AYI;GRQS>CNE_P!%56\4#F9\
MG;)H?."P)>".O-`:]:4?,LR,JT&W=96GZ'W#XF7AD^BVXR2261RW%J"9*?=%
M)U+*Q#@Q8G7BXG5%*L6,R>;^(0'(3+V<(XO?=+W;AS5NUEF.>D\I2#*8EVLR
M`I;G22#/QX)3URR:CK=>TB*2]DMU8F$N#)(SPRN!"$8"<@I`!V;!-:[JT7CF
MDZF=5_*<W[8>-ELYE<W'EMO^I6:PL/.9^D*@Z<3$HC%DTYQ!A13J4U)'B=4D
MB,4(B$44LC!6'HQE[SWFQ4G%2UA*+@XXI3Z`$@$)=4P%GLH27,PS3#8)S$JS
M$35D[.TBS7NKX8UY)MR$`,JFHE*E-A\H`!4H((5(@N$"0RY09#CEJUI;66B&
MHM8Z15YE/J%4T7/YA*)O$(3[OS\(/M)).9.(@"9#5$@(F0+"AMWNUWFBU/I&
MW6RE5FI74#.>T/)6%@2*4GRAC(B4N43CA-TMM7I_4]?6U0RU+2^R.R9YDY22
M05#`&0F#,'D,8V@"JI50J,<%XD-MF&&Q3[3C+X?%&)NZ]TJ4A/PV>&(DB")2
M>27IS9:TK6F:C#D\?1%9U+ERI4F4QXNCP0@L*#FRY+B@:"#:N5/`$RE^"*80
MVL$2^.&3$XJG(L8.++4B_4H^`CWN[!Y?C@$47%'7C^5XMXWRJ.!'Q=44UML(
M,LTSXX21-<JJ\)Z0K[>I/+$R/BB>^9`D=GCB74<1ER<G%0>'.V1<J*BZ3$MG
M@_)S1X0PQ;259L3X</CBF5PW?<OEX6QRUU-M.`DKQ?EB^0*>OP*L9=/Y(J&(
M0X?22VYA*E0YB6N@4,N=L[(H$./7TUJ1AXN1&7X80%(\+I!:7E"/I`WH;[>M
MS:KG%%!P\?1TB/&].4E^%<I.!\'*C+S'XH@,2(E$7@6<#RM3->^\!S^+JBY7
M0,M3F</'UPUB-S1>PA"S@66\;Q4-GM;3X(MBPP9S/Q]<-3"%10>P(C#Q]#+>
MB[4,S21AXH]]U3K)D?X#`2;E!X#M#^2V!VH=DE.SQ0[NF;D2?C@/4V)4`;=Y
M%>SLM"TU&</RP'@^'\$>VRQD+)5B?#RPCBF((BH/NNOM[5>7ZE.[I':&W9_N
MB*:+4U3J+ZC@?#_O&`1&+Z*->H9Q[B+4Z0ZGJSVW)>)K\D5=U:ICV:['^0>L
MP`E@Z5*%&@-3@YUE6=3TI[+D_$U^6&[,U))-=C_(/6(E^;ANN"^L6W<;[4.]
MJ[7()3+\'Y8MLUZN<C/#_E]'@@_-Q.!4<>H^53V6D.U=TF%)G_L\DO!"=[MF
M,\/^7^6(K$03V\%[G(C+7!-12`)4)#Q?EBLIMBC$P9_A_+#4AW:X(&.:$!46
M@;Q5B21/\'1X(LRVS5@3,OP_DAPF(%"`X7@^1+7;-34-ID4X^+HZ.B+FHIF5
MF8./CZ.F(Q=:J'@%C'=B/-L=7*J7U3"?BZ(]TJ:=K`GXX16(@L0=D79?:HZF
MH>5W\L!X.2/2"PV@LSQ/AB42Q#I9>I\[N=JRW7Z]":=*<0.C\D>$,LT:BZL[
M?#^6&/9DN0#CU)Y5YV\%-4]B!\442;TU(@[?U<'@"@=X\2OL":IG%6'X(B=Z
M=),\/^7$.HAQXI>2@86"UMO#[<YB7X.J*F[,NA(G\?7`(HB6EW=Y%:TV&H?7
M*6/X(;LRT#S^.)>(WIY$NN1I!M/?5+F&68\4>`IAO&>/C@;#Q:5+B5'GOL[Z
MI;F)2_!`J8<D9X^/X<D18^]`KR2.]`[B"P6K16@8I(*`*QS2KU+"77V0^.`*
M7``L5Q"MYL;^&R)@^DB1>K^5$]47B]B6=$1'_]2W-UO[U>YH#^\'K'_Q_.KG
M%MON3AS^XK?^H;^:(^"M>_ONNYN^7\XQKZ%5UT5R%X>C[;>S].Y&KN_0)\$5
ML.#VD;6I>G<#WVR]N0+?:'GSC*9_A\<6E;7BWVU-,C:L_CGS'GYX[$;9L['M
M9^75KUNER),MU0U[J/%T#THF20G/R>G8<&/"F\VD\9,.+AQB*.=S6&XQ2W)M
M=;YHU$M>JM5M6P_1,H4^H<Y!*$"8RD$$E4IR()F,!'=['3CA[H,ZL`&\U.5(
M,Y2S+RJP_2`S"0)Y!B,)3CU9[-<YL6^7'2%/4SFO<NO&^*$3ZJISEX,&.?TW
MI5ARK#QHI?A8D,9C'L9#.<GA=,0!ACG>>(<#:J\U3:VULLUV%KI2E&7$A3F4
M9B"G(KL*!2=N50F-L*6Y/<,M)MWV@1.Z5\CGV96TDA`RK#J<<^<$)25`B>P1
MQAPH##]7P</!7"@_Z+E,L>)8?5\1\0M]$UB]VI46RO;RV1*9;9X)`5\F;F!Z
M<?!'#Z:E-R?514:L]XJ5@[)=J95\HA&()Y0!X91TOU%T>^9)JEI5I+HC66VZ
MN\/3G0[+33+T%*)+0)EDUA$YPX3'%/#\0$SH084(*$`!5>2;<GT[=>$5LO\`
M=]7*O30J*E*$Y9504`A/=^3,\@_JTX8X[8ZK?K+Q0KK)9]*?LMQ3-+/EII&9
M"\%`#Q=M7-MPA:ZZ*_,EW'YFB<_J=MMKS$&G5&2JA*4R%,T!*J>EF2I^4'P@
MRCX@(,<1(AA%P``8`+8[3=RX166UW:B%V1FJ5-D]FJQ[LE0VE0Y2-H\<5=1V
M3BG>KE;*UVW+.[H6D3-/@%`#Y(3/\!QYHP%C[#-Z6&?SFU_5O!/\^1PP\AZ\
M0?VVV-WBS:*_^XUS#?\`*<2.;^L0F-?1PUUG02WZG<7X$MGYBU1Y&?V7;O:9
ME,UJ>:[==4I-**;RLTJ*:3W%E\&3]RR^1".>1S4>S,1)PQ`21<AX&U6EXB60
M*"*ZM8=6HX!+J2>3D;29Q3?T5K5Q)-%3N(0`/*0V!S8E:A*.A&M<]F&\S8#1
MF[3!SA.XW:'44IH?4VJLL88:@G,@][2/#DE5P@$8BQ>]\C-NI$ZCGK:3;Z=.
MC-87#1=0B=GKPE38V25W<U`$%:^U@,5I'+&\W%YS5VE:'5[2_P#NE%-+I_.&
M<)2H@A")I,_)0K;+DBW/F+866W!:"[4-\LOR>!EY_7],#236"++G#)-:4C#B
MXL!$`:,,8TCGL,))=#DPK+5="[YI'5MPX9U:O^HJ%)6TJ0\E+2GS(#,/)GM=
M&(D)G"++6ZJ?5NF;?Q&I4R99!0Z)DR5WJ6$GM9#MRGLMF8,SAC')^C*0J"O*
MPI33^D\F,_4E;5!+:;D&6)A`SLRG<X,DDRDDH!QX<+=6U-<TVYAQ]2PE*4DD
MG8`-I,P1+".7VJW_`.9+@RU+,LD``;23+`8IVDQWKJ'Y;^P';W_ROTTW-Z^5
M?!K7JK]7RLDCE$W]PR7%F&+C027$Q9-)\.1U/EJ>D'O6/W?!,)K&D9(!C@:(
M?G)_B7?*IQUZA9912`R2%@J6=G-E2.R09'9LSDQ]&HX>6JU4+*:QQPKY5(,D
MCH,RM1QPG+IRB,=4Y\INB<IO%F&A-6Z@U)4.EDZT9J#56@*DI>;2?*5;!,Y)
M6]/T]C26<Q^Y)Y3L<-->^S[.+PF)828`IA&?<XP5:K<*FDIDBL!$TKFH#&1V
M);PQ[,E3QQ&V6N_^I4-UH8J7SN^/:1($]G"4UKD?SL)8&1V3YW9S9YK#6VNF
MN.E>@&G]4ZAR32;4JM*0BFV+BR7`P\ED9+-IY)9.)O.Y_%2U-13\^YB@$1)1
MBVZ/;^(=!^SZ2JN+[32EMI*IJD"HI&8)!3C(GD*L.4[8Y_6:&K$5CS%(TX[D
M41@F9D%2!5)1E,;<$B<\!LC$M>;?]<=,:WE.G->Z659)ZUJ/.19*E*<CE\,W
MSU41P%(H*-BI_KAGL4$10B6$H;9T:OM3E,:FDJ&W*8?*2K,!(!1F0G`@&9!D
M0-HC7TZ0KTN]R^TMM[#!2<IQ,A@I6()V'$$B0C.LT^7;O?D].8M5Y_;W5,<J
MP,O]9S&4R,SHN:5+EL@`V""12&HHJECQ``X`D)P;;75\3;1WG=-5;2EDR`"P
M9G#`$(Q/0"8SS?#6Y*05KIW$I&.*3+PF:\!X1&-:&VD[G-3*0DM=Z=Z+5C5M
M'U#,(I?+)U)<.20Y+-YN&;122/%C@BJ&&.#!@GT)6(@0@0E2ELK<]?6^PO%@
MU#8>E,IS`*`E.9!2HRVF?,(Q]MT96WQ!=0TLM`RS924S_-!FD3Q`ESF+?UGV
M]ZV[>IO*Y!K1I[,Z$STVP(\>1?7\:2S>63C$PTZ\*4SRG8\2FAB0=0ZH25"M
M%LI8=8T.I4E;;B5@3!(,Y&0,L$)`/AC'7K2M9I]8#C:DJ(!Q$L#A.16HD=(,
M=,-B?R]=OVX_;+66ONL=7:G4Q\%5?6$OF<=)3B2RZ4Y.G:0D\FGD<UBD\<BJ
M6,Q8,$USD1$/5$870NMQG7NO+E;+HU04C2,I0%9E`GY2Q+"0P"0>4XGHCJFA
MM'4%TTT[<ZUU0DM4\NT`9<9DXSQ'DC9X3'H:L_+1T.JO;14.Z/9-KO/=3:9I
M*63.8S21U>9/,#G,M18QHYSEI7,X9!3514]/Z9R^$L,OF<NC$19X?#U8G3'%
M6M%2BDK&T]N<EID!,;`4ELRGC(A1QD"D3F,QJ?AK2(TZJYT*E*2"#(@S*<P"
MC/.D2&TC(DRGB>76[=QMET[TMTXT(G.E.E>OTBJ[4>82S)9W$U%R&)G<K46=
MG=(R>>P26@93)L?%&+C13N*$^&##`(B'B")O>F->NU-56)JG:938<_1AO/G2
MF:L'9I(S2"?)"1,*PYM/U)HH4K-*IE#Z9MS65Y,JE#+BB1G(35M*C(I\>%JM
MV,;OJ$HS%U#J;0:KI;2^0RT<UF6/AYJ132:R>7X4)Q,::361R"HHJFDQPH(2
M8T!Z`&HEL^_Q$M#[G=,5C3CD]B5S)P!PDG&0VR)ERRC6&]#W1I)<>IG4MRVJ
M00!C(3F<)G`9@)\D>1I)LYW1:\4Z*PTJT<G]24O]8BP,I4N8F<AIC(9_#@41
M1R6"HZAP_?N'"6$A0#?;*WS7UIHG$-/U+;;A`("ER,CRR*9RPVG#"+>T:,N%
M6%+88<6@&1*4YA/F)!$CT"<6/@[?=<HM4<?16#2:LX=5\J(8\U0/NZ`3O)X<
M2=$Z]JOLS3L0(2:+[G/&WNUZZMG<+JG'VTTLIE95)($P`<Q3+$R`QE/#;'BY
M:/KTNI80TM3\Y90F:N<C+FG,#$B4P,9RBX]:MIFY';U+<I-=8M)ZAI.3Y_,0
M9;+SN/,2.I:?@F&*(HL*5QSBG8L02$8O2>E4ZD*6QUIXBV^NL]8I#R%.I220
M%3($SM`;!`Z91>W#0E;0W6G;<96E*E`":2D'`3D2LA1'-.-Q/F%[)=+=HU):
M`5%IU.*VF^<U7P*GS<X-7S>33'(Y3`DDJHN<012N&0R&F>@Q13<H4"BZX:OP
MUUN[>+_<Z>K0CNT'L99B8.<8X''LCF\$;'K_`$:+/8[=4,+42XCMSE@9(V8[
M.T>?9MC).Q39SL1W.TAI](*^U\KJ3;CZJCJJ/.Z54K.)-E(X\A(IK/L2#IBG
M5"5*HBIR2>\>F&91'@0ZV`USJ[7FEJLH80A-%(26>Y43,GD[1`V"1'3/FR^@
MM`<-M1MK#U:M53S!%0D>2,-J03.8F%2E\GGO#>1L+V3:#R.J-/M*-9-2ZQW7
M9;)4YB4/HCGIK)YW-9_G9U,I-&8L24233[I(%/G-S$@]($*Q<!:CHW6>NM15
M"55(9_9:0M2W26$9$I2I4R%9<)@`F4@)J,AB/>N>'O#?3[?=MUC@KCE`2&ZE
M>8JD``4E6)!P&;$R&T2/.S4W9#NQT7I'%KC4G0FJZ>I+`R7O":3CVTFJ&.2X
M80&.<X<@J&..10#J"DABVZA9N(%KU&]NR*MI51+!(6"HR$\!E23A,F4Y1SNZ
MZ!UA8D]XME0;G*<FLNW#Y2]O3*/*T=V;;GMP4CQ:FT>T<J2L*9P<>/`AJ./&
MD].2&89["(&)B22;U!4$!GT.'U#J(4!EO5YU[;M-.I8=J6T/$3D5`&1Y9%*C
M+`XG#")M>@]6WY)6EI12,)CNB!T'M(`/@)C:K8OL%PM>=?=2=$MP\IU(TUF]
M#Z?RVLL*32SW-)IUB9L323RB*.#%G4FJ/#GE/Q03;PQB+I5'W:SQ`XGFCHZ:
MHLZF72MP`$S4@IRJ)D4A.PIE/,>42YMLT=P[_P`P5+S-R#J`A"I@=A>::0)A
M1PPQ\D<A!Y\":V[%]RFC64KFOYOH_6DNT=IRK*DR4GJR;1R43<TU[W,GDDXG
M,@$4-3R01X8R<7O+W0%A:ZV1TEQ+MM4\I@/H+IF0,V)$B<!W>)`!)E,@8G",
M1JGAY7:?:#I:5W6`*LO9!F!B>\4)$F4B0"3+;'ATQL9W=5ADJ/F=/:"5?-)5
M7LJP9M2\]Q,Q(L.79J79B4PSC+37$G$50PBGHLP8@(/>J=9B`#;92KXAVEA;
MC:ZMD+1Y0*P"-DIC+,$\@.V+)G15P>2A;=,XI"_)(09*D<98R,N66R,=SO;I
MKO3&JF!HA.M**JR^JLPACQ)91F5R&',<UG)5`8A%.I/C2**+!-/0=)69]72"
M&NMDZ#6]M>IQ5*J&]UD3GS=@`8'M90``9@DG`X'&,'<-)5S#^[]RO>)@9<IS
MDD3`RE1))&(`PE%Y:O;-]TF@E,1UEJMHU4--TU!![3.U%AYB1U+D9=`2!#'/
M(*>J'$BD,$1(0D`6P]JXD6VJM55W=2VNH0"<H5-4I[<N2<NF1&,9RYZ`N%-<
MZ9+C+B6E*`!*<H)(V9BH@GH)!PC;G>)L4T\V^[;]L^K-!3#46?UMK7'0V1S\
MAG6:E=02^//S[3?$G_\`5,HDE.?$!Q/??2R$Q)U-11;6N'?$A^Y7^XL5:$=P
MF8;RA4R.WY1R&9D`3(#'&0V1L.O-`"UV:W5#"E%Q29KF4@`]B83V^E0Q)P$L
M=L:VS[Y?^\VEZ.Q*]G6WFN<O3V%@Q3',00YB2S*I\KDX`8\293:BI%4453>U
MAPX23#T]0A!6VP6CB?:W7$LBL:[TF0&83)YAV!,]`,^B-9N>@=7,)*UTZ^[`
MF3E;``\)49##:1%BZ-[5=Q.XB5SF>:.:4U%6LFI_,XN6F,ZP,:3RO(1S'!`B
MQ95A3>H8L,U!/,+KA,72I"A46U:]<2*&D*4NOH05;,RI$\\IMXRPF8\6K0FJ
MZH$MLJ(&V0;,N;8X``>:,Q:5;.-2);K)H]3NX_1#5R5T+J3,ZHR&6EE,84FR
M]75!F9'1D]G\.'DH,&HX<3"Z2D48)@BZ52UA>=?4:J:H-MJJ=50A.TK*D),C
MBYD$P,#/$'#HC(6O1%3WK`JV'DM+(V)DI29B?=YS(G9+`C$1Y&LFUNHLYNAJ
MS0O;AI%JY,8)=)Z8SN!2U:9;V-3R>73V42*=S>;U;.L7$Q:=D-/F?3L0J8R"
M>VWBQ:^ITT#;]VJ:?O,<RD*4EHG,992M).P"8F25`RYH]W?1#PJG&:)A_*""
M$K2DN@!(GF2A0QYC(`)(GTXDUGVQ;@-NWNK_`)SZ65%1>1G.:P\K*YIB8TEF
MM.9R8Q@Q02DSNG8HZ;$^B@"AK46V:L6N+97%9IWD+`VY59I3V3`1A.6$QCR1
MC+OH6NI<O>MK03LS)E.4IRFLS`PGCAA&1H-@F\_.TA\:X&W:N8I`<#WD,+HD
M?Q.<FJG!%$&HA5!Q>D+T^Z.I&I:WNG$.Q)?-.BM9+TY2SSQP$O)E.>$ML5+;
MP_N2V@\:=WNB"9Y#*6W-/-LZ=D:A_P"ZQO98S<?AX>/W<[;B>:-5'/R1$\6M
M,2KP(`)(',<;3"&A)!"`GL8SO8P)R-D1`SJ3Z+E8GY2<$3N5MD,91__5MO=;
M^]9N:X?K!:QJU$_[_P`Z1W.WW)PZ_<5O_4-_-$?!6O?WW7_KE_.,:_PDF+M)
M^]Y0VVWL_P!X/A$:L]_=QX(950]PX(YAY*EJUR\M/@_'%,?2#X<D=E=WV4,N
MV`_*WTOR1^KY"KH:LJ.:PIT_7)E-\:2'J%ZDUKG>X"W(].+WCBEQ-6L#.%4*
M9]`IRGXDB?@CK.K!W?"GAVM!FF=>9<Q%5/XR?$8M/YS\T@PMVD@H3+0C+R+3
M+1336GY#@0_]EZ89W-L.*(H"L.!!!"O`"UAP382*53R1@M2U>/,0#MYD_P`$
M5.+M0MW62&U'R&4I'0"A)ELYU$QSBT8T\G&J6IU%T'(:CD-(S:H)YB1Y6KJD
MF9R4AIKW%#%/?>TUFP4Q1$25`'DD"W6[S<-P74/EEQPH0594)S+5)(,DI^4H
M[`)CQ".6VZE%1J%AO.A.921-1DD%293)Y`)SGT1W)&WK?G#E@1\US3:#+F$?
MU>-9IV(P.H#H."(>@=)\3'6^=J6_\/$7AU3G"U]:,>SW[Q.S\PX#GER<D?1K
M5CUTWIY+1XBMYBD=KNFI8K'_`!)YMF$]IB&=VV?,3R-"5QJ%D?F64I/Z<TYI
M6;UA5F7IG4RJJB,OELDE&).C'B#+T_BP8?6)5%$.H@Q`F\D6L;?J7AZO5R&W
M>'A33K<",BJI[LYTA,RC*1(3*B!/#IBI_E77M/IQVI.ON\"4*7@PV9Y5$R"B
MN?(!X8U_VI2_YB&Z>@*]U,I?>]4.E5#T!/Y534WF^HE?U3*Y9,)E-)-!.8!%
M.(HL+#$.!ASG(]/5$@&>`#4%MEUK_P"LK'JUEMK3A=8`2>[;+TO(3@$*4E.,
MYX<Q)QE&%X?.\1KI:KI6.WK*A12`I88($BL82"B,9SP$YC:!'F;GZ0W@Z2Z-
M5%/:Z^8%(-5*-GN/+J9F^F=)ZHS"<YZI\C4!CPNF*39;&Q!%*7F)%6$M+;9+
M3]=PTN>HVTITF[3J2G,E2RZ@`@`2["R02<=DB)S,8"\T/$*UZ)N=,_J%JH0X
MI,PDM.'*'`K--:09"6.(QD`(^#Y6V)%4](;[M()@(<U):ZVSY^?9K+%`1GY3
MAU%()4A15&%/8CS(%O?%913>=,+2!G[\C^:K*"/&/B!BOPT=[ZSZC0J>4,`_
MSD=H'9^=\9Y(I:>^SJ_Y->MV5ST7UC%TQW'4],Y0%(.1@F>-0"D/\,)J7/=Y
MNM4J&C_[4M#O(JF6G_902?GQ1IF^\X9WAH_)J4*G_*4!S_Q8YZ[?M1\EHYKA
MI)JMG,IF<_D*"KZG*LFV7R869YR62>;?UV81%X21("6.6W4=2V5%PTS7TS2I
M*<94)\T\)XJ`,O#'-M,755NU!1U+P[*'4GHP((&`)QE'Z1-V6T>@/F,ZAZ,;
MB=+]PE#0:<2>DI?3.H&4P,:":3#%IDS_`#$[PL228@AAP)'4>)!-\[DL2&90
M@P=2=*@PV^8]%ZJO?#NZ5;8H5+5VD@)RD%4B1CE7AC,Y<0)X3CZ.UOIJS\0+
M72.MUZ&E"1S*S32)IVIS(V<F;:98RE&/]F5.[/-"OF'5)1&WVML694W36WVN
M,O6U53^O?B*2&K#6&GL?N&73C%C.%'F:;DT.+U@$000$0JL)B-QJZXZFN7#J
MPTE0VCLONE`2!F"%+![8,^UFS&0V)RSQG%#2=%8+;Q$OE4S4*[M5.T"53RE0
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M)6A`#G\9*)!2AE)PP"YD>420K7K0Z[1,/5*$I1Y*DJ<.29&!5F*4XI&)GD`!
ME(2C?C2"*@M-M;-3I?-O<E/9:82&E,655]6NXJ?UY7^I^3EL&(8HQ1-0S?%-
M"2&D\UC19"*.&(^]8TBB8"3J=RI;C4,M+32N`D^0EHI0B8Q`PQQF9S.W9S[9
M9WK,PXK_`*I)401F+A4I0!PGB>20E(81S)R>J>>TP^3[J9CT17&7H_4Z55GJ
M-[KPY/.Y3E:ID8F6Y&=-E8BZL.'$BD&,L*A2`4<SIUVLE77<<+J\[2ARG6E)
MD4I4DRH6P,T^R)$`C,-H'+(QRFVWJF8__GK3-L9JU-U314DR4M*L;@ZO`IDH
MX*(.57DDXXRC'OS>:]EE>;3]E,W-0RRI*NBBR&8J#,9>:2K/YR+/3G3N213>
M.9+X3USSIZNE`OGR/"FV5MNUE>:C=E-L(>RR("4Y5+<3V><93\D>#DBVXMW6
M@N-MTME>2I89?.!43,AB<\!(S'+&9?E3X5,U)\O+6O3#/UG3-,3FMJUU3D64
M]\S.69&+)1S33VE97EIP9,(H<3HP\;#ZHP!$L,+0C(L/QA8K=/\`&6@NEO9*
MFTEAZ0E@I#:`)3SDXI!D$^$<L9CA8[27WA+<;375*4YB\W,SV+63C+++:0#.
M9(VB/BPIKHM\M+Y?6J6C,TUJH[5+5W4S+ZAYB7R6E<U)LOF,:IJPI;!H_P!C
M))-"<S%*:>D$BRN'US"8]$/2(NJ)3#`:2+==>*.O:>NKZ9;2$)!)7E20E#>P
M`=V%9BF6S`'%0PBJNZVWAQH9^CM]0AUYUR0RYE":G)%1)#A$@2?XQP"3&;]5
MM:M$=/)]\KBK-0JDIC'IZEYI/\C.9O'GY7F)=1E0SW0[$E%/3F;8O7_4\`GV
M*`(X2!"02CA;"T]BN7=<4F0PJ;M12A,Y">1UR4BHC`C89RD0<8S*K];0]PT?
M[].5NGJ2J68D9VVYSD#B"=DIX'9R9GJJN8M.]0M;-9LG+=%)7IM5%/4[F\?5
M:O=TFHF/)*KEYE`CPI=(=.,2DZEI&GXX3#UK+(DF@A\/B(7"FTUU8[H:F[RI
M5NZZ@%M+0;6R7%)((6K*E6>05-2CD"=J1&5-[H*=O7KN6G'?HIB%E96ESNT$
M$%(!4,LRF0"<V;8J-;]E]:YG43;10=-8--Z):L:5PZBY3-RFEZ+U#J#32O\`
M1"FX:RG,Z.//(ICA`S^HM,!$(/ZOQ)09M#"L(Z3$8]BUY:JA6H5U7<.I6H([
M63,@R2E*9%,^;*09&8P`G,X+0MXI6K%NJWD$)*NR595"94HX*`PQS`B8(,B3
M(RNW135C:_I7OVUBI7`UJ^)*OKS2.A<K*9W7=<X]7FF,_))]7)J#2>0Z@3PX
M^;PC'ASN3S,2F*:1XHC/4G4!:UNUJO%=IJC*[86RVX>PE,L)@!>0',#,D%.4
MDSSR`BO9;O:J+4%247#.A;?E$DXR\G/ERG8)*F$X99DQA3=-5YTDV<:MT+J!
M1NCU(RRN<O7&4INB,YN.U"UIKZIJBGV+@X<IJFEQ5E)X>=ABQ*@BAF<$$$4(
ME1P>N(*`;38[,\^IQ0:J2^VSES9$H:3M&12E24I7:P`F1MV`RPNL+Q3?Y/L5
MO;W=*`MR:<ZG%8N!84@IPD)%1*B1(A)Q,C@CYT]14].M,]FF!(Y]*)OBRZ3U
MI]<BE<RE>=ARL9I2B8BD42P1=((=<\.MO?!>BN-LO]T>>IEH3F,BH2G@X)B>
MT>"8QV[(Q''JZ4%WU+I6I8>"LC53.4\,_<D3$@1.1VCDV"-&/E/S>62;?GHE
M-YK,LE*)?DLKJ;%FLS,<U#+\A_9G78$,*HU7*R\VWSBH[5W#AA^S4MDK[U)P
MD3@^%;)"?B,:%P>-+:->*JWG`&^Z6`3,;6U#;VN?FCJ)G];M'J!^=?.:SU"J
M*F<E3<ZTDD]'TE5V?FLK$ADM83:E9/!@QQ3B.(12*+&P(,W+@I"F8-0&W*TZ
M=N:N$K3"&E)(!44D`$@5:E2D3.>Q0'+(2G..B4=\M['&.LN/?)4TI0&83*03
M1H1R`X3[)PPQG(3C;G4BOLOH;E-Q^H524KHA*=,:U]ZXV-4%:;FM1ZKAU;D\
M,FFL&-A2?3?,4C4TAIN:8T6=]WF52K$3&<.J$0`:?;+;57=VAINYJ"XC+L0D
M)1(`=I2@B22!LF<TI8F4;O<KI1VE%6Z'F`%SVJ45*F3Y*4E4U"8VC#:98F-;
M::Q9UNIV/;7:0V::W4YHO5FEN>TN@U#R@J&*2S&G<O1<DQ)+4>7G,JIK#,$[
M!J0"8C"Q(893.1`8C%$(@1E%V^MT]<:Y590K<#B!D5D#B5)(,V\`I()E+*<9
M#$R()PZ+C07ZCI$L5B$E"SF25%!"@1E7CE4=LYC83(8@RR5MFK&.3[^M095J
M5NTI+<+5%/[;()5-ZVR]):>Z>R^GS!7M-3>"E<?#I?%$CF\ZPHL(3".$&&*6
M0Y@PEF(;8J\T-`[H&PTR+$IMQ-6\HGO%J*YG!13/L`$!,I_("L,\7E@K:UK7
M^H'WKVEQM=(TD$(2D)ECE!E)6TF>SMD8Y"(QWHGKC.=1]F?S+\AJCJCDZJST
MHKS<?3E#9*HI])A,,E3$=(P^ZI/)(!%#")!C!1*"D2*2&VV"_P!MMS6N-(NT
M%H[M+2I*RJ(GL!)&$LP)S'$RQG%CIZXURM#:F;JKIG>5E(S)G+&9Q(,]@`&`
MGL$?#K3KS/=/-A_RZ,KIIJ=#3,\S]<[<*;K?W!.I7%,(Z:AI7$,^E4ZBQ`<&
M.GS%!`9JC0!P-K^R:=-1KW53U=;5+97*0<0".03253&,IH(QRXI(C%WG4K#6
MA--L4U:E+B>\*LBE!4\RB)Y1/EDH;,V!G&WE>:\:%45\QK3?.U-5M(Y'-U;M
MCF5'4U5V?FDOPLE@3O\`YBX\V^%(9K'#B12S$J*'&AQ(83_O8L(`>(PBVAVW
M35U7H.],H;4`*II2@<"I*<P,A.:NTI)ERRF)J`$;[<]5V@:YL3A?0I(IW4@X
MJ"5*&$R$X22DB?),3`28UTF\RF>V3:MOKP]V^N5.:EYG6"I-2\WI-(\:H\Q4
MTPF\IJV6XTGDE,R.4U`<#,11X,ZQQ%[LET$6!*8(V$M,.851O7.NT&W14RFZ
MRD0ZEY93DS;%!&(!*@B8Y00L)\F9C7FJZFM[&OW*FI0JGJEL*;2%%9!FH9Y"
M82DJE,X$%!)$Y1]&IFL.CFG^GORIZIU!J&G8Z:HBJ:4AJ/'Q)M+\UATQ,<30
MN?2:1SV9XD(9!3=1XF3C,<'BZE*.MD+9INXJ1Q/;-(I*G>X(*AE!*%K4)$D`
MA6"@1R8B8PBRKM26\/<,EIJ@L-"H!"9D@+#:9$!)D4["#S8R.,;+T[CS_3/=
M3KQNLU#W*4)#M+JG2:F<C1LDS%>XN8E,IFTHP:<BQJ@@E/M(I%@0Q^Y<]#!%
M+8XL2:G/AD1`!TI]=5?-'6&RM4)16M.NJ60@8YG"4E3@2D$92$]I9E*6``C?
M&K77:9UQJ*Z7+LTKC3($SB`&D]G(,Q!'E8)&)F)DF6BNB^O&C&LNQ;6;2#2[
M7^0[1:WQ]3:\GLIJ*:YZ.E\7)4[/=:IS6DEF\HS\,-,8,.6G]/XAR44<NCZL
M,"(`%B[WJRA>MVO;'7U[0J64L*&0)29GNE(5)*E$$9CW@*B93./9G',M,:CT
MR_HB_P!I>N":>K+C:IJ4XG#O$*':`2,V4=V4@@X#LXD1NIN!F\JEVLWRL,_,
M*WEU02_*U)7>9S5>S#,P2W)5,(M!65;"3^;B-2Q>J%Z0<]P2VNZ8WIS2G$U*
M6<7U4,I9<`E]PR`'@V8=`C>-2[HSJOALM;W9816[<W*RT`23TXSQZ3%OZ8ZY
M:)Y7>=OHH''JRE<KJ#J5@Z.3&ALQFZHS5/X-<2R3:.R201R*2U1(NB+KIF?8
MY7Z@LUPOKW4!$8`1EK]IZY5&C>&E6&7"VQOQ("05#/4).8))"CLF9S``!P!Q
MQ%DU+;:75_$E@O-@O[B$DDY26Z=8()`('E2!PG.6T8:G[O-0L+2S:-DM(:\I
M?1+2J:36K:3%#269;@=0]?*PI"?2K4B3SX5\()[3&%550R2E(X3-HP9E^;E)
M$N8L,-O5HMZ#6EW]KOI6VV`%EC*@@_)D5!2I$S,T8$`S&$\=<K@M%(64V9DM
MK63D2^5+21+M3`*4S&`DK$'8<8W+D<PE^ID>6J?7')Z;R3)9+3'&@R>[#;WN
M;G-$2W*>TF\.+%2N'EL*<T_4$IPXH")F(\7&F\H)'3'%U^$X"OHNYIUMT-4^
M/TA_1N,2G.4U!8SI(V`35/`]$]GM-S"G6EU="R3W?EH?G*4Y)*"$*!VSDF4R
M,-LOR"ZG8<BRVI&H>'3%19^K*8P*SJ/W%5LRC]IGZEI_WM.C*)K-\3H@$8J4
MJD72%>@M]BTJWELLKJ&PBH*$E:0<P2HCM)S;"`9@'E`G'Q\ZEM*U)945,A1"
M21EF`<#EQD<LB1/`F+)'`J.`O#"'%I8&\[95'+%@ORH5Y520B=KR7%5(?:G%
M>"]%+D5GJ^15ZOY;[(1__]:V]UO[UFYH*!^T%K(O_P"?SJWW)PY_<5!^H;^:
M(^"M>_ONNY^^7\XQK_!ZS7%3P"*"&!H6VWL_WA7A'QQJ[W]W3X(?+S'T*ER<
MK5KEY0\'XXI#Z0?#DCL3NCS^-5GRROEU:L2<PXT6DU45=IY-`&G*3*'&A$K`
M<HPQ1V'_`.7;D-A<98XK\2J4*_2K31.`=`IP5?@4ZD>..N:I;<<X3</5D2:[
MRN23TFI5+\*6R8\OYQ<LRU0ZS:-Z^2.$8]):Z:!41.93,X4/5,Y=!#G#$@4C
M_N_462[[6?!2I"V'V0F00MP#QG,.3^,1'OB]2%C5].X23WC"%?@3D(V\F4'^
M='(J+!]M`N,G8_M7@T6[%7TO?U1)&,OQ#ICD]%4EF^@C9+^AX(H0Y/(=1)RN
M7%Z_4HCR<"+[5"JS,WY<J[']6O\`JQ'FOJ[HW0M,[M@2?EHYY\T=@-&LIAZ(
M?*5W`ZEG+F7SC<IJEE=+Y1GC$#]?D$J.%3\$'1Z\*84$_:YMN(5-5:U\5&2J
MK_0TX6X%9%8K4@)"92)P"9@_CCM=>U<J;A<E:**:WRV@C.GR0LJ*MO/(2BOK
M'D,31;Y2FW2AHR,O.-SVI,QU*G>10+G:=DN-'/Y=&<0Q"(`PX-/D!!VFUS;[
MBSJWBJMURCFAIIML)SGE&8JG)/1A+8>B9PM=25&EN$ML?9K9./U"E$Y`=CA1
M+$K&$SCA/:(X]8&5R^7,46#ELOEB+S$@+P]#;M]134-IOK#C5NP4#_Q%<J9<
MI5RQS6X.U=<:2A77>4"2,@Y`%;1+XXZ]?+BR^#ISM\W^;AIP!@2R1:,PZ;R;
M-10F(9VHZIAGN()2.$4.8BD(##_U];<,XJY5W[3#&;MEU:_$C*J7CPESXQUW
MAJPIBRZE='D]VE'C7,3\4B3S810DT,>F?R9*B^N].!FM?MR,J,I0@G.9*48L
MF)7@L.E><*&[MM+SA5Q8M;85-":?+X%.(4)'I(`/@BFP\EKAE='"DA1J1XTI
M6G9AR*)$<D?]V$B/,L+!>&`JRW<'U?LIP,O>2<?A+-'(5I37I[UG!0^'+*(Q
M08<`S!P1[$YA/KA\11X;Q2U%VU62I1WZV>V1SN?B(BK17*\(5W"79H&S!'5T
M<\4!@Y:+"&7.`Z]O$=G"WND8LU4A-"XUV6ASKY3T2^,QXJ'[M3K56)<Q</,C
MDPZ?BCZ8L/"7J3_JH_G=@4!CC:M5U%E*T5Q9FML<[G+AS?BBE3,W?(JC#G9<
MQV(Y,?Q<\4C@Y5A.`2.*Q=K"T!+45VZ@;F`B1\*NN(2Y=5_\3'P(B&-@97&;
MBX/UA.<5Z@$-M:.6>W/]HIF/YW^]%TBIO#,I.2)Z$=4/V.`<;ZU[![$"W`![
M`$%KNU"@?U1=[B437E;&U7Y@3_1YHIM*K>X38RO]&B9E)/*<_AVG\X_BAPX.
M7P`HP7HP*B7OX6M[8]0TE@NEQ".W-`G-7Y^4<_.>2*-8JLK_`-&M?T9PP3R_
M@YNF%B9;`Q?'FL!2L*>(A>#B0K+5:>T4"B+U>$YE@3'E"0E('L'^C'IZ[5J<
MMJM2\J"=G9/,=JQ/^&(X6#EX8B<M@'RF)H;>EO`105CRJJU(DH8;5<TOER^*
M/:G:VF9W:XKF#_)'+/Y,^7I@]CEL$+[!>KBK$;Q8EF[6\9^QA48G%6U&/Q^#
MQQ5WNO.0!R88V8)^7XNOQ1]'L<NAX0EOK7^0^FT[M;_T<D84YPQ5\LS^&V&]
M5PS`K^GZ$_(\75XX"("WNX*X+Y+>GVJ"L07EHEXU<GX(\LU%=3'N4K[)Z$_E
MBA#E\M%AC+^Q%Z>L[@A0V\T"+?5J+"VYI`YU>'HYH]5M1<*9(>"\?`G\OQ17
M\(Q1C`,/$E2G`/0BU&F%`VYW`1A/G5AR_#&/.:NJ6@P58-[/)^49_#&*6%A9
M?*@C`P"TK$TH',0J%/<RU]6.T-J2FH:3)6SY7XY\\6A-;>'N_=7F*!A@GE\&
M7FYHKE,982QKVLOY\;4+FY25+[=L4B:)\ZN8'H^./`WN@>WI*NV<.3P=/Q1'
MV67]B<M[$!X<2JQ*ZY+92XJH*6W(MP;DG++:K9,'I^.+LLUV%U*^WMV)\'PP
M@&7APWH3EWO"H>"D&V+I+7;K)CW<AX5=:H]U5SK[O@7/X$\GB3!%@0QXGME0
MN?$B`&Y@;Z+*JCH+N1-O$=*NM/1$TE=6VS_B8^!/48I>SPSA?5CE<L3"Q.L7
MJ?+:OWEP>;10&T]EH8?I4\N/PQ,68;HV%KK1=,7#_5J\'PPA]&$4C^K$I>(@
MP<^(M._U[ZQ6JM/:;_M4\HES?B,>0S2,)-&+G@Y_9JY,1RGXX7LLN#U>P/BY
MEI7O1HM"44#2UUJ4?I'1CBKDP\'\`BX[NN=2FDS]EOH3RX_#&(_5\N,+ZO[%
M%O:Y77(AL3;;:TVN@[OLN=*N3'G_`!P54W!U2:PN8MG#!/+A\,(KB&`7>JMY
M<24YL'IM;4M!;_T9R?W><L5?+GT]?BA4W"NFI.?Z>7YOR9='5%`X>7P!$/8K
MU=*^LB`@\/P65+EOIN\2$?WF0.*L<DAT\_1XXFF%=49"5_0SE@GY4Y_%TQ5B
M]GTC"C*PPW=*/"O`=Z+50QIYEO<*=B63^,YRX\OAYXQC-&RES?J1K*M?23LP
M.T_BC<3;[OFU\VXTG-=.Z+S=#51IQ.LV9QFZ%U$HN65?3OO(@=0E$0C@CZ8^
MD$PJ820"B@6TN_Z#I]95"+L$D/-)RI4%*20#\F:76L,#M!E,\^/1;'Q(U5HU
ME5NMU>6FG%`D!#)GTG.TX1.?YP'+%D;CMU.LNZR;26;:P3N69W#IG+3#*TU3
M<@E'N&0RJ.;PP84XQ)=+(C%CYC&.'@PP]>)%%$D("H!;)6C1]HM6EG>[8"34
MJ!49K)44.$`J)6HF6,ID2F8Q=SU5=;CJ5I3KRCW`(&"))"T`D`!`"03*>!V1
MK<<'+G)C!&`"82@>"V,`,X-ML;G[.;THVC)_=C(8J^4YC^&?3&#0NN7J5:N\
MD7]N"?DHG^+HBNJ8HQO;?GS_`.KX<NUEKQ3_`'8PODI?V,6W<YISLW_YHHG!
MP2!@I^9*_0O[%!:ML<M\.&1OD_\`DQ`4IH@BT8_K8J1*"B@!MR/:@>@_!:BF
M+U<2A)5>):V^]E_WK7R/E19+P5$3?Q0]A)47\`+DMXBO`Q?5+D5`K^"HB,7^
M6R$?_]>V]UJ'=7N:_P`P>L?_`!_.K?<G#G]Q4$_ZAOYHCX*U[/\`;=<1_7+^
M<8U^#>-YYAKVD#T6V]GZ=R-8<^@1$H8>L>50&*>*DA%0V4E&;BA7++X<XB@\
M^;<XGF^'08Z[[!H)9N3V[;D-B$^SN3RM25%D<35_1'.3,8?7\72R."*;2@XF
M)$3!A8>8D>1BB&&/:12C/YSZ(-N&<0Z)RQW2DNC>"4@M._R%&:3B58)7,F6)
MF!L&'<-`UC=XH:BW+\LGO&]OEI3VM@3BM&&.`(/+*+RT;D>)O5V;U5LOJ3!C
ME&ZC:G.<_/-(Y7/((\C,IQ3LB436@,4F$Q8.#A#JE6+%$@A7(1%D)M[OE+3V
M#4E!K:W(*M%U"VTN$3$BE/=@G.2\$Y@9G*G#8%3$_=BJW;O8JO1MP4$ZO;0X
MIH3!F%'O"D9<K)5EDH`J/+,B1CC/,)9,I-,)A*IS*YA)IE(\W,Y/-Y3-,H9?
M,LA,I,>F=2><@I$##'R?;NQJ+9>+2SJ2@<G9.426)'-W?RI.'MX8)EXL8XE7
MTURM5S>L%<W*\@@@S2<",X("9H\GDS?PX1\&(/986+$MT!\SKQ?:O3TZ-/&]
M5WR0E!\20</E<\MD4G7EWW]C40VYE#\)`G\GFYX[+[^I#G*$V[?+TV;23`6I
ML:E9-6]0RGI"PU+6>#A2B4$%?IU+/9T$Y-;;@G"[+4'5.H5`%.=IOI&5)S>)
M1*?D\D=LXE(53JTW9!Y0;=7+GSJ3E_V0D_*^5%L?-^FDFIW5[1?;U2^;,=.;
M?]#*+D<.5(Q0!.)YA86!B$=9ZOSDAI_(Q.`"E`EJ_!2GI:ZD?J+[C7O/*6G;
MB9Y3]').U/*!MBUXS/.6:M88L)E;FF4MG8<!VA])F5\KG)Z8Y7T=156:@5;3
MM`T=)\]4]757-)?*:?D<N,,.?S>?AAZHHHH@4AA`"DD@`!MNMW"H:MCRU:H>
M`LX!()P``$YDM37ATQRVT4CNH4!.GFIW,F1V8DF4@'"E.,^2.R.Z.F9AI1II
MH3\J?0[&P*JU,J>K:4JK7&:2J*&$3C46H,GDL?(9+,8<6#AQY>1X69BBSH&(
M5ADTKR<1`Z[</T]2O.6R[<7+PL(N#:4]PC;GE^@4M12,B>1"9MR$E$IG)<=H
MOB-[N=NX)VL]Y;&"5N+E+*5)WH)2%$*5+-G5)Y4RM(!`!0,5?,_JVGJ+S.B.
MRW3[.9:8TKM:H7(X%3YK*8<>&<_J%.I0()F<2".)F)%AP]98$,QS@NMM/#"A
M?OK]RXC7-7_5./JEC.0RED#LE([(.7Z.1!!$I8:]Q&N--:T4NF;:K-2T*<BC
MC+.HA2QV@20#_&.(\<<GR.E2`H(1"'EC4"AO!]NLQRV#C_1>0T1%BL!*D!>R
MR$-""6!@9"0KPWF45/N2R&V`%S>:*]Q1"%Z661,1O0CD"]I4M:0TE;(1)4^B
M6#M"&(JK023VV1$)0KP5Y(\@DNX<;(F%TNX,:P@_[):2>ZR$.]4!1X!<`]&A
M&'N2R(B2M50#QX-"A6+Z;(1$W=)#0Y&N>J`J4LA!$""$"M!5UP0<F<6V1(@`
MN-X+&L),"(K54V0@1RJ#P3I4JP7-4]UD1`BH&-``4E>4)*@-'ELB80[7*`0P
M7\?Z5D(EQ#+B>KI"MB)/TF(KG61$#5"JC@$0@E%5Y+BMD(0+'0L8&PJ6AY):
MVR$)28@4+7\+U1P=9$PQ>/(`J@N1BW!.^R$-[@51"A;"@82_UKTL^.(A`H".
M99TD@M*H%(8]UD.6`7HQ24!?V'D`U+(F&TO#?HD!$!!)/)]]]D1`H((N//D$
M)<!THY@LA"4$(!<O43<YR%&>2R$"E"KR_D$5$5Y`O?9LA`@NXJQG-%2X^FR)
MA)>X1-\3`UA<`QHX60@`:5"L)`):@%Q`>@[[(1((22`H1JO:T*`5(LB(2H0A
M88@U55@'<6\+(0%C?"5X)%S):ESS_+9"`$E"]I>2CPBJTJMD3`H>K7/"JJO1
M$6]R60C_T+<W6_O5[FO\P6LG#_X_G7>^WW)PY_<5O_4-_-$?!6O?WW7?KE_.
M,:_`!4[47@H;>"MUMP9^G7&KNR[A,X8BZ`T,*%Q>4/#C:\;?_9((Y3\/XW3'
MAZE_:,E`<G5TB+WTXU`J_2VO:7U)H288<LJZCIGD)](\_BP08N%B9V.'ICPL
M3#C)@Q*?Q("1%"01$"AM@KG8F]4!Q*T!04D@@["")&?:3A%W0WMS3BD%M924
MJ!!&T%)!!'95VI@1VNU%IC.[N)=*OF+[%<_%3&YS3PR[/Z]Z+2/,8&%/Q4$J
MEN+!#5$GD0)$^CJ+!A@!*0P3V3Q,'O/KAMPRFN3VE%O<++X\DZ>=60%DI2,B
MB79*R@K!+A$SWJ=N&`CORJ%O4[(XG6IHIOK24J*0"HA:4I;FDJ(20&P3+NCB
M#/$F=J3S.;6_F?X>7SL]FTBVJ;YH<#W3,X9SBX$NT^U@FDIZB@&:Q<'#AG`Q
M43\X)S`(ND0S""!E]<+=>>#;>2LF]H=TS`'=!86<>13CJ@%J3(YA.>R6W#"N
MM/%I<Z4I:UJV!,J[Q2%(&$_);:2HH2K#*=F&.S1"1;2=0*2WG:<[6=3<I*/B
M:8Z@45E*BBD$SBGV0%,3<B>8TVZ8QAQ"*"GH2H(!!%M_K-6(O>A+U=FW,R.Z
M)P&T)5C@4)_-(Q$:33:8<L^L[1:W$95]Z!(RP*@.5*E3':G@=D=1JVR_ZSGS
MNZ>IW"Q3F*5T9F]-9(8<4(&1R.1T;I'XWFT"0F`]4.HDZZ(6@EEN:4KB;#P&
MNUT2K*\ZI)GLG.L2WTXA)Y@9#DE..D5B$7SC?;;8XF;",PEB=E(IS^+@2DC;
MM/+.4:X:M[)=WF\W=?KEJ)3^F6;HZ@YI7F?E\KU#U0Z:)IS+45(88)!))WAX
M%08T=23G#Q)#)X2LMEA$/4.J)%-LSIS7&F=,6)NBN*0;LTT$H0C.I2E2F9!"
M5(FI6/:4!,^5&%NFBK_K.Z&IMR5BU./*)*PD``J,O+4A9``V)!.&R+[P-2-N
MOR[LMG=.]I^>P-TN]RKLM\)S#5V7RO+U'35!S&<X<?5):/D4ABQ,"=S;#ZA_
M5LM,444:F93"'H@R,6,11:@U[4HJ]1.*8TXA17E6&@5)3C)804+2G"9)G@9X
M22J,C555BX:4QI[$T';\M.3,"Z`E1($T]X'4E1G(`<HD,V8IBY*6RLO^6;IU
M/MR>NDPP-0_F!Z\RF:9K3:DYIGOB#/:>2J=!)Y657PD#JG.(21-X^I(D]W2S
MPG/QFTJF!K_5(I;2RI.D62A*I`!)RI&"2KNW"F8^0>SL``*"<@BI;X?::=O]
MR`_S/6I[),QE)4<"$AQJ8S#!24[<3,*EPUGL[G%33F:U-4<RS$VJ&H)K,9K4
M$RF8!F$ZF4[/]<39H8+?0U8W2T5&Q:+6G+3`2ECR2(':F</Y71'SJ!4-U3[%
M>HJJ*@YIX?))7B4X$DDGDY8\?FU5`#>QQ!`_"+5HJPGD@"\L(*$L3D#<UUD(
M<+0T$I<K3>JEJH;N-D1!XFOX%`8>*-4.2R&$+I)B++B0M[;D119X(F&K+[D+
MX@1$P&$O1BV1$)7O'4.KU>*(.8+N=D($(0@%Y/8`'BYHO6R$%ZH+V`>(ESP"
MA/F6R)AF)`C$:B-8TN4(PV0A,[VN*@`\0CDLG"&P*6M*(QS"QRDJ[TV1$($A
MB*G"$<2Q;BIXLLB890->>8A4DM+E5Z<K(CH@<?#U.+.`"*R_GQLAX8B48\H\
M,:BL4%``+(F&P,*A[>Y6]3>KBB60A7=KFHJHIZE15%D(90O:Y(@+E0DAB$C\
M%D(%*$%BJ&B]I)"(P>:R$"E?"AX`@*U0H,0O3RFR(@9>CV^(&]>2(I=^.SQP
MB0/])2Y`5(+7BX#DHLA"(#"T)X6H4(<@'4C7V0A-"/:P\2BJXW<+(F!58K`U
MA`#7-)4%8DLB(3$*-)/8R]IX\+(F&4!1.37CI!6\7$%Z60AJH#?#>4!*@<^7
M*R(@6\L8BM*OYH00H!Y60A'F06WJK#<5527V1,._UD5%`07<F%H[NVR(A<$`
M'$-!-Y+0I'ELB88:"`!W!5<7J@)6R$)Q13R:0H:J@%C;(0U#UBZ>*GB]RJOF
ML^*(Y.F/_]&V]UW[UFYKEN#UC9_]_P`Y6WW)PY_<5O\`U#?S1'P5KV7[;K_U
MR_G&-?@Q2Q6E6M"JQK4MM[/]X<C6'/H$P*%?S"<6,0.$+6WVK0AO"M#0P'I4
M-5"B%;(B,I:.:S:F:#UY*=3M)JMS]'U9+``<QEH1'+)A+20LFG<EB\$^D$1N
M((M9W_3-%KII0N!E*6T*.S9@E3>R0C*674U9HIX*H1B2<1('';BI*Y$\L=.Y
MCK?L/WW1X>8W12*/:EN$S<,9S.M5`Y`9O3^IYK#`D$UJ^7X$$<)P\3$:?>^&
M8H86"9H[B%5;-0<+ZO\`[&^FHHR?)6$(6)?FK.=)!.)S)P``'*J.OTMSLW$9
MD*O:5,50'E)SJ2K^4A.0@@"785B22>:/N^4UIA#5&_*L*DR-59BOY3H92U9Y
MFFJVS.&<;XE]IB0:6TA-NB=E83%3!S_20?"4:RU#B_=**M>;4[;>X?4A`GG4
M<JE9%+$DB1P"P3B"<08M.%EHN+-Z76TM=F:2A4QD2)@)4D>4K#%22!+`"475
MIYM0^;/I?KOJ1KGI?I#3DAU'U'F%9XDXJ&=5KH_48R61K.LH:BFWNF">U)%!
MZT,,0"(4#+>Z_5G!I=FIJ6OMP5E2D$=Y6\DOZML#D&R0YHKT>D^+;>MG[S15
M:DIS*(5W=%*1;RC!Q9Y9#R9RVX$Q?6IFUG>MJ%EQ,?F![\Z,T3T_BP\3,Y^F
ML:L91'A9N6X),4>":.D9I*D9K'UP,ZXIFL3`I9:BUJ30VE*I".$M@6FJ.QPK
M>4!/;VJP.$3.,C(;!%_6V'6&J6LW%*ZMBF;D<F1@;-A":(HGS3`GM.S&,)?K
M7[/]EN1STBV)Z?XFL>L>-E(Y/G=SVJV`8I;*Q'A00GX1DL4&5,>%"8L0'#Z)
M0"D)B,P]6V?;TKQ+XGH[W4]Q+%`G%*0FF5,2PS%E;1(QV$2Y>2,0WJ;AYP_>
M4G3M!O-<H=I2E5")<ARH=0Z!_*&/)@"(Y,5K759ZE5/-ZWKVH)I5-4SS&@Q<
M]-YOF(<WG,Q@X4(PL+!PL/#$,&'A84$(AAA``A"`!+=7IJ9ND:;88:2AA(DE
M*0`E('(`,`(Y8^^7%+<6HEQ1)4HDDDG:23M)BU@>;>YS>]+9)MP``SC".B9,
M]D0#!YP``V$-O4W=UO$7$/J:I!144H3#Z2B#C9$0/)#`]/6*'B/*M]D3`6$!
M_G)1B%K$:/O61$16X,1?,G.+@YWWD3#7B"`B\;@"6]+@C"MD1`H`1ZD!H4."
M%$!+"SC9""$"\("'WH5*.N1]D(%=]%0;W,858X>FR)B11&*40L5K8@5?P1UI
MB(B2`$+2BH44JUJ!0B\;1"&QP)((^B`IZ5"<V>:R$)%85!#2$+7,#U)?9#XH
M.'4JHUIZ@"Y.+[(GP0*B<`UJ,"!&$$W>:R$"=)#QS(#$2Y>++GV0@A!`0$M0
M>K]XO4GE9`P*>IUZ!X'4J!"6GTV0Y(7`!Q:P<2&`]J!M]D1#(%_E00CU1X7I
M<YC[(F`./H!`#P'AP`:]+(B`GBH:A[PQGA("\;-L(D5:%>0%B4"XD%OA7SV0
MB*DM0E`]4/K(Y6,5UD(:N+R0U7->(0@"*+(0BR\MB:;PKV#O([[(0$D/9$ER
MN4%R(0Q.%D(&>%0]%`:R%@">M?9"&7M+O$"T-#"+[Q=9"$\,:H)"O52";@[\
M/:B8$/\`-<IXABDJ7$`OLB($Z@%:Y2$5`+N)2R)V0(5(!0!2J(B!7!(2MD1#
M5"#Q#>+&@'B21WI9"(@W!B(JL4@E`"L*%#R5+(0V</I=+RCD1?-Q2R$?_]*V
M]UJ_K6;F_P#,%K%_Q_.NU7V^Y.'/[BH/U#?S1'P5KW]]UWZY?SC&OP))+2P1
M-8]CAV6V]GZ=<:PY]`F!`K50`DJ+R\=I'&U:$-A:UI9]$%OA`*AK+(B&88B/
M#R5WG4K^&WFLM]94XT!D/YO](B/-+<*6G)%8F9\?]$&'!%AX93%A,1X*1V^J
M"`X6J4%516H9;T.US]KXFP>B/-4S67!>:U>3RCL_&N4>A+YO-I/GQG)1-IQ)
ML\U,U(IO-9?,!X20AD2$):G4.U]SI^^N=K.0"?TJ=G\R4>F&J*ALB:JAKTET
M@'%LRGF`.*YCGC(<6M^L^-!]0S6LFK@ESSE3JA62!(54=-0J'VL*6WZ%K/T=
MSMA[P?VM1_0(B_=J]74NGT7*AK4]T?[-C9GR_*!^*,9Y_-YF9YJ+/3'-3";Y
M\_\`:YIG3GY@@4?2)NM?IIK1;,;-;<I.P]XL_P`#A,6-7676XJ(NEP!3+8&T
M`>9*/GB2/UXT_P!DG@@8B6A;C59)5QK>Z`_B%7-^;*)H0[2'_H*3O</SPGYT
MX+T"LN8JH.2):LXV`""(H!PD3)PB(1A>5[G@*QJ):P6LIV0D5*.,+D2TM+V`
MD+R"L/&UY%Q$R&AZ-)XHK6D`(O<G;9$0@T$-<I4MX)ZP1OFLA"1"KG<@'(KA
M#?Q[[(<D)CQU.55<MY(0EWELB8;03".(XM>]%)7E9"$_\DM:2B<%*7$G\-D(
M8*@=+T104-["!<J([R61$2',-841[RQS$%]D(1B1`[B3RO7I4M/,<K(0+<QJ
M@&YJ`H%**K[(0!X4JXK>5!"M>G8#9"(HY4O[`D5Y5@;9XXF&0X$%6L"DEJM:
M&-YOLB(`%!XQ]1?P0H"A)YV0@5Y>O*$+](JH!0^>R$'B#25`,3D:U7A7I9$P
M@Z]./'@$5".H)Y;(1)253Q("U6.O7E9"$$+FDJ&(&*T`/:+(0[D/(A87$M()
M)`9Y[(B!!V,Y-#(7M(\5HZ8F((0MY1JM#6-X%1>CK3")W>JA#`JDN*`$$D)^
M*R(A,Z6E7$-(:UH5JK^&R)@5B`<WM>26L8>-UD1!U*PE;O5)0*'@Q<!9"`!&
ME6O`8'GUNHIRY=MD(9N"E6,8BJR\JSRV0A%'M#&W`D(PHT-9V61,-K0$:>H*
MC'CU5/#SV0A/8UI>07L**TH`+^/?9"$0?5"(J,5I8QO:\V0AN155R(JK<P(2
M0ED("J`NX$$!%+S<BDV0@Z@]!TN]4=*\5X]UD1'_T[?W7Q)NMW."`^P$.X36
M00X?^\]G"-0ITD'6?%%TABE[[?<_"Z@>38Z)[_,.7,P@Y>X!E-(,ISQELGRQ
M\(\0Z:B-ZJR;+CWJ\>^5CVMLIX3VRC7LDQ1%<7_S!VCE;;W:-Q=2?]28`_5Q
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MKANE=]0\]/7#9Q\QM&Z5'O/Z,.N(W6M^H^>GK@)A;^`KR3C9NE1[S^C#KANM
M=]1\]/7"9Q\Q\_=9NE1[S^C#KANM=C_T/GIZX/#Q5.1'/OLW2H]Y_1AUQ.Z5
MWU#ST]</PJP\;BS\=IW2H]Y_1AUQ&Z5OU'ST]<"PHB^;\5FZ5'O1Z,.N)W2N
M^H^>GKA$P\;^!X>6S=*CWG]&'7$;I7?4//3UP>'\KN2S=*C9_F?T8=<3NM;]
M0\]/7`.GCYCP7A:-TJ/>?T8=<-TKOJ/GIZX%A+CR:"^S=*CWG]&'7$;I7?4?
M/3UP+";^]"$=:=TJ/>CT8=<3NE=/^X^>GK@\/'N0_CLW2I]Y_1AUQ&ZUWU#S
MT]<'A<OF+/)9NE1[T>C#KANE=]0P_EIZX"8>*=QXMLW2H]Y_1AUPW2N^H^>G
MK@6$%_D!N54M&Z5'O/Z,.N)W2N^H>>GK@6%']K#=9NE1[S^C#KANE=]0\]/7
M`L''R`_?%FZ5'O/Z,.N&Z5WU'ST]<"P\>;B[G9NE1[S^C#KANE=]0\]/7`L+
M&W\"WE:=TJ/>?T8=<-TKOJ'GIZX%AX\W%WW"S=*CWG]&'7$;I7?4//3UP'IX
MIV@_<RT;I4>\_HPZX;I7?4?/3UP,XKW%X\]FZU'O1Z,.N)W6M^H^>GK@6'CW
M(1QXV;I4>\_HPZX;I7?4//3UP`PN5?*_DZT[I4>\_HPZXC=*[ZCYZ>N!83?Y
MCZ+1NE1[T>C#KANE=]0\]/7!X2Q?,76;K4>\_HPZX;I6_4?/3UP>'B_E_(+-
MTJ/>?T8=<-UKOJ'GIZX/#Q[7^=C+3NE1[S^C#KANE=]1\]/7`##Q\Q[/OVC=
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MAX^:R.1BCA`B&%`O2/LW0]1J$6&A%':*!3?<MR*JQU)EE$I@4*ACR@$@'`$C
M&/B36%/83=ZW>[Q7A?>KG*C9(GF^237)/@F`2-LC&%8:8V@,37#<@8E8#M7T
MMA"_TOUQHB1W6R;-3JG>WIV:WS_^8]_@(U^KIM);NB=[N,I<E$S[0BK\,;1?
MMPW(?Z6-+"/_`!BBUSO.J?4MN^VO?X",'NG#WW@NDO\`Q[7M.'\,;15_MPW(
M(I_A8TKX<?UQ4LWG5/J6W?;7O9\-TX>>\%T^[VO:<`IC:+]M^Y!Q_A8TLY+_
M`!BV;SJGU+;OMKWL^&Z<//>"Z?=[7M.`TQM%:FN&X]X_A8TM1+_XQ76;SJGU
M+;OMKWL^)W3AYA_J"Z?=[7M.$*8VC-_3AN0Y?LL:6#L7]L4WV;SJGU+;OMKW
ML^(W3AY[P73[O:]IP_AC:*K-<-R'^EC2Q_)=XJHMF\ZI]2V[[:]_@(&DX>>\
M%T^[VO:<!IC:-]M^Y!$*?LL:6HK?\8O;9O.J?4MN^VO>SX;IP\]X+I/_`,>U
M[3@^&-HJMUOW((S^%C2Q77IO%1//9O.J?4MN^VO>SX"DX>^\%T^[VO:<`IC:
M,G]N&Y!%_NL:6<0[]L5Z6;SJKU+;OMKWL^&Z</)__8+I]WM>TX#3&T5&:X;D
M'C^%C2SFX?KBJEF\ZI]2V[[:]_@(;IP]]X+I]WM>TX?PQM%^V_<@ER;6=+.?
M'>)^.S>=4^I;=/\`^:][/B=TX>^\%TE_X]KVG"^&-HOVX;D4_P`K&E?/_&+9
MO.J?4MN^VO>SXC=.'GO!=/N]KVG!\,;15_MOW(_Z6=*S_P#N(+-YU3ZEMWVU
M[V?#=.'OO!=/N]KVG`:8VC?;AN0_TL:5O2_]L53SM.\ZI]2V[[:][/ANG#SW
M@NGW>U[3@%,;14_MOW(*@_A8TL16.7>*UMHWG5/J6W?;7O\``1.Z</?>"Z?=
M[7M.#X8VC_;AN02_]EC2O_\`L5%LWG5/J6W?;7O9\0*3A[[P73[O:]IP?#&T
M9!^G#<A_I8TM^_O%LWG5/J6W?;7O9\-TX>8_Z@NGW>U[3@^&-HJ#].&Y!>6U
MC2SN4'>*GDM.\ZJ]2V[[:]_@(;IP\]X+I]WM>TX8IC:*O]M^Y!.>UG2SO5-X
MB]EHWG5/J6W?;7O9\-TX>^\%T^[VO:<+X8VC,77#<?W;6-+/O[Q76;SJGU+;
MOMKWL^&Z</?>"Z?=[7M.#X8VB_;?N01K]K&EG!CMXO&S>=4^I;=]M>]GPW3A
M[[P73[O:]IPOAC:-]N&Y#_2QI9Q/^,7A9O.J?4MN^VO>SX;IP]]X+I]WM>TX
ME\,;16_IPW'O9^RQI:Y.>\5"WC9O.J?4MN^VO>SXG=.'GO!=/N]KVG"%,;15
M/Z<-R'+]EC2QZ_YQ4-F\ZJ]2V[[:]_@(C=.'F/\`J"Z?=[7M.#X8VBK_`&X;
MD$4?PL:6(]O\8I*6;SJGU+;OMKWL^)W3A[[P73[O:]IP_AC:+]M^Y"Y$VL:5
MN2_]L5]F\ZI]2V[[:]_@(C=.'OO!=/N]KVG`*8VBH%UPW(/_`+K&EG+CO%(L
MWG5/J6W?;7O9\-TX>>\%T^[VO:<'PQM%^W#<@BW;6-+5_P#&*@'GLWG5/J2W
M?;7O9\-TX>\FH+I]WM>TX/AC:+]N&Y![4VL:6\.>\7C9O.J?4MN^VO>SX;IP
M\]X+I]WM>TX/AC:*G]N&X]S/V6-+5Y+^V*CON6S>=4^I;=]M>]GPW3AY[P73
M[O:]IPC3&T5GZ<-R#@[:QI9YUWBV;SJGU+;OMKWL^&Z</?>"Z?=[7M.#X8VC
M-_3AN0>?X6-*^!O_`%Q2%LWG5/J6W?;7O9\-TX>X?Z@NGW>U[3AFF-HOVW[D
M.7[+&EG`/_;%X_<EF\ZI]2V[[:][/B32</,?]073[O:]IPOAC:+]M^Y!]VUC
M2Q;G`[Q3^&S>=4^I;=]M>]GQ&Z<//>"Z?=[7M.#X8VBWZW[D.?[+&E??_&*Z
MS>=4^I;=]M>]GPW3A[[P73[O:]IP_AC:+]M^Y#UO[K&EBW?XQ>E%LWG5/J6W
M?;7O9\3NG#V7_P!@NGW>U[3@^&-HMVM^X]4NVL:6K<A"[Q+-YU3ZEMWVU[_`
M0-)P\]X+I]WM>TX7PQM%^W#<@\NVL:6=R+O%4"S>=4^I;=]M>]GQ&Z<//>"Z
M?=[7M.%\,;1;M<-R%_\`"QI:MUPWBI9O.J?4EN^VO>SX;IP\]X+I]WM>TX?P
MQM%^W#<>Z_:QI86]V\4?@LWG5/J6W?;7O9\-TX>^\%T^[VO:<!IC:*I37#<@
MYB[6-+/-^V+PLWG5/J6W?;7O\!$FDX>^\%T^[VO:</X8VBH/TW[C[_X6-+5<
M?\8J/=9O.J?4MN^VO>SX;IP\]X+I]WM>TX0IC:*U=;]R%W\+&EB_^,1'6;SJ
MGU+;OMKWL^(W3A[[P73[O:]IP"F-HS?TW[D'-_98TL?>[>*P.LWG5/J6W?;7
MO9\-TX>8?Z@NGW>U[3@%,;14;K?N0?\`W6-+!Q_QBFY+-YU5ZEMWVU[_``$-
MTX>>\%T^[VO:<+X8VB_;AN0_TL:5N3_.*^S>=4^I;=]M>]GPW3A[[P73[O:]
$IQ__V3\_
`
end
</TEXT>
</DOCUMENT>
</SUBMISSION>
